|
|
| Line 9: |
Line 9: |
| | !width="50"|Mesh Ontology | | !width="50"|Mesh Ontology |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289501 HSALNT0289501] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267755 HSALNT0267755] |
| − | |[[HPVC1]] | + | |[[LINC02597]] |
| − | |PE5L,HPV18E5L | + | |Transcriptional regulation |
| − | |NA
| + | |Pathogenic process |
| − | |pathogenic process
| + | |Postmenopausal osteoporosis (PMOP) |
| − | |NA
| + | |Musculoskeletal Diseases |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289605 HSALNT0289605]
| |
| − | |[[NONHSAT104559]]
| |
| − | |lnc-C9orf53-2:1
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0199632 HSALNT0199632]
| |
| − | |[[N4BP2L2-IT2]]
| |
| − | |CG030
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0171094 HSALNT0171094]
| |
| − | |[[LINC01150]]
| |
| − | |2G7,TCONS_00019134
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Wilms' tumor
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289115 HSALNT0289115]
| |
| − | |[[LINC01587]]
| |
| − | |C4orf6,aC1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |neuroblastoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290105 HSALNT0290105]
| |
| − | |[[NONHSAT115106]]
| |
| − | |NONHSAT115106
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289234 HSALNT0289234]
| |
| − | |[[RNF217-AS1]]
| |
| − | |STL
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |acute lymphoblastic leukemia
| |
| − | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0280481 HSALNT0280481]
| |
| − | |[[INE2]]
| |
| − | |NCRNA00011
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289485 HSALNT0289485]
| |
| − | |[[INE1]]
| |
| − | |NCRNA00010
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289511 HSALNT0289511]
| |
| − | |[[LINC01565]]
| |
| − | |C3orf27,GR6
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |leukemia
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289068 HSALNT0289068]
| |
| − | |[[LINC00869]]
| |
| − | |KIAA0493
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289430 HSALNT0289430]
| |
| − | |[[ERC2-IT1]]
| |
| − | |C1orf1,C3orf51,Po42
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290394 HSALNT0290394]
| |
| − | |[[Lnc-PDIA4-1:1]]
| |
| − | |lnc-PDIA4-1:1
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289195 HSALNT0289195]
| |
| − | |[[NOP14-AS1]]
| |
| − | |C4orf10,RES4-24
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290309 HSALNT0290309]
| |
| − | |[[NONHSAT022116]]
| |
| − | |NONHSAT022116,AF080092,TSU
| |
| − | |NA
| |
| − | |developmental process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289243 HSALNT0289243]
| |
| − | |[[SMAD5-AS1]]
| |
| − | |SMAD5O,DAMS
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |malignant hematopoietic
| |
| − | |Cell Physiological Phenomena
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289025 HSALNT0289025]
| |
| − | |[[LINC00244]]
| |
| − | |C7orf4,NCRNA00244
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |preaxial polydactyly
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289017 HSALNT0289017]
| |
| − | |[[KIF25-AS1]]
| |
| − | |C6orf54,NCRNA00300,HGC6.1.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ovarian cancer
| |
| − | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289332 HSALNT0289332]
| |
| − | |[[LINC01558]]
| |
| − | |C6orf123,LINC01557,HGC6.2,dJ431P23.4
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ovarian cancer
| |
| − | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289438 HSALNT0289438]
| |
| − | |[[AFDN-AS1]]
| |
| − | |C6orf124,MLLT4-AS1,HGC6.4,dJ431P23.3
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289232 HSALNT0289232]
| |
| − | |[[RFPL3S]]
| |
| − | |RFPL3-AS1,RFPL3-A, NCRNA00005
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |opitz syndrome
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289393 HSALNT0289393]
| |
| − | |[[RFPL1S]]
| |
| − | |RFPL1-AS1,RFPL1-A, NCRNA00006
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289500 HSALNT0289500]
| |
| − | |[[HCG4B]]
| |
| − | |HCG4P6,HCGIV-6,HCGIV.5,HCGIV-06,bCX67J3.3,Em:AB023056.16,bPG309N1.1,bQB90C11.3
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289894 HSALNT0289894]
| |
| − | |[[LINC00294]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289345 HSALNT0289345]
| |
| − | |[[LINC00893]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hunter syndrome
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290133 HSALNT0290133]
| |
| − | |[[PCBP3-OT1]]
| |
| − | |PCBP3-OT1,FLJ44028
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289488 HSALNT0289488]
| |
| − | |[[ENST00000418282.1]]
| |
| − | |NCRNA00187
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |blepharophimosis syndrome
| |
| − | |Eye Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289712 HSALNT0289712]
| |
| − | |[[COPG2IT1]]
| |
| − | |CIT1,NCRNA00170,COPG2AS
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0265040 HSALNT0265040]
| |
| − | |[[LINC00652]]
| |
| − | |HSPC072
| |
| − | |NA
| |
| − | |developmental process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289282 HSALNT0289282]
| |
| − | |[[WASIR2]]
| |
| − | |NCRNA00286A
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0246856 HSALNT0246856]
| |
| − | |[[LINC00470]]
| |
| − | |C18orf2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |age-related macular degeneration
| |
| − | |Eye Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289507 HSALNT0289507]
| |
| − | |[[LINC00588]]
| |
| − | |C8orf71,DKFZP434F122
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0276604 HSALNT0276604]
| |
| − | |[[TTC28-AS1]]
| |
| − | |TTC28AS,TTC28-AS,KIAA1648
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0237577 HSALNT0237577]
| |
| − | |[[CDRT7]]
| |
| − | |NCRNA00025,LINC00025
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288912 HSALNT0288912]
| |
| − | |[[CDRT8]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275048 HSALNT0275048]
| |
| − | |[[CECR3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cat eye syndrome
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288915 HSALNT0288915]
| |
| − | |[[CECR9]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cat eye syndrome
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288998 HSALNT0288998]
| |
| − | |[[HDHD5-AS1]]
| |
| − | |CECR4,CECR5-AS1,NCRNA00017
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cat eye syndrome
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288914 HSALNT0288914]
| |
| − | |[[CECR5-AS1]]
| |
| − | |NCRNA00017
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cat eye syndrome
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288919 HSALNT0288919]
| |
| − | |[[CLRN1-AS1]]
| |
| − | |CLRN1O,UCRP
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |usher syndrome type 3
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289271 HSALNT0289271]
| |
| − | |[[TMEM9B-AS1]]
| |
| − | |C11orf18
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289324 HSALNT0289324]
| |
| − | |[[LINC01547]]
| |
| − | |C21orf69,C21orf67
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Down syndrome
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0270409 HSALNT0270409]
| |
| − | |[[LINC00029]]
| |
| − | |C20orf51,NCRNA00029,bA305P22.4
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289336 HSALNT0289336]
| |
| − | |[[LINC00529]]
| |
| − | |C8orf8
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |keratolytic winter erythema
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288978 HSALNT0288978]
| |
| − | |[[FLVCR1-AS1]]
| |
| − | |FLVCR1-DT,LQK1
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0238050 HSALNT0238050]
| |
| − | |[[SMCR2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Smith-Magenis syndrome
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289401 HSALNT0289401]
| |
| − | |[[SMCR5]]
| |
| − | |NCRNA00034
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Smith-Magenis syndrome
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290246 HSALNT0290246]
| |
| − | |[[SMCR6]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Smith-Magenis syndrome
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274626 HSALNT0274626]
| |
| − | |[[LINC00205]]
| |
| − | |C21orf86,NCRNA00205,
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271512 HSALNT0271512]
| |
| − | |[[C21orf91-OT1]]
| |
| − | |NCRNA00285,D21S2089E
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0272596 HSALNT0272596]
| |
| − | |[[LINC00307]]
| |
| − | |NCRNA00307,D21S2091E
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274502 HSALNT0274502]
| |
| − | |[[TSPEAR-AS2]]
| |
| − | |C21orf90
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274807 HSALNT0274807]
| |
| − | |[[MCM3AP-AS1]]
| |
| − | |C21orf85,MCM3APAS,MCM3AP-AS,FLJ10508,NCRNA00031
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288888 HSALNT0288888]
| |
| − | |[[B3GALT5-AS1]]
| |
| − | |C21orf88
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288898 HSALNT0288898]
| |
| − | |[[BRWD1-AS2]]
| |
| − | |C21orf87,NCRNA00257,BRWD1-IT2
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289031 HSALNT0289031]
| |
| − | |[[LINC00315]]
| |
| − | |C21orf93,NCRNA00315
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289033 HSALNT0289033]
| |
| − | |[[LINC00334]]
| |
| − | |C21orf89,NCRNA00334
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289322 HSALNT0289322]
| |
| − | |[[LINC00314]]
| |
| − | |C21orf94,NCRNA00314
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271821 HSALNT0271821]
| |
| − | |[[LINC00308]]
| |
| − | |C21orf74,NCRNA00308,PRED16
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289023 HSALNT0289023]
| |
| − | |[[LINC00189]]
| |
| − | |C21orf109,NCRNA00189
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289375 HSALNT0289375]
| |
| − | |[[NCRUPAR]]
| |
| − | |ncR-uPAR,ncRuPAR,NCRNA00193
| |
| − | |transcriptional regulation
| |
| − | |developmental process | |
| − | |NA | |
| − | |NA | |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273467 HSALNT0273467]
| |
| − | |[[DSCR10]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289480 HSALNT0289480]
| |
| − | |[[DSCR9]]
| |
| − | |NCRNA00038
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290051 HSALNT0290051]
| |
| − | |[[MDS2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |myelodysplastic syndrome
| |
| − | |Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127810 HSALNT0127810]
| |
| − | |[[ST7-AS2]]
| |
| − | |ST7OT2,ST7AS2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |autism
| |
| − | |Mental Disorders
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127813 HSALNT0127813]
| |
| − | |[[ST7-OT3]]
| |
| − | |ST7OT3,NCRNA00026
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |autism
| |
| − | |Mental Disorders
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290258 HSALNT0290258]
| |
| − | |[[ST7-OT4]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |autism
| |
| − | |Mental Disorders
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290257 HSALNT0290257]
| |
| − | |[[NONHSAT122926]]
| |
| − | |NONHSAT122926
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289372 HSALNT0289372]
| |
| − | |[[MIR600HG]]
| |
| − | |C9orf45,NCRNA00287,GL012,FLJ22161
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0013239 HSALNT0013239]
| |
| − | |[[ATP1A1-AS1]]
| |
| − | |C1orf203,ATP1A1OS,MGC16179
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0048563 HSALNT0048563]
| |
| − | |[[SPATA3-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0050859 HSALNT0050859]
| |
| − | |[[LINC00852]]
| |
| − | |C3orf42,GHRLOS2,NAG73,GHRL-AS2
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0069395 HSALNT0069395]
| |
| − | |[[LINC01096]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072367 HSALNT0072367]
| |
| − | |[[LINC02260]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0077259 HSALNT0077259]
| |
| − | |[[LINC01091]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0096480 HSALNT0096480]
| |
| − | |[[SAP30L-AS1]]
| |
| − | |FLJ38109,GALNT10-AS1
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0098558 HSALNT0098558]
| |
| − | |[[PRR7-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0099356 HSALNT0099356]
| |
| − | |[[LINC01622]]
| |
| − | |TCONS_00011202
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0113415 HSALNT0113415]
| |
| − | |[[LINC01312]]
| |
| − | |MGC34034
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0134652 HSALNT0134652]
| |
| − | |[[EXTL3-AS1]]
| |
| − | |C8orf50
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0138253 HSALNT0138253]
| |
| − | |[[C8orf34-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154876 HSALNT0154876]
| |
| − | |[[PSMD5-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0163228 HSALNT0163228]
| |
| − | |[[LINC01553]]
| |
| − | |C10orf40,AC023904.2
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0175689 HSALNT0175689]
| |
| − | |[[LINC00301]]
| |
| − | |C11orf64,NCRNA00301,MGC39681
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247235 HSALNT0247235]
| |
| − | |[[DLGAP1-AS3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0254200 HSALNT0254200]
| |
| − | |[[CIRBP-AS1]]
| |
| − | |C19orf23,MGC39338
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0257335 HSALNT0257335]
| |
| − | |[[LINC01785]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0261582 HSALNT0261582]
| |
| − | |[[LINC01869]]
| |
| − | |MGC45922
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0269743 HSALNT0269743]
| |
| − | |[[LINC01711]]
| |
| − | |MGC4294
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288468 HSALNT0288468]
| |
| − | |[[FAM41AY1]]
| |
| − | |FAM41AY
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288899 HSALNT0288899]
| |
| − | |[[C5orf66-AS2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288922 HSALNT0288922]
| |
| − | |[[CSTF3-AS1]]
| |
| − | |CSTF3-DT
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288923 HSALNT0288923]
| |
| − | |[[CYP1B1-AS1]]
| |
| − | |C2orf58,MGC34824
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288957 HSALNT0288957]
| |
| − | |[[ENTPD3-AS1]]
| |
| − | |FLJ36665
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288970 HSALNT0288970]
| |
| − | |[[FAM27E3]]
| |
| − | |MGC42630
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288972 HSALNT0288972]
| |
| − | |[[FAM41C]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288977 HSALNT0288977]
| |
| − | |[[FLG-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288983 HSALNT0288983]
| |
| − | |[[GABPB1-IT1]]
| |
| − | |FLJ10038
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289010 HSALNT0289010]
| |
| − | |[[ILF3-AS1]]
| |
| − | |ILF3-DT
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289034 HSALNT0289034]
| |
| − | |[[LINC00347]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289039 HSALNT0289039]
| |
| − | |[[LINC00466]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289040 HSALNT0289040]
| |
| − | |[[LINC00471]]
| |
| − | |C2orf52,MGC43122
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289044 HSALNT0289044]
| |
| − | |[[LINC00526]]
| |
| − | |C18orf18,MGC17515,HsT959
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289048 HSALNT0289048]
| |
| − | |[[LINC00593]]
| |
| − | |C15orf50,MGC42951
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289050 HSALNT0289050]
| |
| − | |[[LINC00608]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289054 HSALNT0289054]
| |
| − | |[[LINC00638]]
| |
| − | |MGC23270
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289056 HSALNT0289056]
| |
| − | |[[LINC00661]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289057 HSALNT0289057]
| |
| − | |[[LINC00662]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289062 HSALNT0289062]
| |
| − | |[[LINC00692]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289064 HSALNT0289064]
| |
| − | |[[LINC00705]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289067 HSALNT0289067]
| |
| − | |[[LINC00868]]
| |
| − | |C17orf52
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0130693 HSALNT0130693]
| |
| − | |[[LINC00996]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289101 HSALNT0289101]
| |
| − | |[[LINC01252]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289131 HSALNT0289131]
| |
| − | |[[LINC02135]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289193 HSALNT0289193]
| |
| − | |[[NIFK-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289244 HSALNT0289244]
| |
| − | |[[SMG7-AS1]]
| |
| − | |DKFZP564C196
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0235326 HSALNT0235326]
| |
| − | |[[SNAI3-AS1]]
| |
| − | |MGC23284
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0215205 HSALNT0215205]
| |
| − | |[[SNHG10]]
| |
| − | |C14orf62,FLJ40557,NCRNA00063,LINC00063
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289290 HSALNT0289290]
| |
| − | |[[ZNF205-AS1]]
| |
| − | |MGC3771
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289294 HSALNT0289294]
| |
| − | |[[LINC00260]]
| |
| − | |C1orf217,NCRNA00260,MGC5457
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289295 HSALNT0289295]
| |
| − | |[[LINC00337]]
| |
| − | |C1orf211,NCRNA00337,MGC40168
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289298 HSALNT0289298]
| |
| − | |[[WAC-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289299 HSALNT0289299]
| |
| − | |[[LINC00839]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289303 HSALNT0289303]
| |
| − | |[[LINC00612]]
| |
| − | |C12orf33,MGC40170,FLJ41814
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289312 HSALNT0289312]
| |
| − | |[[LINC00663]]
| |
| − | |MGC39821
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289320 HSALNT0289320]
| |
| − | |[[LINC00494]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289330 HSALNT0289330]
| |
| − | |[[LINC01019]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289333 HSALNT0289333]
| |
| − | |[[LINC00265]]
| |
| − | |NCRNA00265,NCRNA00265-1
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289334 HSALNT0289334]
| |
| − | |[[LINC00689]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289337 HSALNT0289337]
| |
| − | |[[LINC01591]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289340 HSALNT0289340]
| |
| − | |[[LINC01501]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289346 HSALNT0289346]
| |
| − | |[[LINC01560]]
| |
| − | |CXorf24
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289352 HSALNT0289352]
| |
| − | |[[LINC01959]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289353 HSALNT0289353]
| |
| − | |[[LINC02175]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289354 HSALNT0289354]
| |
| − | |[[LINC02209]]
| |
| − | |FAM183CP
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289359 HSALNT0289359]
| |
| − | |[[LINGO1-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289362 HSALNT0289362]
| |
| − | |[[MAFG-AS1]]
| |
| − | |MAFG-DT
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289373 HSALNT0289373]
| |
| − | |[[MORF4L2-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289381 HSALNT0289381]
| |
| − | |[[NPHP3-AS1]]
| |
| − | |NCRNA00119
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289385 HSALNT0289385]
| |
| − | |[[PAXIP1-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289413 HSALNT0289413]
| |
| − | |[[TOLLIP-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289416 HSALNT0289416]
| |
| − | |[[LINC00311]]
| |
| − | |TMEM148,NCRNA00311,MGC22001
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289422 HSALNT0289422]
| |
| − | |[[ZNF252P-AS1]]
| |
| − | |C8orf77
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289423 HSALNT0289423]
| |
| − | |[[ZNF436-AS1]]
| |
| − | |C1orf213,FLJ90508
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289429 HSALNT0289429]
| |
| − | |[[BFSP2-AS1]]
| |
| − | |MGC2848
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289432 HSALNT0289432]
| |
| − | |[[CTBP1-AS1]]
| |
| − | |C4orf42,CTBP1-DT,CTBP1-DT,MGC21675
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289436 HSALNT0289436]
| |
| − | |[[EXOC3-AS1]]
| |
| − | |C5orf55
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289441 HSALNT0289441]
| |
| − | |[[HCG27]]
| |
| − | |bPG299F13.9,bCX101P6.9,bQB115I13.2,FLJ40123
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289450 HSALNT0289450]
| |
| − | |[[BAALC-AS2]]
| |
| − | |C8orf56,BAALCOS,MGC39526
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289453 HSALNT0289453]
| |
| − | |[[FAM87A]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289459 HSALNT0289459]
| |
| − | |[[JMJD1C-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289465 HSALNT0289465]
| |
| − | |[[ATP2B1-AS1]]
| |
| − | |LINC00936
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289466 HSALNT0289466]
| |
| − | |[[CEP83-AS1]]
| |
| − | |CEP83-DT
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289470 HSALNT0289470]
| |
| − | |[[HEXA-AS1]]
| |
| − | |C15orf34,FLJ13315
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289487 HSALNT0289487]
| |
| − | |[[BIN3-IT1]]
| |
| − | |FLJ14107
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289490 HSALNT0289490]
| |
| − | |[[CSNK1G2-AS1]]
| |
| − | |C19orf34,MGC39696
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289508 HSALNT0289508]
| |
| − | |[[LINC00634]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289510 HSALNT0289510]
| |
| − | |[[LINC00685]]
| |
| − | |CXYorf10,NCRNA00107,PPP2R3B-AS1,OTTHUMT00000055574
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289515 HSALNT0289515]
| |
| − | |[[SHANK2-AS3]]
| |
| − | |C11orf76
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290073 HSALNT0290073]
| |
| − | |[[NCBP2-AS2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289502 HSALNT0289502]
| |
| − | |[[NONHSAT095745]]
| |
| − | |NCRNA00099,UM9-5
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289856 HSALNT0289856]
| |
| − | |[[GTSCR1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Gilles de la Tourette syndrome
| |
| − | |Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289325 HSALNT0289325]
| |
| − | |[[LINC00272]]
| |
| − | |C1orf120,NCRNA00272,RP1-223H12.3
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288512 HSALNT0288512]
| |
| − | |[[TTTY9B]]
| |
| − | |NCRNA00132
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290155 HSALNT0290155]
| |
| − | |[[Prion-associated RNAs]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prion disease
| |
| − | |Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289444 HSALNT0289444]
| |
| − | |[[BLACE]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |acute B lymphoblastic leukemias
| |
| − | |Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0060411 HSALNT0060411]
| |
| − | |[[H1FX-AS1]]
| |
| − | |C3orf47,FLJ34151
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0186668 HSALNT0186668]
| |
| − | |[[LINC00477]]
| |
| − | |C12orf67,FLJ32894,FAM191B
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275096 HSALNT0275096]
| |
| − | |[[LINC00528]]
| |
| − | |C22orf37,FLJ40542
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287824 HSALNT0287824]
| |
| − | |[[ASMTL-AS1]]
| |
| − | |CXYorf2,NCRNA00105,ASMTLAS,ASMTL-AS,FLJ13330
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288887 HSALNT0288887]
| |
| − | |[[ANP32A-IT1]]
| |
| − | |C15orf28,NCRNA00321,FLJ11722,HsT18971
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289370 HSALNT0289370]
| |
| − | |[[MIR29B2CHG]]
| |
| − | |C1orf132,FLJ35650
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289396 HSALNT0289396]
| |
| − | |[[RUSC1-AS1]]
| |
| − | |C1orf104,FLJ35976
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0084628 HSALNT0084628]
| |
| − | |[[LINC01194]]
| |
| − | |CT49,TAG
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |melanoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289468 HSALNT0289468]
| |
| − | |[[NONHSAT040032]]
| |
| − | |C14orf134,NCRNA00041,DIO3-AS1,NONHSAT040032,NONHSAT040039,BC111049
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0121060 HSALNT0121060]
| |
| − | |[[NPSR1-AS1]]
| |
| − | |AAA1,IMAGE:4827585
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0074370 HSALNT0074370]
| |
| − | |[[LINC00575]]
| |
| − | |C4orf11
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0137345 HSALNT0137345]
| |
| − | |[[LINC01602]]
| |
| − | |T1560
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289433 HSALNT0289433]
| |
| − | |[[FAM13A-AS1]]
| |
| − | |FAM13A1OS,FAM13AOS,NCRNA00039
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289186 HSALNT0289186]
| |
| − | |[[MIRLET7DHG]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0155254 HSALNT0155254]
| |
| − | |[[MIR181A2HG]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289283 HSALNT0289283]
| |
| − | |[[WDFY3-AS2]]
| |
| − | |C4orf12,NCRNA00247,FBI4
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154555 HSALNT0154555]
| |
| − | |[[PAPPA-AS1]]
| |
| − | |PAPPAS,PAPPA-AS,DIPAS,TAF4B,TAF2C2,TAFII105,NCRNA00156
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0136307 HSALNT0136307]
| |
| − | |[[LINC00293]]
| |
| − | |BEYLA
| |
| − | |NA
| |
| − | |developmental process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030983 HSALNT0030983]
| |
| − | |[[SIX3-AS1]]
| |
| − | |SIX3OS
| |
| − | |NA
| |
| − | |developmental process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211503 HSALNT0211503]
| |
| − | |[[Lnc-C14orf101-5:1]]
| |
| − | |OTX2OS1
| |
| − | |NA
| |
| − | |developmental process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0063422 HSALNT0063422]
| |
| − | |[[LINC01192]]
| |
| − | |CT64
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217123 HSALNT0217123]
| |
| − | |[[LINC01193]]
| |
| − | |CT60,LOC348120
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289664 HSALNT0289664]
| |
| − | |[[C1QTNF9B-AS1]]
| |
| − | |PCOTH
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289623 HSALNT0289623]
| |
| − | |[[ATP6V1G2-DDX39B]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |dilated cardiomyopathy
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289498 HSALNT0289498]
| |
| − | |[[FAM226B]]
| |
| − | |CXorf50B,NCRNA00246B,LINC00246B
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289321 HSALNT0289321]
| |
| − | |[[LINC00163]]
| |
| − | |C21orf134,NCRNA00163,NLC1-A,NLC1A
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |narcolepsy
| |
| − | |Mental Disorders;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289505 HSALNT0289505]
| |
| − | |[[LINC00165]]
| |
| − | |C21orf135,NCRNA00165,NLC1-B
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290297 HSALNT0290297]
| |
| − | |[[NONHSAT035776]]
| |
| − | |ENSG00000251002
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274212 HSALNT0274212]
| |
| − | |[[LINC00322]]
| |
| − | |C21orf136,NCRNA00322,FLJ16545
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289741 HSALNT0289741]
| |
| − | |[[NONHSAT102417]]
| |
| − | |DHFR minor transcript 5'-UTR,ENSG00000228716,NONHSAT102417
| |
| − | |transcriptional regulation
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289527 HSALNT0289527]
| |
| − | |[[NONHSAT128494]]
| |
| − | |ncRNA 21A,NONHSAT128494
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289409 HSALNT0289409]
| |
| − | |[[TLX1NB]]
| |
| − | |TD1,TDI,APT-B7
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |leukemogenesis
| |
| − | |Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289662 HSALNT0289662]
| |
| − | |[[C15orf2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Angelman syndrome
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290097 HSALNT0290097]
| |
| − | |[[NPAP1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Angelman syndrome
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217406 HSALNT0217406]
| |
| − | |[[NONHSAT040875]]
| |
| − | |NCRNA00199
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Prader-Willi syndrome
| |
| − | |Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289227 HSALNT0289227]
| |
| − | |[[NONHSAT040920]]
| |
| − | |NCRNA00198
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Prader-Willi syndrome
| |
| − | |Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262816 HSALNT0262816]
| |
| − | |[[MIMT1]]
| |
| − | |MIM1,NCRNA00067,LINC00067
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289180 HSALNT0289180]
| |
| − | |[[MIR34AHG]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289357 HSALNT0289357]
| |
| − | |[[LINC02570]]
| |
| − | |XXbac-BPG27H4.8
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |MHC-associated diseases
| |
| − | |Immune System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290177 HSALNT0290177]
| |
| − | |[[RNY1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cervix cancer;prostate cancer;colorectal cancer;bladder cancer;kidney cancer;lung cancer
| |
| − | |Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289378 HSALNT0289378]
| |
| − | |[[NKX2-2-AS1]]
| |
| − | |NKX2-2AS
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290151 HSALNT0290151]
| |
| − | |[[NONHSAT023851]]
| |
| − | |FJ515872.1,NONHSAT023851
| |
| − | |transcriptional regulation
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0180290 HSALNT0180290]
| |
| − | |[[PGR-AS1,PR antisense transcripts]]
| |
| − | |AT1,AT2,AT3
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289607 HSALNT0289607]
| |
| − | |[[Anti-NOS2A]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |meningioma;glioblastoma
| |
| − | |Neoplasms;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289687 HSALNT0289687]
| |
| − | |[[CDKN1A-AS1]]
| |
| − | |p21NAT
| |
| − | |transcriptional regulation
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289166 HSALNT0289166]
| |
| − | |[[ENST00000553584.1]]
| |
| − | |LINC00584
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0116668 HSALNT0116668]
| |
| − | |[[RPS6KA2-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289384 HSALNT0289384]
| |
| − | |[[PAPPA-AS2]]
| |
| − | |AGU1
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262802 HSALNT0262802]
| |
| − | |[[ZIM2-AS1]]
| |
| − | |ZIM2as
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289824 HSALNT0289824]
| |
| − | |[[Lnc-DLX5-3:1]]
| |
| − | |Evf-2,Dlx6as1,Dlx6os1,ENSG00000231764, ENST00000430027.2,lnc-DLX5-3:1
| |
| − | |transcriptional regulation
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289481 HSALNT0289481]
| |
| − | |[[ADORA2A-AS1]]
| |
| − | |C22orf45,FLJ34651
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290146 HSALNT0290146]
| |
| − | |[[POU5F1P4]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290033 HSALNT0290033]
| |
| − | |[[LSINCT1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer;breast cancer
| |
| − | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290034 HSALNT0290034]
| |
| − | |[[LSINCT10]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer;breast cancer
| |
| − | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290035 HSALNT0290035]
| |
| − | |[[LSINCT11]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer;breast cancer
| |
| − | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290036 HSALNT0290036]
| |
| − | |[[LSINCT12]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer;breast cancer
| |
| − | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290037 HSALNT0290037]
| |
| − | |[[LSINCT2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer;breast cancer
| |
| − | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290038 HSALNT0290038]
| |
| − | |[[LSINCT3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer;breast cancer
| |
| − | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290039 HSALNT0290039]
| |
| − | |[[LSINCT4]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer;breast cancer
| |
| − | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290041 HSALNT0290041]
| |
| − | |[[LSINCT6]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer;breast cancer
| |
| − | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290042 HSALNT0290042]
| |
| − | |[[LSINCT7]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer;breast cancer
| |
| − | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290043 HSALNT0290043]
| |
| − | |[[LSINCT8]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer;breast cancer
| |
| − | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290044 HSALNT0290044]
| |
| − | |[[LSINCT9]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer;breast cancer
| |
| − | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289676 HSALNT0289676]
| |
| − | |[[NONHSAT016928]]
| |
| − | |FLJ31066,NONHSAT016928,lnc-FANK1-3:1
| |
| − | |transcriptional regulation
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290032 HSALNT0290032]
| |
| − | |[[LRRC3DN]]
| |
| − | |C21orf30,DKFZP434C128
| |
| − | |transcriptional regulation
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266984 HSALNT0266984]
| |
| − | |[[SNHG11]]
| |
| − | |C20orf198,LINC00101,NCRNA00101
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |obesity
| |
| − | |Nutritional and Metabolic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289880 HSALNT0289880]
| |
| − | |[[NONHSAT113225]]
| |
| − | |NONHSAT113225,ENSG00000220635
| |
| − | |ceRNA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0006368 HSALNT0006368] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0178412 HSALNT0178412] |
| − | |[[ENST00000444042.2]] | + | |[[UVRAG-DT]] |
| − | |ncRNA-a3
| + | |Transcriptional regulation |
| − | |transcriptional regulation
| + | |Pathogenic process |
| − | |NA
| + | |Postmenopausal osteoporosis (PMOP) |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027470 HSALNT0027470]
| |
| − | |[[ENST00000417473.2]]
| |
| − | |ncRNA-a5 | |
| − | |transcriptional regulation
| |
| − | |NA | |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289066 HSALNT0289066]
| |
| − | |[[ENST00000429328.2]]
| |
| − | |PDZK1IP1-AS1,ncRNA-a4
| |
| − | |transcriptional regulation
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289936 HSALNT0289936]
| |
| − | |[[NONHSAT059436]]
| |
| − | |ROR,lincRNA-ST8SIA3,ENSG00000258609,NONHSAT059436
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289705 HSALNT0289705]
| |
| − | |[[CHL1-AS2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |adolescent idiopathic scoliosis | |
| | |Musculoskeletal Diseases | | |Musculoskeletal Diseases |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0076084 HSALNT0076084] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0185540 HSALNT0185540] |
| − | |[[SEC24B-AS1]] | + | |[[LINC02598]] |
| − | |1/2-SBSRNA4 | + | |_ |
| − | |siRNA | + | |Pathogenic process |
| − | |NA
| + | |Lung squamous cell carcinoma (LUSC) |
| − | |NA
| + | |Neoplasms; Respiratory Tract Diseases |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290137 HSALNT0290137]
| |
| − | |[[PDZRN3-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |type 2 diabetes
| |
| − | |Nutritional and Metabolic Diseases;Endocrine System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290237 HSALNT0290237]
| |
| − | |[[SCAANT1]]
| |
| − | |ATXN7-AS1
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |spinocerebellar ataxia | |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289594 HSALNT0289594] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0278274 HSALNT0278274] |
| − | |[[AK123790]] | + | |[[SREBF2-AS1]] |
| − | |NA | + | |_ |
| − | |NA | + | |Pathogenic process |
| − | |pathogenic process
| + | |Lung squamous cell carcinoma (LUSC) |
| − | |hepatocelluar cancer | + | |Neoplasms; Respiratory Tract Diseases |
| − | |Neoplasms;Digestive System Diseases | |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289911 HSALNT0289911] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0021177 HSALNT0021177] |
| − | |[[LINC01451]] | + | |[[LINC02602]] |
| − | |NA | + | |_ |
| − | |NA | + | |Pathogenic process |
| − | |pathogenic process
| + | |Non-small cell lung cancer (NSCLC) |
| − | |hepatocelluar cancer | + | |Neoplasms; Respiratory Tract Diseases |
| − | |Neoplasms;Digestive System Diseases | |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290401 HSALNT0290401] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0021052 HSALNT0021052] |
| − | |[[ZNF350-AS1]] | + | |[[MIR205HG]] |
| − | |NA | + | |CeRNA |
| − | |NA | + | |Pathogenic process |
| − | |pathogenic process
| + | |Head & neck squamous cell carcinoma (HNSCC) |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289845 HSALNT0289845]
| |
| − | |[[GADD45G]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |pituitary adenoma
| |
| − | |Endocrine System Diseases;Neoplasms;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289410 HSALNT0289410]
| |
| − | |[[Lnc-RASA1-3:23]]
| |
| − | |AK082072,linc-POLR3G-8,ENSG00000247828
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289736 HSALNT0289736]
| |
| − | |[[DAPK1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Pancreatic ductal adenocarcinoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290048 HSALNT0290048]
| |
| − | |[[MAP3K14]]
| |
| − | |MAP3K14
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Pancreatic ductal adenocarcinoma | |
| | |Neoplasms | | |Neoplasms |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290150 HSALNT0290150] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0107588 HSALNT0107588] |
| − | |[[PPP3CB]] | + | |[[ZNF451-AS1]] |
| − | |NA | + | |Transcriptional regulation |
| − | |NA | + | |Pathogenic process |
| − | |pathogenic process
| + | |Pancreatic ductal adenocarcinoma (PDAC) |
| − | |Pancreatic ductal adenocarcinoma | |
| | |Neoplasms | | |Neoplasms |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0151531 HSALNT0151531] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189537 HSALNT0189537] |
| − | |[[DAPK1-IT1]] | + | |[[SCAT2]] |
| − | |NA | + | |_ |
| − | |NA | + | |Pathogenic process |
| − | |pathogenic process
| + | |Kidney clear cell carcinoma (KIRC) |
| − | |NA | + | |Neoplasm |
| − | |NA | |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288990 HSALNT0288990] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0107867 HSALNT0107867] |
| − | |[[GDNF-AS1]] | + | |[[SCAT8]] |
| − | |GDNFOS | + | |_ |
| − | |transcriptional regulation | + | |Pathogenic process |
| − | |pathogenic process
| + | |Kidney clear cell carcinoma (KIRC) |
| − | |Alzheimer's disease | + | |Neoplasm |
| − | |Mental Disorders;Nervous System Diseases | |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029702 HSALNT0029702] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0158500 HSALNT0158500] |
| − | |[[BIRC6-AS2]] | + | |[[LINC00707]] |
| − | |megamind | + | |Transcriptional regulation |
| − | |NA | + | |Pathogenic process |
| − | |developmental process
| + | |Lung cancer (LC) |
| − | |NA | + | |Neoplasms; Respiratory Tract Diseases |
| − | |NA | |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029692 HSALNT0029692] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0185476 HSALNT0185476] |
| − | |[[BIRC6-AS1]] | + | |[[LINC02470]] |
| − | |NA | + | |_ |
| − | |NA | + | |Pathogenic process |
| − | |NA | + | |Non-small cell lung cancer (NSCLC) and overian cancer |
| − | |NA
| + | |Neoplasm |
| − | |NA | |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289310 HSALNT0289310] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0068302 HSALNT0068302] |
| − | |[[LINC00854]] | + | |[[LINC02600]] |
| − | |NA | + | |_ |
| − | |NA | + | |Pathogenic process |
| − | |NA | + | |Non-small cell lung cancer (NSCLC) and overian cancer |
| − | |NA | + | |Neoplasm |
| − | |NA
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290332 HSALNT0290332] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0123915 HSALNT0123915] |
| − | |[[Uc.73]] | + | |[[LINC02604]] |
| − | |NA | + | |CeRNA |
| − | |NA | + | |Pathogenic process |
| − | |pathogenic process
| + | |Glioblastoma |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289841 HSALNT0289841]
| |
| − | |[[FR0257520]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290104 HSALNT0290104]
| |
| − | |[[NRG1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289689 HSALNT0289689]
| |
| − | |[[CDKN2B-AS11]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process;developmental process
| |
| − | |stroke
| |
| − | |Cardiovascular Diseases;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289690 HSALNT0289690]
| |
| − | |[[CDKN2B-AS12]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |glioma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289691 HSALNT0289691]
| |
| − | |[[CDKN2B-AS13]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |plexiform neurofibroma
| |
| − | |Neoplasms;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289697 HSALNT0289697]
| |
| − | |[[CDKN2B-AS7]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |acute lymphoblastic leukemia
| |
| − | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289826 HSALNT0289826]
| |
| − | |[[FADS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lipid metabolism disorder
| |
| − | |Nutritional and Metabolic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289698 HSALNT0289698]
| |
| − | |[[CDKN2B-AS8]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |melanoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289696 HSALNT0289696]
| |
| − | |[[CDKN2B-AS6]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |neuroblastoma | |
| | |Neoplasms | | |Neoplasms |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289699 HSALNT0289699] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0160932 HSALNT0160932] |
| − | |[[CDKN2B-AS9]] | + | |[[MACORIS]] |
| − | |NA | + | |Transcriptional regulation |
| − | |NA | + | |_ |
| − | |pathogenic process | + | |Cardiometabolic Diseases |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289688 HSALNT0289688]
| |
| − | |[[CDKN2B-AS10]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |stroke
| |
| − | |Cardiovascular Diseases;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288950 HSALNT0288950]
| |
| − | |[[ENST00000456816]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |clear cell renal cell cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290021 HSALNT0290021]
| |
| − | |[[LOC389332]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |clear cell renal cell cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290306 HSALNT0290306]
| |
| − | |[[TMEM72]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |clear cell renal cell cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289641 HSALNT0289641]
| |
| − | |[[BC029135]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |renal clear cell cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290374 HSALNT0290374]
| |
| − | |[[X91348]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |renal clear cell cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289694 HSALNT0289694]
| |
| − | |[[CDKN2B-AS4]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289692 HSALNT0289692]
| |
| − | |[[CDKN2B-AS2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |coronary heart disease
| |
| | |Cardiovascular Diseases | | |Cardiovascular Diseases |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289693 HSALNT0289693] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0171022 HSALNT0171022] |
| − | |[[CDKN2B-AS3]] | + | |[[KRTAP5-AS1]] |
| − | |NA | + | |CeRNA |
| − | |NA | + | |Pathogenic process |
| − | |pathogenic process
| + | |Gastric Cancer |
| − | |intracranial aneurysm | + | |Neoplasms; Digestive System Diseases |
| − | |Cardiovascular Diseases;Nervous System Diseases | |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289695 HSALNT0289695] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0215076 HSALNT0215076] |
| − | |[[CDKN2B-AS5]] | + | |[[GSC-DT]] |
| − | |NA | + | |_ |
| − | |NA | + | | Developmental process |
| − | |pathogenic process
| + | |_ |
| − | |type 2 diabetes
| + | |_ |
| − | |Nutritional and Metabolic Diseases;Endocrine System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290319 HSALNT0290319]
| |
| − | |[[T-UCRs]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |neuroblastoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289530 HSALNT0289530]
| |
| − | |[[51A]]
| |
| − | |NA
| |
| − | |splicing regulation
| |
| − | |pathogenic process
| |
| − | |Alzheimer's disease | |
| − | |Mental Disorders;Nervous System Diseases | |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290163 HSALNT0290163] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072605 HSALNT0072605] |
| − | |[[RAB4B-EGLN2]] | + | |[[CHAER1]] |
| − | |NA | + | |Translational control |
| − | |NA | + | |Pathogenic process |
| − | |pathogenic process
| + | |Cardiac hypertrophy |
| − | |cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290167 HSALNT0290167]
| |
| − | |[[RERT]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0265263 HSALNT0265263]
| |
| − | |[[LINC00237]]
| |
| − | |NCRNA00237
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |macrocephaly;obesity
| |
| − | |Musculoskeletal Diseases;Pathological Conditions, Signs and Symptoms;Nutritional and Metabolic Diseases;Physiological Phenomena
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267186 HSALNT0267186]
| |
| − | |[[LINC01370]]
| |
| − | |HI-LNC25,HILNC25
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |type 2 diabetes
| |
| − | |Nutritional and Metabolic Diseases;Endocrine System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289114 HSALNT0289114]
| |
| − | |[[LINC01574]]
| |
| − | |HI-LNC12,TCONS_00009551
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |type 2 diabetes
| |
| − | |Nutritional and Metabolic Diseases;Endocrine System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290159 HSALNT0290159]
| |
| − | |[[PTHLH]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |brachydactyly
| |
| − | |Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189394 HSALNT0189394]
| |
| − | |[[NONHSAT028496]]
| |
| − | |CISTR-ACT,CISTRACT,re52431
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |brachydactyly
| |
| − | |Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289862 HSALNT0289862]
| |
| − | |[[HELLPAR]]
| |
| − | |LINC-HELLP
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |HELLP syndrome
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289904 HSALNT0289904]
| |
| − | |[[LINC01125]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |uremia
| |
| − | |Male Urogenital Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289544 HSALNT0289544]
| |
| − | |[[AC002511.1]]
| |
| − | |LINC01531
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |enterovirus 71 infection
| |
| − | |Virus Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289609 HSALNT0289609]
| |
| − | |[[AP000688.29]]
| |
| − | |AP000688.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |enterovirus 71 infection
| |
| − | |Virus Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289832 HSALNT0289832]
| |
| − | |[[FFAR2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |enterovirus 71 infection
| |
| − | |Virus Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290222 HSALNT0290222]
| |
| − | |[[RP4-620F22.3]]
| |
| − | |AC099063.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |enterovirus 71 infection
| |
| − | |Virus Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290227 HSALNT0290227]
| |
| − | |[[RP5-843L14.1]]
| |
| − | |LINC01716
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |enterovirus 71 infection
| |
| − | |Virus Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287285 HSALNT0287285]
| |
| − | |[[MAGEA8-AS1]]
| |
| − | |RP5-869M20.2
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289019 HSALNT0289019]
| |
| − | |[[LHX5-AS1]]
| |
| − | |locus4010
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288902 HSALNT0288902]
| |
| − | |[[CAPN10-AS1]]
| |
| − | |CAPN10-DT,locus959
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289404 HSALNT0289404]
| |
| − | |[[STAM-AS1]]
| |
| − | |locus3182
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0148276 HSALNT0148276]
| |
| − | |[[PTENP1-AS]]
| |
| − | |PTENpg1-asRNA
| |
| − | |transcriptional regulation
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289562 HSALNT0289562]
| |
| − | |[[AF116616]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |osteosarcoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289589 HSALNT0289589]
| |
| − | |[[AK094838]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |osteosarcoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289620 HSALNT0289620]
| |
| − | |[[ASLNC00339]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |osteosarcoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289629 HSALNT0289629]
| |
| − | |[[BC002350]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |osteosarcoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289651 HSALNT0289651]
| |
| − | |[[BC091525]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |osteosarcoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289652 HSALNT0289652]
| |
| − | |[[BE503655]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |osteosarcoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289753 HSALNT0289753]
| |
| − | |[[ENO1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |osteosarcoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289835 HSALNT0289835]
| |
| − | |[[FKBP10]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |osteosarcoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290064 HSALNT0290064]
| |
| − | |[[MYHAS]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |osteosarcoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289985 HSALNT0289985]
| |
| − | |[[LncRNA-LALR1]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |liver cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289934 HSALNT0289934]
| |
| − | |[[LincRNA-LALR1]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091577 HSALNT0091577]
| |
| − | |[[NR2F1-AS1]]
| |
| − | |FLJ42709
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289709 HSALNT0289709]
| |
| − | |[[CK19]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289943 HSALNT0289943]
| |
| − | |[[Llme23]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |melanoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289553 HSALNT0289553]
| |
| − | |[[AC096655.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289178 HSALNT0289178]
| |
| − | |[[ENST00000602507.1]]
| |
| − | |Lnc-Ang362
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Ang II-associated cardiovascular disease | |
| | |Cardiovascular Diseases | | |Cardiovascular Diseases |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289261 HSALNT0289261] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027291 HSALNT0027291] |
| − | |[[STX18-AS1]] | + | |[[ODC1-DT]] |
| − | |LOC100507266 | + | |CeRNA |
| − | |NA | + | |Pathogenic process |
| − | |pathogenic process
| + | |Head and neck carcinoma |
| − | |atrial septal defect | + | |Neoplasm |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289849 HSALNT0289849]
| |
| − | |[[GHSR]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289850 HSALNT0289850]
| |
| − | |[[GHSROS]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289210 HSALNT0289210]
| |
| − | |[[ENST00000452148.2]]
| |
| − | |PCAN-R2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289702 HSALNT0289702]
| |
| − | |[[CES1P1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289892 HSALNT0289892]
| |
| − | |[[LINC00210]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290006 HSALNT0290006]
| |
| − | |[[LOC100506974]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290219 HSALNT0290219]
| |
| − | |[[RP3-508I15.14]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290243 HSALNT0290243]
| |
| − | |[[SLC6A6]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms | |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290342 HSALNT0290342] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0039409 HSALNT0039409] |
| − | |[[Uc003bgl.1]] | + | |[[MAP3K2-DT]] |
| − | |NA
| + | |_ |
| − | |NA
| + | |Pathogenic process |
| − | |pathogenic process
| + | |Polycystic ovary syndrome (PCOS) |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289075 HSALNT0289075]
| |
| − | |[[LINC00970]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211868 HSALNT0211868]
| |
| − | |[[SALRNA1]]
| |
| − | |SAL-RNA1,XLOC_023166
| |
| − | |NA
| |
| − | |developmental process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222267 HSALNT0222267]
| |
| − | |[[SALRNA3]]
| |
| − | |SAL-RNA3,XLOC_025918
| |
| − | |NA
| |
| − | |developmental process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222274 HSALNT0222274]
| |
| − | |[[SALRNA2]]
| |
| − | |SAL-RNA2,XLOC_025931
| |
| − | |NA
| |
| − | |developmental process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289428 HSALNT0289428]
| |
| − | |[[NONHSAT076558]]
| |
| − | |GPR1-AS1,GPR1AS
| |
| − | |transcriptional regulation
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0226207 HSALNT0226207]
| |
| − | |[[LINC00235]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |anorexia nervosa
| |
| − | |Mental Disorders
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289526 HSALNT0289526]
| |
| − | |[[1B FGF-antisense transcripts]]
| |
| − | |NA
| |
| − | |NA | |
| − | |pathogenic process | |
| − | |endometriosis | |
| | |Female Urogenital Diseases and Pregnancy Complications | | |Female Urogenital Diseases and Pregnancy Complications |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290171 HSALNT0290171] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0208284 HSALNT0208284] |
| − | |[[RNA polymerase III-dependent lncRNAs]] | + | |[[ZFHX2-AS1]] |
| − | |NA | + | |Transcriptional regulation |
| − | |NA | + | |Developmental process |
| − | |pathogenic process
| + | |_ |
| − | |diffuse cerebral hypomyelination
| + | |_ |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290168 HSALNT0290168]
| |
| − | |[[REST/CoREST-regulated lncRNAs]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Huntington disease
| |
| − | |Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289606 HSALNT0289606]
| |
| − | |[[Alu lncRNAs]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |macular degeneration
| |
| − | |Eye Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290358 HSALNT0290358]
| |
| − | |[[UCH1LAS]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Parkinson's disease
| |
| − | |Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290244 HSALNT0290244]
| |
| − | |[[SLC7A2-IT1A/B]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |progressive encephalopathy with severe infantile anorexia | |
| − | |Nervous System Diseases | |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289877 HSALNT0289877] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0152349 HSALNT0152349] |
| − | |[[Kcna2-AS]] | + | |[[LINC02603]] |
| − | |NA | + | |_ |
| − | |NA | + | |_ |
| − | |pathogenic process | + | |_ |
| − | |neuropathic pain | + | |_ |
| − | |Nervous System Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289191 HSALNT0289191] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0081596 HSALNT0081596] |
| − | |[[NCOA7-AS1]] | + | |[[TENM3-AS1]] |
| − | |NA | + | |_ |
| − | |NA | + | |_ |
| − | |pathogenic process | + | |_ |
| − | |NA | + | |_ |
| − | |NA
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290020 HSALNT0290020] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0165522 HSALNT0165522] |
| − | |[[LOC389023]] | + | |[[LINC00858]] |
| − | |NA | + | |_ |
| − | |transcriptional regulation | + | |_ |
| − | |pathogenic process
| |
| − | |psychiatric disease
| |
| − | |Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0175124 HSALNT0175124]
| |
| − | |[[PTPRJ-AS1]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289654 HSALNT0289654]
| |
| − | |[[BM742401]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289331 HSALNT0289331]
| |
| − | |[[LINC00951]]
| |
| − | |lincRNA-uc003opf.1,FLJ41649
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |esophageal squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290130 HSALNT0290130]
| |
| − | |[[PAWR]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |acute lymphoblastic leukemia
| |
| − | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290264 HSALNT0290264]
| |
| − | |[[T-ALL-R-LncR1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |acute lymphoblastic leukemia
| |
| − | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289599 HSALNT0289599]
| |
| − | |[[AK130977]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |malignant pleural mesothelioma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289625 HSALNT0289625]
| |
| − | |[[AX746718]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |malignant pleural mesothelioma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289738 HSALNT0289738]
| |
| − | |[[DDR2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |malignant pleural mesothelioma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290003 HSALNT0290003]
| |
| − | |[[LOC100131831]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |malignant pleural mesothelioma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290144 HSALNT0290144]
| |
| − | |[[POT1-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |malignant pleural mesothelioma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290253 HSALNT0290253]
| |
| − | |[[SNORA17B]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |malignant pleural mesothelioma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0207421 HSALNT0207421]
| |
| − | |[[GAS6-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| | |non-small cell lung cancer | | |non-small cell lung cancer |
| − | |Respiratory Tract Diseases;Neoplasms | + | | Respiratory Tract Diseases |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289838 HSALNT0289838] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0281930 HSALNT0281930] |
| − | |[[FMR5]] | + | |[[SCAT1]] |
| − | |NA | + | |_ |
| − | |NA | + | |_ |
| − | |pathogenic process | + | |esophagal cancer |
| − | |fragile X syndrome | + | |Digestive system Diseases |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0208907 HSALNT0208907] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0191750 HSALNT0191750] |
| − | |[[FOXG1-AS1]] | + | |[[LNCOG]] |
| − | |FOXG1-AS | + | |_ |
| − | |NA | + | |_ |
| − | |pathogenic process | + | |osteogenic differenciation |
| − | |autism spectrum disorder | + | |Musculoskeletal Diseases |
| − | |Mental Disorders
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290263 HSALNT0290263]
| |
| − | |[[SYNGAP1-AS1]]
| |
| − | |SYNGAP1-AS
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |autism spectrum disorder
| |
| − | |Mental Disorders
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290176 HSALNT0290176]
| |
| − | |[[RNase MRP]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cartilage hair hypoplaisia
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289469 HSALNT0289469]
| |
| − | |[[GABPB1-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289009 HSALNT0289009]
| |
| − | |[[IDI2-AS1]]
| |
| − | |C10orf110,IDI2-A,HT009,Em:AC022536.4
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289093 HSALNT0289093]
| |
| − | |[[LINC01184]]
| |
| − | |FLJ33630
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290108 HSALNT0290108]
| |
| − | |[[OGT]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290077 HSALNT0290077]
| |
| − | |[[NcNRFR]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290337 HSALNT0290337]
| |
| − | |[[Uc001lsz]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer;prostate cancer;liver cancer;lung cancer
| |
| − | |Respiratory Tract Diseases;Male Urogenital Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289087 HSALNT0289087]
| |
| − | |[[LINC01090]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |post-traumatic stress disorder
| |
| − | |Mental Disorders
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289746 HSALNT0289746]
| |
| − | |[[DQ786227]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289981 HSALNT0289981]
| |
| − | |[[LncRNA-DQ786227]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289876 HSALNT0289876]
| |
| − | |[[JADRR]]
| |
| − | |LINC00915,lncRNA-JADE
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290254 HSALNT0290254]
| |
| − | |[[SOX2OT-S1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |esophageal squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290404 HSALNT0290404]
| |
| − | |[[SOX2OT-S2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289870 HSALNT0289870]
| |
| − | |[[HOXA13]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0078946 HSALNT0078946]
| |
| − | |[[SMAD1-AS1]]
| |
| − | |ENST00000513542
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ventricular septal defects
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0087329 HSALNT0087329]
| |
| − | |[[FGF10-AS1]]
| |
| − | |RP11-473L15.2
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |ventricular septal defects
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290318 HSALNT0290318]
| |
| − | |[[TUC339]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289819 HSALNT0289819]
| |
| − | |[[Lnc-CHRAC1-2:1]]
| |
| − | |LINC01130,TCONS_00014875,ERIC
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |retinoblastoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289615 HSALNT0289615]
| |
| − | |[[ARA]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289822 HSALNT0289822]
| |
| − | |[[ESCCAL-5]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |esophageal squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290074 HSALNT0290074]
| |
| − | |[[NcC11orf49]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |renal cell cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290076 HSALNT0290076]
| |
| − | |[[NcHDAC5]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |renal cell cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290078 HSALNT0290078]
| |
| − | |[[NcRAB31]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |renal cell cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290080 HSALNT0290080]
| |
| − | |[[NcSRPK1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |renal cell cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0018253 HSALNT0018253]
| |
| − | |[[ENST00000442621.1]]
| |
| − | |LINC01131,OVAL
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ovarian cancer
| |
| − | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289884 HSALNT0289884]
| |
| − | |[[LALR]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289701 HSALNT0289701]
| |
| − | |[[CEACAMP8]]
| |
| − | |CEACAMP8
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |pre-eclampsia
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290018 HSALNT0290018]
| |
| − | |[[LOC284100]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |pre-eclampsia
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290023 HSALNT0290023]
| |
| − | |[[LOC391533]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |pre-eclampsia
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189558 HSALNT0189558]
| |
| − | |[[LINC01154]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0196616 HSALNT0196616]
| |
| − | |[[Lnc-DHX37-1:1]]
| |
| − | |BRI3BP-AS1,BRI3BPAS1,Linc1992,TCONS_00020260
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |Kawasaki disease
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289235 HSALNT0289235]
| |
| − | |[[RNF219-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |blood pressure
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289561 HSALNT0289561]
| |
| − | |[[AF086415]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |nasopharyngeal cancer
| |
| − | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289583 HSALNT0289583]
| |
| − | |[[AK056098]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |nasopharyngeal cancer
| |
| − | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289590 HSALNT0289590]
| |
| − | |[[AK095147]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |nasopharyngeal cancer
| |
| − | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289600 HSALNT0289600]
| |
| − | |[[AK294004]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |nasopharyngeal cancer
| |
| − | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289612 HSALNT0289612]
| |
| − | |[[AP5M1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |nasopharyngeal cancer
| |
| − | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290110 HSALNT0290110]
| |
| − | |[[ORAOV1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |nasopharyngeal cancer
| |
| − | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290210 HSALNT0290210]
| |
| − | |[[RP1-179N16.3]]
| |
| − | |Z95152.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |nasopharyngeal cancer
| |
| − | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0037026 HSALNT0037026]
| |
| − | |[[LINC01159]]
| |
| − | |linc-Brn1b
| |
| − | |NA
| |
| − | |developmental process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289014 HSALNT0289014]
| |
| − | |[[ENST00000604849.1]]
| |
| − | |KDM5C adjacent non-coding transcript
| |
| − | |NA
| |
| − | |developmental process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289905 HSALNT0289905]
| |
| − | |[[LINC01157]]
| |
| − | |TCONS_00010378,linc-Enc1
| |
| − | |NA
| |
| − | |developmental process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289460 HSALNT0289460]
| |
| − | |[[ENST00000444200.1]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290400 HSALNT0290400]
| |
| − | |[[ZNF300P1]]
| |
| − | |ZNF300P1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ovarian cancer
| |
| − | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289750 HSALNT0289750]
| |
| − | |[[EEF1A1P9]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cardia adenocarcinoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289796 HSALNT0289796]
| |
| − | |[[ENST00000318333]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cardia adenocarcinoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289797 HSALNT0289797]
| |
| − | |[[ENST00000374520]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cardia adenocarcinoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289800 HSALNT0289800]
| |
| − | |[[ENST00000422362]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cardia adenocarcinoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289808 HSALNT0289808]
| |
| − | |[[ENST00000455912]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cardia adenocarcinoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289809 HSALNT0289809]
| |
| − | |[[ENST00000456007]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cardia adenocarcinoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289810 HSALNT0289810]
| |
| − | |[[ENST00000456185]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cardia adenocarcinoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289817 HSALNT0289817]
| |
| − | |[[EPOR]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cardia adenocarcinoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289913 HSALNT0289913]
| |
| − | |[[LINC01550]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cardia adenocarcinoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290142 HSALNT0290142]
| |
| − | |[[PMS2P5]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cardia adenocarcinoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290269 HSALNT0290269]
| |
| − | |[[TCF7]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cardia adenocarcinoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290345 HSALNT0290345]
| |
| − | |[[Uc003jfz.2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cardia adenocarcinoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289095 HSALNT0289095]
| |
| − | |[[ENST00000412690.1]]
| |
| − | |VIN,lnc-ACTR3
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |influenza A virus
| |
| − | |Virus Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288976 HSALNT0288976]
| |
| − | |[[ENST00000427391.1]]
| |
| − | |LINC01200
| |
| − | |transcriptional regulation
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289097 HSALNT0289097]
| |
| − | |[[LINC01202]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290271 HSALNT0290271]
| |
| − | |[[TCONS_00014512]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatoblastoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290272 HSALNT0290272]
| |
| − | |[[TCONS_00014978]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatoblastoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290274 HSALNT0290274]
| |
| − | |[[TCONS_00024647]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatoblastoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290279 HSALNT0290279]
| |
| − | |[[TCONS_00090092_MEG3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatoblastoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290280 HSALNT0290280]
| |
| − | |[[TCONS_l2_00000179]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatoblastoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290283 HSALNT0290283]
| |
| − | |[[TCONS_l2_00004424]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatoblastoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290284 HSALNT0290284]
| |
| − | |[[TCONS_l2_00006843]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatoblastoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290289 HSALNT0290289]
| |
| − | |[[TCONS_l2_00014091]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatoblastoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290291 HSALNT0290291]
| |
| − | |[[TCONS_l2_00018070]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatoblastoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290292 HSALNT0290292]
| |
| − | |[[TCONS_l2_00020565]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatoblastoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290293 HSALNT0290293]
| |
| − | |[[TCONS_l2_00021262]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatoblastoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290296 HSALNT0290296]
| |
| − | |[[TCONS_l2_00030560]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatoblastoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289927 HSALNT0289927]
| |
| − | |[[LincRNA1611]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Pancreatic ductal adenocarcinoma
| |
| − | |Neoplasms
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290149 HSALNT0290149] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0246388 HSALNT0246388] |
| − | |[[Ppp3ca]] | + | |[[DCXR-DT]] |
| − | |NA
| + | |_ |
| − | |NA
| + | |_ |
| − | |pathogenic process
| |
| − | |Pancreatic ductal adenocarcinoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290265 HSALNT0290265]
| |
| − | |[[TC0100223]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |epithelial ovarian cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290267 HSALNT0290267]
| |
| − | |[[TC0101686]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |epithelial ovarian cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290268 HSALNT0290268]
| |
| − | |[[TC1500845]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ovarian cancer
| |
| − | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289318 HSALNT0289318]
| |
| − | |[[LAMP5-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |acute lymphoblastic leukemia
| |
| − | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0234022 HSALNT0234022]
| |
| − | |[[LINC01228]]
| |
| − | |lincRNA-DYNLRB2-2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0162654 HSALNT0162654]
| |
| − | |[[SGMS1-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289206 HSALNT0289206]
| |
| − | |[[PCAT19]]
| |
| − | |LOC100505495,LINC01190
| |
| − | |NA | |
| − | |pathogenic process | |
| | |prostate cancer | | |prostate cancer |
| − | |Male Urogenital Diseases;Neoplasms | + | |Male Urogenital Diseases |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289521 HSALNT0289521]
| |
| − | |[[ABHD15-AS1]]
| |
| − | |linc-TP53I13,lnc-TP53I13
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cardiometabolic disease
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289100 HSALNT0289100]
| |
| − | |[[LINC01230]]
| |
| − | |linc-DMRT2,lnc-DRMT2,TCONS_00015639
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cardiometabolic disease
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0249183 HSALNT0249183]
| |
| − | |[[PCAT18]]
| |
| − | |LINC01092
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290029 HSALNT0290029]
| |
| − | |[[LOC728606]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288956 HSALNT0288956]
| |
| − | |[[ENST00000547963.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |esophageal squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289802 HSALNT0289802]
| |
| − | |[[ENST00000435885]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |oesophageal squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0205898 HSALNT0205898]
| |
| − | |[[LINC01232]]
| |
| − | |FLJ41590,TCONS_00021520
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0257311 HSALNT0257311]
| |
| − | |[[LINC01233]]
| |
| − | |XLOC_013014
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0183247 HSALNT0183247]
| |
| − | |[[ENST00000526269.2]]
| |
| − | |FLI1-AS1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |vascular SMC phenotype
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289296 HSALNT0289296]
| |
| − | |[[LINC00467]]
| |
| − | |C1orf97,MGC14801
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |neuroblastoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143586 HSALNT0143586]
| |
| − | |[[CASC21]]
| |
| − | |LINC01244,CARLo-2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288906 HSALNT0288906]
| |
| − | |[[CASC19]]
| |
| − | |LINC01245,CARLo-6
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289754 HSALNT0289754]
| |
| − | |[[ENSG00000135253.9]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289755 HSALNT0289755]
| |
| − | |[[ENSG00000147753.5]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289756 HSALNT0289756]
| |
| − | |[[ENSG00000196096]]
| |
| − | |AC079610.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289757 HSALNT0289757]
| |
| − | |[[ENSG00000197251.3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289758 HSALNT0289758]
| |
| − | |[[ENSG00000203325]]
| |
| − | |AL445248.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289759 HSALNT0289759]
| |
| − | |[[ENSG00000206129]]
| |
| − | |AC006305.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289760 HSALNT0289760]
| |
| − | |[[ENSG00000215231.3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289761 HSALNT0289761] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0209659 HSALNT0209659] |
| − | |[[ENSG00000215374.4]] | + | |[[NKX2-1-AS1]] |
| − | |NA
| + | |_ |
| − | |NA
| + | |_ |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289762 HSALNT0289762]
| |
| − | |[[ENSG00000215808.2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289763 HSALNT0289763]
| |
| − | |[[ENSG00000226496.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289764 HSALNT0289764]
| |
| − | |[[ENSG00000229563.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289765 HSALNT0289765]
| |
| − | |[[ENSG00000230133.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289766 HSALNT0289766]
| |
| − | |[[ENSG00000230544.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289767 HSALNT0289767]
| |
| − | |[[ENSG00000231133.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289768 HSALNT0289768]
| |
| − | |[[ENSG00000231185]]
| |
| − | |AC010317.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289769 HSALNT0289769]
| |
| − | |[[ENSG00000232021.2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289770 HSALNT0289770]
| |
| − | |[[ENSG00000232046.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289771 HSALNT0289771]
| |
| − | |[[ENSG00000232956.3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289772 HSALNT0289772]
| |
| − | |[[ENSG00000233154.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289773 HSALNT0289773]
| |
| − | |[[ENSG00000233251]]
| |
| − | |AC007743.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289774 HSALNT0289774]
| |
| − | |[[ENSG00000235285.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289775 HSALNT0289775]
| |
| − | |[[ENSG00000237036.3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289776 HSALNT0289776]
| |
| − | |[[ENSG00000237548.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289777 HSALNT0289777]
| |
| − | |[[ENSG00000240453.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289778 HSALNT0289778]
| |
| − | |[[ENSG00000241269.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289779 HSALNT0289779]
| |
| − | |[[ENSG00000245910.3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289780 HSALNT0289780]
| |
| − | |[[ENSG00000248176]]
| |
| − | |AC109349.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289781 HSALNT0289781]
| |
| − | |[[ENSG00000249364]]
| |
| − | |AC112206.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289782 HSALNT0289782]
| |
| − | |[[ENSG00000249772]]
| |
| − | |AC026427.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289783 HSALNT0289783]
| |
| − | |[[ENSG00000250195]]
| |
| − | |AC109927.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289784 HSALNT0289784]
| |
| − | |[[ENSG00000250608]]
| |
| − | |AC010210.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289785 HSALNT0289785]
| |
| − | |[[ENSG00000254154]]
| |
| − | |AL359075.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289786 HSALNT0289786]
| |
| − | |[[ENSG00000255471]]
| |
| − | |AP001528.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289787 HSALNT0289787]
| |
| − | |[[ENSG00000256218]]
| |
| − | |AC007848.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289788 HSALNT0289788]
| |
| − | |[[ENSG00000259150.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289789 HSALNT0289789]
| |
| − | |[[ENSG00000259334.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289790 HSALNT0289790]
| |
| − | |[[ENSG00000259484.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289791 HSALNT0289791]
| |
| − | |[[ENSG00000259758.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289793 HSALNT0289793]
| |
| − | |[[ENSG00000263753.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289794 HSALNT0289794]
| |
| − | |[[ENSG00000264772]]
| |
| − | |AC016876.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289795 HSALNT0289795]
| |
| − | |[[ENSG00000266952.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289828 HSALNT0289828]
| |
| − | |[[FAM66B]]
| |
| − | |FAM66E
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289895 HSALNT0289895]
| |
| − | |[[LINC00336]]
| |
| − | |C6orf227,NCRNA00336
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289899 HSALNT0289899]
| |
| − | |[[LINC00929]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289906 HSALNT0289906]
| |
| − | |[[LINC01204]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289912 HSALNT0289912]
| |
| − | |[[LINC01538]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289915 HSALNT0289915]
| |
| − | |[[LINC01721]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289916 HSALNT0289916]
| |
| − | |[[LINC01762]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289917 HSALNT0289917]
| |
| − | |[[LINC01798]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290247 HSALNT0290247]
| |
| − | |[[SMIM2-IT1]]
| |
| − | |C13orf44-IT1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290316 HSALNT0290316]
| |
| − | |[[TTTY7]]
| |
| − | |CLONE795723,LINC00129,NCRNA00129A,TTTY7B,TTY7,TTTY7
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289872 HSALNT0289872]
| |
| − | |[[HTTAS_v1]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |Huntington disease
| |
| − | |Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290175 HSALNT0290175]
| |
| − | |[[RNA-a]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |Opitz-Kaveggia syndrome
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289525 HSALNT0289525]
| |
| − | |[[116HG]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |Prader-Willi syndrome
| |
| − | |Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290320 HSALNT0290320]
| |
| − | |[[U1 spliceosomal lncRNA]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Parkinson's disease
| |
| − | |Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289102 HSALNT0289102]
| |
| − | |[[LINC01262]]
| |
| − | |TCONS_l2_00021807,RP11-462G22.1
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |Parkinson's disease
| |
| − | |Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289681 HSALNT0289681]
| |
| − | |[[CCAT1-L]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290062 HSALNT0290062]
| |
| − | |[[MT-LIPCAR]]
| |
| − | |uc022bqs.1,LIPCAR
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |heart disease
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289941 HSALNT0289941]
| |
| − | |[[LIPCAR]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |heart failure
| |
| − | |Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0200965 HSALNT0200965]
| |
| − | |[[TUSC8]]
| |
| − | |LINC01071,XLOC_010588
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cervical cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0161787 HSALNT0161787]
| |
| − | |[[LINC01264]]
| |
| − | |RP11-124O11.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289733 HSALNT0289733]
| |
| − | |[[D4Z4]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process;developmental process
| |
| − | |facioscapulohumeral muscular dystrophy
| |
| − | |Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289678 HSALNT0289678]
| |
| − | |[[CARL]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |myocardial infarction
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289923 HSALNT0289923]
| |
| − | |[[Linc-CBR1-2]]
| |
| − | |NA
| |
| − | |NA | |
| − | |pathogenic process | |
| | |lung cancer | | |lung cancer |
| − | |Respiratory Tract Diseases;Neoplasms | + | | Respiratory Tract Diseases |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0243354 HSALNT0243354] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0038250 HSALNT0038250] |
| − | |[[Lnc-HEATR6-1:4]] | + | |[[ACTR3-AS1]] |
| − | |WAP four-disulfide core domain 21,pseudogene | + | |_ |
| − | |transcriptional regulation
| + | |_ |
| − | |pathogenic process | + | |glioblastoma |
| − | |DC dysfunction | + | |Nervous system diseases |
| − | |NA | |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290232 HSALNT0290232] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0043145 HSALNT0043145] |
| − | |[[RUNX1]] | + | |[[ITGA6-AS1]] |
| − | |NA | + | |_ |
| − | |NA | + | |_ |
| − | |pathogenic process | + | |glioblastoma |
| − | |acute myeloid leukemia | + | |Nervous system diseases |
| − | |Neoplasms
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290234 HSALNT0290234] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0281822 HSALNT0281822] |
| − | |[[RUNXOR]] | + | |[[LINC02601]] |
| − | |NA | + | |_ |
| − | |NA | + | |_ |
| − | |pathogenic process | + | |glioblastoma |
| − | |hematopoietic malignancies | + | |Nervous system diseases |
| − | |Neoplasms;Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289979 HSALNT0289979]
| |
| − | |[[LncRNA-CIR]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |osteoarthritis
| |
| − | |Musculoskeletal Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290368 HSALNT0290368]
| |
| − | |[[VIM2P]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |osteoarthritis
| |
| − | |Musculoskeletal Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289879 HSALNT0289879]
| + | |[[ZKSCAN7-AS1]] |
| − | |[[KRAS1P]] | + | |_ |
| − | |NA | + | |_ |
| − | |NA
| + | |glioblastoma |
| − | |pathogenic process | + | |Nervous system diseases |
| − | |cancer | |
| − | |Neoplasms | |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290054 HSALNT0290054] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0120721 HSALNT0120721] |
| − | |[[MINA]] | + | |[[GARS-DT ]] |
| − | |NA | + | |_ |
| − | |NA | + | |_ |
| − | |pathogenic process | + | |heroine addiction |
| − | |esophageal squamous cell cancer;gastric cancer;lung cancer;hepatocelluar cancer | + | |Nervous system diseases |
| − | |Respiratory Tract Diseases;Neoplasms;Digestive System Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289270 HSALNT0289270] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0093136 HSALNT0093136] |
| − | |[[TMEM92-AS1]] | + | |[[LINCADL]] |
| − | |RP11-893F2.9,lncRNA-508851,TCONS_00025237 | + | |_ |
| − | |NA | + | |_ |
| − | |pathogenic process | + | |obesity |
| − | |hepatocellular cancer | + | |Digestive system Diseases |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288900 HSALNT0288900]
| |
| − | |[[ENST00000604200.1]]
| |
| − | |LINC00468
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289593 HSALNT0289593]
| |
| − | |[[AK123657]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289659 HSALNT0289659]
| |
| − | |[[BX648207]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289660 HSALNT0289660]
| |
| − | |[[BX649059]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289846 HSALNT0289846]
| |
| − | |[[GAS2L3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289633 HSALNT0289633]
| |
| − | |[[BC011663]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289867 HSALNT0289867]
| |
| − | |[[HIV1230]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290045 HSALNT0290045]
| |
| − | |[[M14574]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290245 HSALNT0290245]
| |
| − | |[[SLCO5A1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290326 HSALNT0290326]
| |
| − | |[[Uc.341]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290344 HSALNT0290344]
| |
| − | |[[Uc003iqu]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290346 HSALNT0290346]
| |
| − | |[[Uc003tfx]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289950 HSALNT0289950]
| |
| − | |[[Lnc-AL355149.1-1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |nasopharyngeal cancer
| |
| − | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290001 HSALNT0290001]
| |
| − | |[[Lnc-ZNF674-1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |nasopharyngeal cancer
| |
| − | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0286909 HSALNT0286909]
| |
| − | |[[LINC00632]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289105 HSALNT0289105]
| |
| − | |[[LINC01317]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0234804 HSALNT0234804]
| |
| − | |[[LINC01081]]
| |
| − | |TCONS_00024764
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |alveolar capillary dysplasia
| |
| − | |Respiratory Tract Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289840 HSALNT0289840]
| |
| − | |[[FOSB]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289587 HSALNT0289587]
| |
| − | |[[AK093543]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289732 HSALNT0289732]
| |
| − | |[[D16366]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289814 HSALNT0289814]
| |
| − | |[[ENST00000501583]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290273 HSALNT0290273]
| |
| − | |[[TCONS_00018278]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289907 HSALNT0289907]
| |
| − | |[[LINC01374]]
| |
| − | |TCONS_00018278
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0231106 HSALNT0231106]
| |
| − | |[[CASC22]]
| |
| − | |LINC01373,TCONS_00024290,LincRNA-ENST00000515084
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0058246 HSALNT0058246]
| |
| − | |[[LINC00882]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |airway diseases
| |
| − | |Respiratory Tract Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0018288 HSALNT0018288]
| |
| − | |[[KIAA1614-AS1]]
| |
| − | |RP11-46A10.4
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |airway smooth muscle (ASM) disease
| |
| − | |Respiratory Tract Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0142310 HSALNT0142310]
| |
| − | |[[LINC00536]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |trichorhinophalangeal syndrome
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0034200 HSALNT0034200]
| |
| − | |[[LBX2-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |renal cell cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0149799 HSALNT0149799]
| |
| − | |[[ENST00000414223]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |renal cell cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290012 HSALNT0290012]
| |
| − | |[[LOC105374631]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |renal cell cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290305 HSALNT0290305]
| |
| − | |[[TMEM179]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |renal cell cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290315 HSALNT0290315]
| |
| − | |[[TSPAN8]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |renal cell cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290334 HSALNT0290334]
| |
| − | |[[Uc001aka.2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |renal cell cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290339 HSALNT0290339]
| |
| − | |[[Uc001vjj.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |renal cell cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290343 HSALNT0290343]
| |
| − | |[[Uc003erl.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |renal cell cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290354 HSALNT0290354]
| |
| − | |[[Uc009wkz.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |renal cell cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027893 HSALNT0027893]
| |
| − | |[[ENST00000433810.1]]
| |
| − | |MYCNUN,lncUSMycN
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |neuroblastoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273205 HSALNT0273205]
| |
| − | |[[LINC01436]]
| |
| − | |AP000688.8
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Down syndrome
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266116 HSALNT0266116]
| |
| − | |[[MIR663AHG]]
| |
| − | |RP3-410C9.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |turner syndrome
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289108 HSALNT0289108]
| |
| − | |[[LINC01435]]
| |
| − | |RP11-215N21.1,TCONS_00018040
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289674 HSALNT0289674]
| |
| − | |[[CADM3-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |bladder cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289882 HSALNT0289882]
| |
| − | |[[KRT19P3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |bladder cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290310 HSALNT0290310]
| |
| − | |[[TNXA]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |bladder cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0008750 HSALNT0008750]
| |
| − | |[[ZRANB2-AS2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289745 HSALNT0289745]
| |
| − | |[[DMTF1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290059 HSALNT0290059]
| |
| − | |[[MRUL]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0185163 HSALNT0185163]
| |
| − | |[[FAM66C]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289476 HSALNT0289476]
| |
| − | |[[ENST00000357401.3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289535 HSALNT0289535]
| |
| − | |[[AA174084]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266298 HSALNT0266298]
| |
| − | |[[ABALON]]
| |
| − | |INXS
| |
| − | |splicing regulation
| |
| − | |pathogenic process
| |
| − | |renal cell cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290370 HSALNT0290370]
| |
| − | |[[VTRNA2-1]]
| |
| − | |CBL-3,CBL3,MIR886,MIRN886,VTRNA2,hsa-mir-886,hvg-5,nc886,svtRNA2-1a
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289619 HSALNT0289619]
| |
| − | |[[ASK00420]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cervical cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289749 HSALNT0289749]
| |
| − | |[[EBIC]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |cervical cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290299 HSALNT0290299]
| |
| − | |[[TI09485]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cervical cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290300 HSALNT0290300]
| |
| − | |[[TI10124]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cervical cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290301 HSALNT0290301]
| |
| − | |[[TI13831]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cervical cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290302 HSALNT0290302]
| |
| − | |[[TI18318]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cervical cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290303 HSALNT0290303]
| |
| − | |[[TI21327]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cervical cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290304 HSALNT0290304]
| |
| − | |[[TI22687]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cervical cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290307 HSALNT0290307]
| |
| − | |[[TMPOP2]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |cervical cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289570 HSALNT0289570]
| |
| − | |[[AK021444]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289601 HSALNT0289601]
| |
| − | |[[AK307796]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289801 HSALNT0289801]
| |
| − | |[[ENST00000425785]]
| |
| − | |SEC63P1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289871 HSALNT0289871]
| |
| − | |[[HOXB-AS3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290367 HSALNT0290367]
| |
| − | |[[URHC]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289085 HSALNT0289085]
| |
| − | |[[LINC01080]]
| |
| − | |TCONS_00021856
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Alzheimer's disease
| |
| − | |Mental Disorders;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289751 HSALNT0289751]
| |
| − | |[[EFNA3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289798 HSALNT0289798]
| |
| − | |[[ENST00000395084]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289829 HSALNT0289829]
| |
| − | |[[FAM83A-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290164 HSALNT0290164]
| |
| − | |[[RAD1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289585 HSALNT0289585]
| |
| − | |[[AK056988]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289638 HSALNT0289638]
| |
| − | |[[BC017743]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290156 HSALNT0290156]
| |
| − | |[[PRR26]]
| |
| − | |C10orf108
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290349 HSALNT0290349]
| |
| − | |[[Uc003yqb.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289675 HSALNT0289675]
| |
| − | |[[CAI2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |neuroblastoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289673 HSALNT0289673]
| |
| − | |[[CADM1-AS1]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |renal clear cell cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290313 HSALNT0290313]
| |
| − | |[[TSLC1-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |glioma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0013359 HSALNT0013359]
| |
| − | |[[LINC01525]]
| |
| − | |lnc-MAN1A2-1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0109106 HSALNT0109106]
| |
| − | |[[LINC01526]]
| |
| − | |Lnc-FAM46A-1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0162774 HSALNT0162774]
| |
| − | |[[LINC01468]]
| |
| − | |lnc-MBL2-4
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289110 HSALNT0289110]
| |
| − | |[[LINC01503]]
| |
| − | |lnc-PPP2R4-5
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |tongue squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289968 HSALNT0289968]
| |
| − | |[[Lnc-MBL2-4:3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |tongue squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289993 HSALNT0289993]
| |
| − | |[[Lnc-STXBP5-1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |tongue squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289563 HSALNT0289563]
| |
| − | |[[AF118081]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289597 HSALNT0289597]
| |
| − | |[[AK124939]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |pulmonary adenocarcinoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290153 HSALNT0290153]
| |
| − | |[[PRAS]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290249 HSALNT0290249]
| |
| − | |[[SNAR-A1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289929 HSALNT0289929]
| |
| − | |[[LincRNA-BC2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289930 HSALNT0289930]
| |
| − | |[[LincRNA-BC4]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289931 HSALNT0289931]
| |
| − | |[[LincRNA-BC5]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289932 HSALNT0289932]
| |
| − | |[[LincRNA-BC8]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0083190 HSALNT0083190]
| |
| − | |[[LINC01511]]
| |
| − | |RP11-325I22.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290026 HSALNT0290026]
| |
| − | |[[LOC440905]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0083190 HSALNT0083190]
| |
| − | |[[LINC01511]]
| |
| − | |RP11-325I22.2
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289552 HSALNT0289552]
| |
| − | |[[AC079776.2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289720 HSALNT0289720]
| |
| − | |[[CTA-363E6.2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289901 HSALNT0289901]
| |
| − | |[[LINC00987]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290185 HSALNT0290185]
| |
| − | |[[RP11-1C1.7]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290197 HSALNT0290197]
| |
| − | |[[RP11-445K13.2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290199 HSALNT0290199]
| |
| − | |[[RP11-473M20.11]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290213 HSALNT0290213]
| |
| − | |[[RP11-893F2.6]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290217 HSALNT0290217]
| |
| − | |[[RP13-514E23.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290218 HSALNT0290218]
| |
| − | |[[RP1-90D4.3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290220 HSALNT0290220]
| |
| − | |[[RP4-575N6.5]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290226 HSALNT0290226]
| |
| − | |[[RP5-826L7.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290378 HSALNT0290378]
| |
| − | |[[XLOC_003286]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290379 HSALNT0290379]
| |
| − | |[[XLOC_003405]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290389 HSALNT0290389]
| |
| − | |[[XLOC_012255]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290056 HSALNT0290056]
| |
| − | |[[MIR21]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |laryngeal squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289621 HSALNT0289621]
| |
| − | |[[ASncmtRNAs]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289316 HSALNT0289316]
| |
| − | |[[LINC01614]]
| |
| − | |LCAL4,TCONS_00003105
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289982 HSALNT0289982]
| |
| − | |[[LncRNA-FER1L4]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290016 HSALNT0290016]
| |
| − | |[[LOC283177]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |diffuse large B-cell lymphoma
| |
| − | |Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289003 HSALNT0289003]
| |
| − | |[[HORMAD2-AS1]]
| |
| − | |MTMR3-AS1,NONHSAG033653
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |type 1 diabetes;bowel disease
| |
| − | |Nutritional and Metabolic Diseases;Endocrine System Diseases;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290372 HSALNT0290372]
| |
| − | |[[WNT4]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |endometriosis
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289540 HSALNT0289540]
| |
| − | |[[AB074278]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |bladder cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290166 HSALNT0290166]
| |
| − | |[[RCCRT1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |renal cell cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289043 HSALNT0289043]
| |
| − | |[[LINC00491]]
| |
| − | |BC008363
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |pancreatic ductal adenocarcinoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289632 HSALNT0289632]
| |
| − | |[[BC008363]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Pancreatic ductal adenocarcinoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289858 HSALNT0289858]
| |
| − | |[[H1.3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ovarian cancer
| |
| − | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289896 HSALNT0289896]
| |
| − | |[[LINC00582]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |endometrial cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289301 HSALNT0289301]
| |
| − | |[[LINC01537]]
| |
| − | |RP11-169D4.1-001
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |laryngeal squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289551 HSALNT0289551]
| |
| − | |[[AC026166.2]]
| |
| − | |MTCO1P5
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |laryngeal squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290184 HSALNT0290184]
| |
| − | |[[RP11-169D4.1-001]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |laryngeal squamous cell cancer
| |
| − | |Neoplasms
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289545 HSALNT0289545]
| |
| − | |[[AC006050.3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung squamous cell cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289556 HSALNT0289556]
| + | |[[GPRACR]] |
| − | |[[AC138128.1]]
| + | |_ |
| − | |NA
| + | |_ |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289818 HSALNT0289818]
| |
| − | |[[ERCC1]] | |
| − | |NA | |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290061 HSALNT0290061]
| |
| − | |[[MT1DP]]
| |
| − | |MT1DP
| |
| − | |NA
| |
| − | |pathogenic process | |
| | |liver cancer | | |liver cancer |
| − | |Neoplasms;Digestive System Diseases | + | |Digestive system Diseases |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289578 HSALNT0289578] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0082561 HSALNT0082561] |
| − | |[[AK023096]] | + | |[[LINC01060]] |
| − | |NA | + | |_ |
| − | |NA | + | |_ |
| − | |pathogenic process | + | |pancreatic cancer |
| − | |Wilmsâ tumor;uterine leiomyomas
| + | |Digestive system Diseases |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289112 HSALNT0289112]
| |
| − | |[[LINC01562]]
| |
| − | |RP11-296A18.3
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |intervertebral disc degeneration
| |
| − | |Musculoskeletal Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289567 HSALNT0289567]
| |
| − | |[[AK000974]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289579 HSALNT0289579]
| |
| − | |[[AK024118]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289645 HSALNT0289645]
| |
| − | |[[BC040204]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290321 HSALNT0290321]
| |
| − | |[[U79277]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289869 HSALNT0289869]
| |
| − | |[[HOST2]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |epithelial ovarian cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289368 HSALNT0289368]
| |
| − | |[[MGAT3-AS1]]
| |
| − | |TapSAKI
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |acute kidney injury
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289624 HSALNT0289624]
| |
| − | |[[ATXN7L3B]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |spinocerebellar ataxia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289990 HSALNT0289990]
| |
| − | |[[Lnc-SCA7]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |spinocerebellar ataxia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290004 HSALNT0290004]
| |
| − | |[[LOC100287482]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290383 HSALNT0290383]
| |
| − | |[[XLOC_007697]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290384 HSALNT0290384]
| |
| − | |[[XLOC_008559]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms | |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290385 HSALNT0290385]
| |
| − | |[[XLOC_009911]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289813 HSALNT0289813]
| |
| − | |[[ENST00000480739]]
| |
| − | |RPL13AP23
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Pancreatic ductal adenocarcinoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290111 HSALNT0290111]
| |
| − | |[[OS9]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Pancreatic ductal adenocarcinoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290324 HSALNT0290324]
| |
| − | |[[Uc.283-plus]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |glioma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289117 HSALNT0289117]
| |
| − | |[[LINC01611]]
| |
| − | |RP1-90L14.1,TCONS_l2_00025430
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |diabetic retinopathy
| |
| − | |Endocrine System Diseases;Male Urogenital Diseases;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289529 HSALNT0289529]
| |
| − | |[[2900055J20Rik]]
| |
| − | |2900055J20Rik
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |left ventricular hypertrophy
| |
| − | |Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289792 HSALNT0289792] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0058704 HSALNT0058704] |
| − | |[[ENSG00000261777]] | + | |[[TBILA]] |
| − | |AC012184.3 | + | |_ |
| − | |NA | + | |_ |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289618 HSALNT0289618]
| |
| − | |[[Asb3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cardiovascular and renal disease
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289703 HSALNT0289703]
| |
| − | |[[Chac2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cardiovascular and renal disease
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290139 HSALNT0290139]
| |
| − | |[[Pex11b]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cardiovascular and renal disease
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290255 HSALNT0290255]
| |
| − | |[[Sp5]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cardiovascular and renal disease
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211639 HSALNT0211639]
| |
| − | |[[PSMA3-AS1]]
| |
| − | |FLJ31306
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289319 HSALNT0289319]
| |
| − | |[[LINC00493]]
| |
| − | |LOC388789
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288903 HSALNT0288903]
| |
| − | |[[CARD8-AS1]]
| |
| − | |LOC100505812
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |leukemia and neuroblastoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0064729 HSALNT0064729]
| |
| − | |[[KCNMB2-AS1]]
| |
| − | |RP11-385J1.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289548 HSALNT0289548]
| |
| − | |[[AC013264.2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289857 HSALNT0289857]
| |
| − | |[[GUCY1B2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| | |non-small cell lung cancer | | |non-small cell lung cancer |
| − | |Respiratory Tract Diseases;Neoplasms | + | | Respiratory Tract Diseases |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290190 HSALNT0290190]
| |
| − | |[[RP11-385J1.2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290216 HSALNT0290216] | + | |[[UGDH-AS1]] |
| − | |[[RP1-317E23.3]]
| + | |_ |
| − | |NA
| + | |_ |
| − | |NA
| + | |invertebral disc degeneration |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290317 HSALNT0290317]
| |
| − | |[[TUBA4B]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290375 HSALNT0290375]
| |
| − | |[[XLOC_000371]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290397 HSALNT0290397]
| |
| − | |[[Z82214.3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289735 HSALNT0289735]
| |
| − | |[[DALIR]]
| |
| − | |DALI
| |
| − | |transcriptional regulation
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290376 HSALNT0290376]
| |
| − | |[[XLOC_000620]]
| |
| − | |NA | |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |H. pylori-related diseases
| |
| − | |Bacterial Infections and Mycoses
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290380 HSALNT0290380]
| |
| − | |[[XLOC_004122]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |H. pylori-related diseases
| |
| − | |Bacterial Infections and Mycoses
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290381 HSALNT0290381]
| |
| − | |[[XLOC_004562]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |H. pylori-related diseases
| |
| − | |Bacterial Infections and Mycoses
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290382 HSALNT0290382]
| |
| − | |[[XLOC_005912]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |H. pylori-related diseases
| |
| − | |Bacterial Infections and Mycoses
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290391 HSALNT0290391]
| |
| − | |[[XLOC_014388]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |H. pylori-related diseases
| |
| − | |Bacterial Infections and Mycoses
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290028 HSALNT0290028]
| |
| − | |[[LOC652276]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290162 HSALNT0290162]
| |
| − | |[[R05532]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0098175 HSALNT0098175]
| |
| − | |[[LINC01411]]
| |
| − | |RP11-267A15.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290025 HSALNT0290025]
| |
| − | |[[LOC401317]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |nasopharyngeal cancer
| |
| − | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289726 HSALNT0289726]
| |
| − | |[[CTD-2574D22.4]]
| |
| − | |AC120114.2
| |
| − | |NA
| |
| − | |pathogenic process | |
| − | |osteoarthritis | |
| | |Musculoskeletal Diseases | | |Musculoskeletal Diseases |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290141 HSALNT0290141] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0245777 HSALNT0245777] |
| − | |[[PMS2L2]] | + | |[[TNRC6C-AS1]] |
| − | |NA | + | |_ |
| − | |NA | + | |_ |
| − | |pathogenic process | + | |Thyroid cancer |
| − | |osteoarthritis | + | |Endocrine system Disease |
| − | |Musculoskeletal Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289974 HSALNT0289974] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0225753 HSALNT0225753] |
| − | |[[LncRNA-422]] | + | |[[LINC02244]] |
| − | |NA | + | |_ |
| − | |NA | + | |_ |
| − | |pathogenic process | + | |obesity |
| − | |colorectal cancer | + | |Digestive system Diseases |
| − | |Neoplasms;Digestive System Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289520 HSALNT0289520]
| |
| − | |[[AATBC]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |bladder cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289311 HSALNT0289311] | + | |[[NKAIN3-IT1]] |
| − | |[[LINC00974]]
| + | |_ |
| − | |NA
| + | |_ |
| − | |ceRNA
| + | |glioblastoma |
| − | |pathogenic process
| + | |Nervous system diseases |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0089943 HSALNT0089943]
| |
| − | |[[ZBED3-AS1]]
| |
| − | |NA | |
| − | |NA | |
| − | |developmental process | |
| − | |NA | |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289116 HSALNT0289116]
| |
| − | |[[LINC01589]]
| |
| − | |CTA-941F9.9,TCONS_00029353
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289910 HSALNT0289910]
| |
| − | |[[LINC01426]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |esophageal squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290341 HSALNT0290341]
| |
| − | |[[Uc002yug.2]]
| |
| − | |NA
| |
| − | |splicing regulation
| |
| − | |pathogenic process
| |
| − | |esophageal squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290250 HSALNT0290250]
| |
| − | |[[SNCG]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289949 HSALNT0289949]
| |
| − | |[[Lnc-AF085935]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289996 HSALNT0289996]
| |
| − | |[[Lnc-uc003wbd]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289559 HSALNT0289559]
| |
| − | |[[AF085935]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290347 HSALNT0290347]
| |
| − | |[[Uc003wbd]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290098 HSALNT0290098]
| |
| − | |[[NR_001284]]
| |
| − | |TNXA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |chronic thromboembolic pulmonary hypertension
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290327 HSALNT0290327]
| |
| − | |[[Uc.343]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |osteoarthritis
| |
| − | |Musculoskeletal Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289196 HSALNT0289196]
| |
| − | |[[NRAV]]
| |
| − | |DYNLL1-AS1
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |influenza A virus
| |
| − | |Virus Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290140 HSALNT0290140]
| |
| − | |[[PLEC]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |chronic obstructive pulmonary disease
| |
| − | |Respiratory Tract Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290172 HSALNT0290172]
| |
| − | |[[RNA44121]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |chronic obstructive pulmonary disease
| |
| − | |Respiratory Tract Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290173 HSALNT0290173]
| |
| − | |[[RNA50010]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |chronic obstructive pulmonary disease
| |
| − | |Respiratory Tract Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290174 HSALNT0290174]
| |
| − | |[[RNA58351]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |chronic obstructive pulmonary disease
| |
| − | |Respiratory Tract Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289714 HSALNT0289714]
| |
| − | |[[CR613944]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289933 HSALNT0289933]
| |
| − | |[[LincRNA-CALCA]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290200 HSALNT0290200]
| |
| − | |[[RP11-501G6.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290208 HSALNT0290208]
| |
| − | |[[RP11-672F9.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290405 HSALNT0290405]
| |
| − | |[[C14orf132]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289937 HSALNT0289937]
| |
| − | |[[LincRNA-TSPAN8]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290225 HSALNT0290225]
| |
| − | |[[RP5-1014O16.1]]
| |
| − | |AC244098.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290275 HSALNT0290275]
| |
| − | |[[TCONS_00026102]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |atrial fibrillation
| |
| − | |Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290277 HSALNT0290277]
| |
| − | |[[TCONS_00032546]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |atrial fibrillation
| |
| − | |Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289037 HSALNT0289037]
| |
| − | |[[LINC00441]]
| |
| − | |RB1-DT,ncRNA-RB1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289661 HSALNT0289661]
| |
| − | |[[C1401f132]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289141 HSALNT0289141]
| |
| − | |[[LINC02365]]
| |
| − | |LVCAT8
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288885 HSALNT0288885]
| |
| − | |[[ADGRD1-AS1]]
| |
| − | |LACAT8
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289142 HSALNT0289142]
| |
| − | |[[LINC02475]]
| |
| − | |LVCAT1
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289542 HSALNT0289542]
| |
| − | |[[Abhd11os]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |neurodegenerative diseases
| |
| − | |Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288895 HSALNT0288895]
| |
| − | |[[BISPR]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |virus infection
| |
| − | |Virus Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0233975 HSALNT0233975]
| |
| − | |[[MAFTRR]]
| |
| − | |linc-MAF-4
| |
| − | |transcriptional regulation
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290058 HSALNT0290058]
| |
| − | |[[MRAK052686]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |nonalcoholic fatty liver disease
| |
| − | |Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290221 HSALNT0290221]
| |
| − | |[[RP4-583P15.10]]
| |
| − | |AL121845.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211341 HSALNT0211341]
| |
| − | |[[KTN1-AS1]]
| |
| − | |C14orf33,MYCLo-3
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266752 HSALNT0266752]
| |
| − | |[[DLGAP4-AS1]]
| |
| − | |CCAT7
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289682 HSALNT0289682]
| |
| − | |[[CCAT3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289684 HSALNT0289684]
| |
| − | |[[CCAT8]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289898 HSALNT0289898]
| |
| − | |[[LINC00659]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289683 HSALNT0289683]
| |
| − | |[[CCAT7]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289627 HSALNT0289627]
| |
| − | |[[BALR-2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |B cell acute lymphoblastic leukemia
| |
| − | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289948 HSALNT0289948]
| |
| − | |[[Lnc-ACACA-1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |clear cell renal cell cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289953 HSALNT0289953]
| |
| − | |[[Lnc-BMP2-2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |clear cell renal cell cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289955 HSALNT0289955]
| |
| − | |[[Lnc-CPN2-1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |clear cell renal cell cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289958 HSALNT0289958]
| |
| − | |[[Lnc-FOXG1-2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |clear cell renal cell cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289960 HSALNT0289960]
| |
| − | |[[Lnc-FZD1-2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |clear cell renal cell cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289962 HSALNT0289962]
| |
| − | |[[Lnc-ITPR2-3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |clear cell renal cell cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289965 HSALNT0289965]
| |
| − | |[[Lnc-LCP2-2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |clear cell renal cell cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289988 HSALNT0289988]
| |
| − | |[[Lnc-RP3-368B9]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |clear cell renal cell cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289991 HSALNT0289991]
| |
| − | |[[Lnc-SLC30A4-1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |clear cell renal cell cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289992 HSALNT0289992]
| |
| − | |[[Lnc-SPAM1-6]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |clear cell renal cell cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289995 HSALNT0289995]
| |
| − | |[[Lnc-TTC34-3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |clear cell renal cell cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222064 HSALNT0222064] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0013113 HSALNT0013113] |
| − | |[[DRAIC]] | + | |[[NGF-AS1]] |
| − | |NA | + | |_ |
| − | |NA | + | |_ |
| − | |pathogenic process | + | |dysmenorhea |
| − | |prostate cancer;glioma;cancer;bladder cancer;renal clear cell cancer;skin melanoma;hepatocellular cancer;lung adenocarcinoma;stomach adenocarcinoma | + | |Female Urogenital Diseases |
| − | |Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0005037 HSALNT0005037] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0031057 HSALNT0031057] |
| − | |[[LINC01137]] | + | |[[LINC01121]] |
| − | |LOC728431 | + | |_ |
| − | |NA | + | |_ |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290390 HSALNT0290390]
| |
| − | |[[XLOC_014172]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290014 HSALNT0290014]
| |
| − | |[[LOC149086]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290183 HSALNT0290183]
| |
| − | |[[RP11-160H22.5]]
| |
| − | |AL121983.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289945 HSALNT0289945]
| |
| − | |[[LNC00964-3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289616 HSALNT0289616]
| |
| − | |[[Arid2-IR]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |renal inflammation
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289716 HSALNT0289716]
| |
| − | |[[CR619813]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| | |pancreatic cancer | | |pancreatic cancer |
| − | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | + | |Digestive system Diseases |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289739 HSALNT0289739]
| |
| − | |[[DDX6P1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |pancreatic cancer
| |
| − | |Endocrine System Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289938 HSALNT0289938]
| |
| − | |[[LincRNA-ZNF532]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |pancreatic cancer
| |
| − | |Endocrine System Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290011 HSALNT0290011]
| |
| − | |[[LOC105372753]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |pancreatic cancer
| |
| − | |Endocrine System Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290013 HSALNT0290013]
| |
| − | |[[LOC105377769]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |pancreatic cancer
| |
| − | |Endocrine System Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290205 HSALNT0290205]
| |
| − | |[[RP11-58D2.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |pancreatic cancer
| |
| − | |Endocrine System Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288946 HSALNT0288946]
| |
| − | |[[ENST00000434223]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288947 HSALNT0288947]
| |
| − | |[[ENST00000442037]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288953 HSALNT0288953]
| |
| − | |[[ENST00000540136]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290103 HSALNT0290103]
| |
| − | |[[NR_038125]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290136 HSALNT0290136]
| |
| − | |[[PDLIM3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290335 HSALNT0290335]
| |
| − | |[[Uc001gch.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290336 HSALNT0290336]
| |
| − | |[[Uc001gzl.3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290351 HSALNT0290351]
| |
| − | |[[Uc004bbl.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290369 HSALNT0290369]
| |
| − | |[[VNN2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289577 HSALNT0289577]
| |
| − | |[[AK022798]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289663 HSALNT0289663]
| |
| − | |[[C1orf74]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289602 HSALNT0289602]
| |
| − | |[[AKR7L]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289711 HSALNT0289711]
| |
| − | |[[COL3A1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289878 HSALNT0289878]
| |
| − | |[[KCNE2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289636 HSALNT0289636]
| |
| − | |[[BC015134]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289713 HSALNT0289713] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0234176 HSALNT0234176] |
| − | |[[CR594506]] | + | |[[ARLNC1]] |
| − | |NA | + | |_ |
| − | |NA | + | |_ |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289928 HSALNT0289928]
| |
| − | |[[LincRNA-BBOX1-2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271719 HSALNT0271719]
| |
| − | |[[LINC00320]]
| |
| − | |PRED14,FLJ37539
| |
| − | |NA
| |
| − | |pathogenic process;developmental process
| |
| − | |cortical white matter
| |
| − | |Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289823 HSALNT0289823]
| |
| − | |[[EVADR]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |pancreatic cancer;lung cancer;colorectal cancer;rectal cancer
| |
| − | |Respiratory Tract Diseases;Endocrine System Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289944 HSALNT0289944]
| |
| − | |[[Lnc_bc060912]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289952 HSALNT0289952]
| |
| − | |[[Lnc-bc060912]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289613 HSALNT0289613]
| |
| − | |[[APF]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |myocardial infarction
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289617 HSALNT0289617]
| |
| − | |[[AS Uchl1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Parkinson's disease
| |
| − | |Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289104 HSALNT0289104]
| |
| − | |[[LINC01296]]
| |
| − | |FLJ39632
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290403 HSALNT0290403]
| |
| − | |[[ZXF2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290113 HSALNT0290113]
| |
| − | |[[P14695]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290114 HSALNT0290114]
| |
| − | |[[P16984]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290115 HSALNT0290115]
| |
| − | |[[P19780]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290116 HSALNT0290116]
| |
| − | |[[P23099]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290117 HSALNT0290117]
| |
| − | |[[P24363]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290118 HSALNT0290118]
| |
| − | |[[P28210]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290120 HSALNT0290120]
| |
| − | |[[P33863]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290121 HSALNT0290121]
| |
| − | |[[P4091]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290122 HSALNT0290122]
| |
| − | |[[P6391]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290123 HSALNT0290123]
| |
| − | |[[P6488]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290124 HSALNT0290124]
| |
| − | |[[P700]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290125 HSALNT0290125]
| |
| − | |[[P8611]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290126 HSALNT0290126]
| |
| − | |[[P8725]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290127 HSALNT0290127]
| |
| − | |[[P8860]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290128 HSALNT0290128]
| |
| − | |[[P9745]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289269 HSALNT0289269]
| |
| − | |[[TH2LCRR]]
| |
| − | |TH2-LCR
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |allergic asthma
| |
| − | |Respiratory Tract Diseases;Immune System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289964 HSALNT0289964]
| |
| − | |[[Lnc-LCE5A-1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |laryngeal cancer;head and neck squamous cell cancer
| |
| − | |Respiratory Tract Diseases;Otorhinolaryngologic Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0055198 HSALNT0055198]
| |
| − | |[[FAM3D-AS1]]
| |
| − | |lnc-KCTD6-3
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |tongue cancer;pharyngeal cancer;head and neck squamous cell cancer;laryngeal cancer
| |
| − | |Respiratory Tract Diseases;Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289843 HSALNT0289843]
| |
| − | |[[FRLnc1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0242005 HSALNT0242005]
| |
| − | |[[ENST00000575202]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288952 HSALNT0288952]
| |
| − | |[[ENST00000539009]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288954 HSALNT0288954]
| |
| − | |[[ENST00000544591]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289752 HSALNT0289752]
| |
| − | |[[EHHADH-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289812 HSALNT0289812]
| |
| − | |[[ENST00000468960]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290276 HSALNT0290276]
| |
| − | |[[TCONS_00026506]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189952 HSALNT0189952]
| |
| − | |[[LRP1-AS]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |Alzheimer's disease
| |
| − | |Mental Disorders;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0032045 HSALNT0032045]
| |
| − | |[[LINC01122]]
| |
| − | |FLJ30838,AC007092.1
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289565 HSALNT0289565]
| |
| − | |[[AI364715]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289921 HSALNT0289921]
| |
| − | |[[LINC0949]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |systemic lupus erythematosus
| |
| − | |Immune System Diseases;Skin and Connective Tissue Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289680 HSALNT0289680]
| |
| − | |[[CCAL]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289079 HSALNT0289079]
| |
| − | |[[LINC00993]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289811 HSALNT0289811]
| |
| − | |[[ENST00000460164]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |triple-negative breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290282 HSALNT0290282]
| |
| − | |[[TCONS_l2_00003938]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |triple-negative breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289888 HSALNT0289888]
| |
| − | |[[LGALS3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |papillary thyroid cancer
| |
| − | |Endocrine System Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289963 HSALNT0289963]
| |
| − | |[[Lnc-KCMF1-2:1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |papillary thyroid cancer
| |
| − | |Endocrine System Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289967 HSALNT0289967]
| |
| − | |[[Lnc-LLPH-2:1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |papillary thyroid cancer
| |
| − | |Endocrine System Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289971 HSALNT0289971]
| |
| − | |[[Lnc-PLA2R1-1:1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |papillary thyroid cancer
| |
| − | |Endocrine System Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289972 HSALNT0289972]
| |
| − | |[[Lnc-PSD4-1:14]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |papillary thyroid cancer
| |
| − | |Endocrine System Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290066 HSALNT0290066]
| |
| − | |[[N335550]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |papillary thyroid cancer
| |
| − | |Endocrine System Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290070 HSALNT0290070]
| |
| − | |[[N340790]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |papillary thyroid cancer
| |
| − | |Endocrine System Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290072 HSALNT0290072]
| |
| − | |[[N386477]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |papillary thyroid cancer
| |
| − | |Endocrine System Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290286 HSALNT0290286]
| |
| − | |[[TCONS_l2_00010365]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |papillary thyroid cancer
| |
| − | |Endocrine System Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288944 HSALNT0288944]
| |
| − | |[[ENST00000422494]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289118 HSALNT0289118]
| |
| − | |[[LINC01612]]
| |
| − | |RP11-789C1.1,TCONS_00008319
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289610 HSALNT0289610]
| |
| − | |[[AP001439.2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289671 HSALNT0289671]
| |
| − | |[[CACNAICAS3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289853 HSALNT0289853]
| |
| − | |[[GS1-5L10.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289875 HSALNT0289875]
| |
| − | |[[INTS7]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290065 HSALNT0290065]
| |
| − | |[[MYLK-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290157 HSALNT0290157]
| |
| − | |[[PRSS21]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290202 HSALNT0290202]
| |
| − | |[[RP11-528G1.2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290207 HSALNT0290207]
| |
| − | |[[RP11-643M14.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290209 HSALNT0290209]
| |
| − | |[[RP11-789C1.1]]
| |
| − | |LINC01612
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290314 HSALNT0290314]
| |
| − | |[[TSNAX-DISC1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290386 HSALNT0290386]
| |
| − | |[[XLOC_010235]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289558 HSALNT0289558]
| |
| − | |[[AF075041]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |pancreatic cancer
| |
| − | |Endocrine System Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289564 HSALNT0289564]
| |
| − | |[[AF339813]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |pancreatic cancer
| |
| − | |Endocrine System Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289575 HSALNT0289575]
| |
| − | |[[AK022029]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |pancreatic cancer
| |
| − | |Endocrine System Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289576 HSALNT0289576]
| |
| − | |[[AK022159]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |pancreatic cancer
| |
| − | |Endocrine System Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289604 HSALNT0289604]
| |
| − | |[[AL389956]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |pancreatic cancer
| |
| − | |Endocrine System Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289640 HSALNT0289640]
| |
| − | |[[BC023629]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |pancreatic cancer
| |
| − | |Endocrine System Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290096 HSALNT0290096]
| |
| − | |[[NONHSAT125629]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290393 HSALNT0290393]
| |
| − | |[[XR_250621.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288951 HSALNT0288951]
| |
| − | |[[ENST00000503938]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |triple-negative breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290085 HSALNT0290085]
| |
| − | |[[NONHSAT012762]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |triple-negative breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289151 HSALNT0289151]
| |
| − | |[[LMCD1-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |acute kidney injury
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289926 HSALNT0289926]
| |
| − | |[[Linc-PXN-1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| | |prostate cancer | | |prostate cancer |
| − | |Male Urogenital Diseases;Neoplasms | + | |Male Urogenital Diseases |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290281 HSALNT0290281]
| |
| − | |[[TCONS_l2_00001418]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290285 HSALNT0290285]
| |
| − | |[[TCONS_l2_00008237]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290287 HSALNT0290287]
| |
| − | |[[TCONS_l2_00011130]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290288 HSALNT0290288]
| |
| − | |[[TCONS_l2_00013175]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290294 HSALNT0290294]
| |
| − | |[[TCONS_l2_00022611]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290295 HSALNT0290295]
| |
| − | |[[TCONS_l2_00022670]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290352 HSALNT0290352]
| |
| − | |[[Uc004bdv.3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290363 HSALNT0290363]
| |
| − | |[[ULK4P2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289942 HSALNT0289942]
| |
| − | |[[LK4P2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289538 HSALNT0289538]
| |
| − | |[[AB019562]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hypopharyngeal squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091661 HSALNT0091661]
| |
| − | |[[ENST00000503710]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |endometrial cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289806 HSALNT0289806]
| |
| − | |[[ENST00000445734]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |endometrial cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289807 HSALNT0289807]
| |
| − | |[[ENST00000448093]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |endometrial cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289815 HSALNT0289815]
| |
| − | |[[ENST00000502941]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |endometrial cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290340 HSALNT0290340]
| |
| − | |[[Uc002nbr.3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |endometrial cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290348 HSALNT0290348]
| |
| − | |[[Uc003xut.]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |endometrial cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290356 HSALNT0290356]
| |
| − | |[[Uc021re1.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |endometrial cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289549 HSALNT0289549]
| |
| − | |[[AC016745.3]]
| |
| − | |AC016745.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |glioma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290180 HSALNT0290180]
| |
| − | |[[RP11-128A17.1]]
| |
| − | |AC078909.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |glioma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290377 HSALNT0290377]
| |
| − | |[[XLOC_001711]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |glioma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289975 HSALNT0289975]
| |
| − | |[[LncRNA-AK058003]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289061 HSALNT0289061]
| |
| − | |[[LINC00682]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289305 HSALNT0289305]
| |
| − | |[[LINC01559]]
| |
| − | |FLJ33810
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Huntington disease
| |
| − | |Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289854 HSALNT0289854]
| |
| − | |[[GSTT1-AS1]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |mycobacterium tuberculosis infection
| |
| − | |Bacterial Infections and Mycoses
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289978 HSALNT0289978]
| |
| − | |[[LncRNA-CD244]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |tuberculosis infection
| |
| − | |Bacterial Infections and Mycoses
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289237 HSALNT0289237]
| |
| − | |[[SAMD12-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |neuroblastoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290179 HSALNT0290179]
| |
| − | |[[RP11-119F7.4]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290278 HSALNT0290278]
| |
| − | |[[TCONS_00068220]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0285573 HSALNT0285573]
| + | |[[MPPED2-AS1]] |
| − | |[[DANT1]] | + | |_ |
| − | |NA | + | |_ |
| − | |transcriptional regulation
| + | |thyroid neoplasias |
| − | |NA | + | |Endocrine system Disease |
| − | |NA | |
| − | |NA | |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288926 HSALNT0288926]
| |
| − | |[[DANT2]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290399 HSALNT0290399]
| + | |[[ZKSCAN2-DT]] |
| − | |[[ZMAT1]] | + | |_ |
| − | |NA | + | |_ |
| − | |NA
| + | |Hepatocellular carcinoma |
| − | |pathogenic process | + | |Digestive system Diseases |
| − | |gastric cancer | |
| − | |Neoplasms;Digestive System Diseases | |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289554 HSALNT0289554]
| |
| − | |[[AC100865.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |coronary artery disease
| |
| − | |Cardiovascular Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289228 HSALNT0289228] | + | |[[LINC01703]] |
| − | |[[RAD51-AS1]]
| + | |_ |
| − | |TODRA
| + | |_ |
| − | |transcriptional regulation
| + | |Hepatocellular carcinoma |
| − | |pathogenic process
| + | |Digestive system Diseases |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289743 HSALNT0289743]
| |
| − | |[[DKFZP434K028]]
| |
| − | |NA
| |
| − | |NA | |
| − | |pathogenic process | |
| − | |gastric cancer | |
| − | |Neoplasms;Digestive System Diseases | |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289630 HSALNT0289630] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0144162 HSALNT0144162] |
| − | |[[BC002811]] | + | |[[HPYR1]] |
| − | |NA | + | |_ |
| − | |NA
| |
| | |pathogenic process | | |pathogenic process |
| − | |astrocytoma | + | |H. pylori infection |
| − | |Neoplasms | + | |_ |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290387 HSALNT0290387] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0172266 HSALNT0172266] |
| − | |[[XLOC_010967]] | + | |[[LINC00958]] |
| − | |NA | + | |protein localization,transcriptional regulation |
| − | |NA
| |
| | |pathogenic process | | |pathogenic process |
| − | |astrocytoma | + | |bladder cancer, glioma |
| − | |Neoplasms | + | |_ |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288955 HSALNT0288955] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0167574 HSALNT0167574] |
| − | |[[ENST00000545440]] | + | |[[SH3PXD2A-AS1]] |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |pediatric acute myeloid leukemia
| |
| − | |Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288981 HSALNT0288981]
| |
| − | |[[FRGCA]]
| |
| − | |LncRNA-AP001631.9
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289976 HSALNT0289976]
| |
| − | |[[LncRNA-AP001631.9]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289686 HSALNT0289686]
| |
| − | |[[CD99P1]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |idiopathic pulmonary fibrosis
| |
| − | |Respiratory Tract Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289119 HSALNT0289119]
| |
| − | |[[LINC01613]]
| |
| − | |n341773
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |idiopathic pulmonary fibrosis
| |
| − | |Respiratory Tract Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289844 HSALNT0289844]
| |
| − | |[[FTH1P3]]
| |
| − | |FTH1P3
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |oral squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289855 HSALNT0289855]
| |
| − | |[[GTF2IRD2P1]]
| |
| − | |GTF2IRD2P1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |oral squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290135 HSALNT0290135]
| |
| − | |[[PDIA3F]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |oral squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289329 HSALNT0289329]
| |
| − | |[[LINC00994]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |inflammatory bowel disease
| |
| − | |Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289208 HSALNT0289208]
| |
| − | |[[PCAT5]]
| |
| − | |LINC01452,TPCAT-10-36067
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0114870 HSALNT0114870]
| |
| − | |[[LUADT1]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289154 HSALNT0289154]
| |
| − | |[[LOXL1-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |exfoliation syndrome
| |
| − | |Eye Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289734 HSALNT0289734]
| |
| − | |[[DACOR1]]
| |
| − | |TCONS_00023265
| |
| | |transcriptional regulation | | |transcriptional regulation |
| | |pathogenic process | | |pathogenic process |
| | |colorectal cancer | | |colorectal cancer |
| − | |Neoplasms;Digestive System Diseases | + | |_ |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289060 HSALNT0289060]
| |
| − | |[[LINC00675]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Pancreatic ductal adenocarcinoma
| |
| − | |Neoplasms
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288889 HSALNT0288889]
| + | |[[SSTR5-AS1]] |
| − | |[[B4GALT1-AS1]] | |
| − | |NA
| |
| | |transcriptional regulation | | |transcriptional regulation |
| | |pathogenic process | | |pathogenic process |
| − | |NA | + | |neuroendocrine prostate cancer |
| − | |NA
| + | |_ |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289348 HSALNT0289348]
| |
| − | |[[LINC01616]]
| |
| − | |n341006
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Alzheimer's disease
| |
| − | |Mental Disorders;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290068 HSALNT0290068]
| |
| − | |[[N336934]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Alzheimer's disease
| |
| − | |Mental Disorders;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290240 HSALNT0290240]
| |
| − | |[[SIRT1-AS]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290198 HSALNT0290198]
| |
| − | |[[RP11-457M11.2]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0150768 HSALNT0150768]
| |
| − | |[[LINC01507]]
| |
| − | |XLOC_000303
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases | |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289903 HSALNT0289903]
| |
| − | |[[LINC01057]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289914 HSALNT0289914]
| + | |[[TSPOAP1-AS1]] |
| − | |[[LINC01617]]
| + | |_ |
| − | |C8orf23,NCRNA00249,XLOC_006844
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290015 HSALNT0290015]
| |
| − | |[[LOC152578]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072252 HSALNT0072252]
| |
| − | |[[LINC01618]]
| |
| − | |LOC152578
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0156870 HSALNT0156870]
| |
| − | |[[NALT1]]
| |
| − | |MIR4674HG,LINC01573,TCONS_l2_00029132
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |acute lymphoblastic leukemia
| |
| − | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289083 HSALNT0289083]
| |
| − | |[[MALINC1]]
| |
| − | |LINC01024,MA-linc1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |human breast and lung cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289902 HSALNT0289902]
| |
| − | |[[LINC01024]] | |
| − | |MA-linc1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |osteosarcoma;lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289120 HSALNT0289120]
| |
| − | |[[LINC01627]]
| |
| − | |RP11-397D12.4
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289121 HSALNT0289121]
| |
| − | |[[LINC01628]]
| |
| − | |AC007403.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289820 HSALNT0289820]
| |
| − | |[[ERICH1-AS1]]
| |
| − | |NA | |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290193 HSALNT0290193]
| |
| − | |[[RP11-397D12.4]]
| |
| − | |LINC01627
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289122 HSALNT0289122]
| |
| − | |[[LINC01629]]
| |
| − | |linc-KIAA1737-2
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |hypoxic and inflammatory renal epithelial injury
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290161 HSALNT0290161]
| |
| − | |[[PTPRG-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| | |pathogenic process | | |pathogenic process |
| | |breast cancer | | |breast cancer |
| − | |Skin and Connective Tissue Diseases;Neoplasms | + | |_ |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289980 HSALNT0289980]
| |
| − | |[[LncRNA-DLEU1]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289983 HSALNT0289983]
| |
| − | |[[LncRNA-Hh]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288986 HSALNT0288986]
| |
| − | |[[GAS1RR]]
| |
| − | |LncRNA-Hh
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288908 HSALNT0288908]
| |
| − | |[[CCDC18-AS1]]
| |
| − | |ENST00000440778.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |adolescent idiopathic scoliosis
| |
| − | |Musculoskeletal Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289055 HSALNT0289055]
| |
| − | |[[LINC00649]]
| |
| − | |TCONS_00028768
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |adolescent idiopathic scoliosis
| |
| − | |Musculoskeletal Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289219 HSALNT0289219]
| |
| − | |[[PRKCQ-AS1]]
| |
| − | |ENST00000414894.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |adolescent idiopathic scoliosis
| |
| − | |Musculoskeletal Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290203 HSALNT0290203]
| |
| − | |[[RP11-567G11.1]]
| |
| − | |LINC02041
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |pancreatic cancer
| |
| − | |Endocrine System Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289805 HSALNT0289805]
| |
| − | |[[ENST00000438550]]
| |
| − | |RPS24P1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |nasopharyngeal cancer
| |
| − | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290083 HSALNT0290083]
| |
| − | |[[NONHSAG011351]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |type 1 diabetes
| |
| − | |Nutritional and Metabolic Diseases;Endocrine System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290049 HSALNT0290049]
| |
| − | |[[MCHR2-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |psychiatric disease
| |
| − | |Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289799 HSALNT0289799]
| |
| − | |[[ENST00000414355]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cadmium toxicology
| |
| − | |Disorders of Environmental Origin
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290241 HSALNT0290241]
| |
| − | |[[SKP2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289837 HSALNT0289837]
| + | |[[LINC00174]] |
| − | |[[FLJ90757]] | |
| − | |NA
| |
| | |ceRNA | | |ceRNA |
| | |pathogenic process | | |pathogenic process |
| − | |hepatocellular cancer | + | |colorectal carcinoma |
| − | |Neoplasms;Digestive System Diseases | + | |_ |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290017 HSALNT0290017] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0169064 HSALNT0169064] |
| − | |[[LOC283663]] | + | |[[LINC01561]] |
| − | |NA
| |
| | |ceRNA | | |ceRNA |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290019 HSALNT0290019]
| |
| − | |[[LOC338651]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290132 HSALNT0290132]
| |
| − | |[[PCATs]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0086786 HSALNT0086786]
| |
| − | |[[EGFLAM-AS1]]
| |
| − | |lncRNA-LOWEG
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290031 HSALNT0290031]
| |
| − | |[[LOWEG]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289635 HSALNT0289635]
| |
| − | |[[BC014579]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289721 HSALNT0289721]
| |
| − | |[[CTB-167B5.2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289863 HSALNT0289863]
| |
| − | |[[HELLS]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |leukemia
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290195 HSALNT0290195]
| |
| − | |[[RP11-401P9.4]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290252 HSALNT0290252]
| |
| − | |[[SNHG19]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289557 HSALNT0289557]
| |
| − | |[[AF070632]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289569 HSALNT0289569]
| |
| − | |[[AK021443]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289728 HSALNT0289728]
| |
| − | |[[CTD-3080P12.3]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289987 HSALNT0289987]
| |
| − | |[[LncRNA-n336928]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |bladder cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289723 HSALNT0289723]
| |
| − | |[[CTC-523E23.5]]
| |
| − | |AC008555.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |intervertebral disc degeneration
| |
| − | |Musculoskeletal Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289724 HSALNT0289724]
| |
| − | |[[CTD-2246P4.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |intervertebral disc degeneration
| |
| − | |Musculoskeletal Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290055 HSALNT0290055]
| |
| − | |[[MIR132]]
| |
| − | |MIRN132,miRNA132,mir-132
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |intervertebral disc degeneration
| |
| − | |Musculoskeletal Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290189 HSALNT0290189]
| |
| − | |[[RP11-363G2.4]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |intervertebral disc degeneration
| |
| − | |Musculoskeletal Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290191 HSALNT0290191]
| |
| − | |[[RP11-38F22.1]]
| |
| − | |LINC02424
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |intervertebral disc degeneration
| |
| − | |Musculoskeletal Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290223 HSALNT0290223]
| |
| − | |[[RP4-639J15.1]]
| |
| − | |AC006967.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |intervertebral disc degeneration
| |
| − | |Musculoskeletal Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290233 HSALNT0290233]
| |
| − | |[[RUNX1-IT1]]
| |
| − | |C21orf96
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288943 HSALNT0288943]
| |
| − | |[[ENST00000415964]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |pediatric acute myeloid leukemia
| |
| − | |Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290009 HSALNT0290009]
| |
| − | |[[LOC101927497]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289956 HSALNT0289956]
| |
| − | |[[Lnc-CYP4A22-2/3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |clear cell renal cell cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289999 HSALNT0289999]
| |
| − | |[[Lnc-ZNF180-2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |renal clear cell cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290086 HSALNT0290086]
| |
| − | |[[NONHSAT037832]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |papillary thyroid cancer
| |
| − | |Endocrine System Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289658 HSALNT0289658]
| |
| − | |[[BX647187]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288920 HSALNT0288920]
| |
| − | |[[CNNM3-DT]]
| |
| − | |LOC100506036
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289584 HSALNT0289584]
| |
| − | |[[AK056155]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Loeys-Dietz syndrome
| |
| − | |Musculoskeletal Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290057 HSALNT0290057]
| |
| − | |[[MR1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Loeys-Dietz syndrome
| |
| − | |Musculoskeletal Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289543 HSALNT0289543]
| |
| − | |[[AC002454.1]]
| |
| − | |AC002454.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |endometriosis
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289909 HSALNT0289909]
| |
| − | |[[LINC01420]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |systemic lupus erythematosus
| |
| − | |Immune System Diseases;Skin and Connective Tissue Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289531 HSALNT0289531]
| |
| − | |[[53BP1]]
| |
| − | |NA
| |
| − | |NA
| |
| | |pathogenic process | | |pathogenic process |
| | |breast cancer | | |breast cancer |
| − | |Skin and Connective Tissue Diseases;Neoplasms | + | |_ |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290101 HSALNT0290101]
| |
| − | |[[NR_024118]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |rheumatoid arthritis
| |
| − | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290239 HSALNT0290239] | + | |[[LINC00514]] |
| − | |[[SGO1-AS1]]
| + | |transcriptional regulation |
| − | |SGOL1-AS1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289293 HSALNT0289293]
| |
| − | |[[ZNF667-AS1]]
| |
| − | |MORT
| |
| − | |NA | |
| | |pathogenic process | | |pathogenic process |
| − | |breast cancer | + | |neuroendocrine prostate cancer |
| − | |Skin and Connective Tissue Diseases;Neoplasms | + | |_ |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289984 HSALNT0289984] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0282164 HSALNT0282164] |
| − | |[[LncRNA-HIF2PUT]] | + | |[[LINC02595]] |
| − | |NA | + | |_ |
| − | |NA
| |
| | |pathogenic process | | |pathogenic process |
| | |colorectal cancer | | |colorectal cancer |
| − | |Neoplasms;Digestive System Diseases | + | |_ |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288945 HSALNT0288945]
| |
| − | |[[ENST00000433673]]
| |
| − | |AC068282.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |polycystic ovary syndrome
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288948 HSALNT0288948]
| |
| − | |[[ENST00000454271]]
| |
| − | |AL021940.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |polycystic ovary syndrome
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289495 HSALNT0289495] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0197396 HSALNT0197396] |
| − | |[[ENST00000432431]] | + | |[[FZD10-AS1]] |
| − | |AC023128.1 | + | |_ |
| − | |NA | + | |_ |
| − | |pathogenic process | + | |_ |
| − | |polycystic ovary syndrome | + | |_ |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289918 HSALNT0289918]
| |
| − | |[[LINC01828]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |polycystic ovary syndrome
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290388 HSALNT0290388]
| + | |[[LINC01567]] |
| − | |[[XLOC_011402]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |polycystic ovary syndrome
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289873 HSALNT0289873]
| |
| − | |[[ICAM-1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289668 HSALNT0289668]
| |
| − | |[[C5T1lncRNA]] | |
| − | |NA
| |
| | |transcriptional regulation | | |transcriptional regulation |
| | |pathogenic process | | |pathogenic process |
| − | |rheumatoid arthritis | + | |colon cancer |
| − | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
| + | |_ |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289667 HSALNT0289667]
| |
| − | |[[C5T1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289666 HSALNT0289666]
| |
| − | |[[C5-OT1]]
| |
| − | |C5T1lncRNA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |rheumatoid arthritis
| |
| − | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289626 HSALNT0289626]
| |
| − | |[[AX800134]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290338 HSALNT0290338]
| |
| − | |[[Uc001ncr]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases | |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290330 HSALNT0290330]
| |
| − | |[[Uc.48+]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |diabetic neuropathic pain
| |
| − | |Male Urogenital Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289098 HSALNT0289098]
| |
| − | |[[LINC01207]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289628 HSALNT0289628]
| + | |[[ADPGK-AS1]] |
| − | |[[BALR-6]] | |
| − | |NA
| |
| | |transcriptional regulation | | |transcriptional regulation |
| − | |pathogenic process
| |
| − | |B-lymphoblastic leukemia
| |
| − | |Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290022 HSALNT0290022]
| |
| − | |[[LOC389641]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Pancreatic ductal adenocarcinoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289725 HSALNT0289725]
| |
| − | |[[CTD-2541M15]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289940 HSALNT0289940]
| |
| − | |[[LINK-A]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |triple-negative breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290107 HSALNT0290107]
| |
| − | |[[NUTF2P3]]
| |
| − | |NUTF2P3
| |
| − | |NA
| |
| | |pathogenic process | | |pathogenic process |
| | |pancreatic cancer | | |pancreatic cancer |
| − | |Endocrine System Diseases;Neoplasms;Digestive System Diseases | + | |_ |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290095 HSALNT0290095]
| |
| − | |[[NONHSAT123350]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |renal clear cell cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290362 HSALNT0290362]
| |
| − | |[[UHRF1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290366 HSALNT0290366]
| |
| − | |[[UPAT]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289307 HSALNT0289307]
| |
| − | |[[LINC00324]]
| |
| − | |FLJ34790,MGC104931
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289969 HSALNT0289969]
| |
| − | |[[Lnc-MX1-1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290024 HSALNT0290024]
| |
| − | |[[LOC400891]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289883 HSALNT0289883]
| |
| − | |[[LA16c-313D11.11]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |endometrial cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290192 HSALNT0290192]
| |
| − | |[[RP11-395G23.3]]
| |
| − | |AC027031.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |endometrial cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289742 HSALNT0289742]
| |
| − | |[[DILC]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |liver cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289957 HSALNT0289957]
| |
| − | |[[Lnc-DILC]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |liver cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289581 HSALNT0289581]
| |
| − | |[[AK027294]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290371 HSALNT0290371]
| |
| − | |[[WISP1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0206117 HSALNT0206117]
| |
| − | |[[FGF14-AS2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290131 HSALNT0290131]
| |
| − | |[[PCAT2]]
| |
| − | |CARLo-4,PCA2,TCONS_00015167
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289528 HSALNT0289528]
| |
| − | |[[2700086A05Rik]]
| |
| − | |2700086A05Rik
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |idiopathic pulmonary fibrosis
| |
| − | |Respiratory Tract Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290251 HSALNT0290251]
| |
| − | |[[SNED1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Idiopathic pulmonary fibrosis
| |
| − | |Respiratory Tract Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290333 HSALNT0290333]
| |
| − | |[[Uc.77]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |idiopathic pulmonary fibrosis
| |
| − | |Respiratory Tract Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289816 HSALNT0289816]
| |
| − | |[[ENST00000537266]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |papillary thyroid cancer
| |
| − | |Endocrine System Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289860 HSALNT0289860]
| |
| − | |[[HAGLROS]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |papillary thyroid cancer
| |
| − | |Endocrine System Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289881 HSALNT0289881]
| |
| − | |[[KRT18P55]]
| |
| − | |KRT18P55
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0229266 HSALNT0229266]
| |
| − | |[[IL21R-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |coronary artery disease
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290112 HSALNT0290112]
| |
| − | |[[OTTHUMT00000387022]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |coronary artery disease
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0000551 HSALNT0000551]
| |
| − | |[[PRKCZ-AS1]]
| |
| − | |RP11-181G12.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030981 HSALNT0030981]
| |
| − | |[[LINC01833]]
| |
| − | |RP11-89,K21.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290214 HSALNT0290214]
| |
| − | |[[RP11-89K21]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0165271 HSALNT0165271]
| |
| − | |[[LINC00857]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290109 HSALNT0290109]
| |
| − | |[[OR3A4]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290046 HSALNT0290046]
| |
| − | |[[MAGI1-IT1]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |cardiac hypertrophy
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290242 HSALNT0290242]
| |
| − | |[[SLC26A4-AS1]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |cardiac hypertrophy
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289302 HSALNT0289302]
| |
| − | |[[KRT7-AS]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0218672 HSALNT0218672]
| |
| − | |[[LINC01852]]
| |
| − | |ENST00000434223
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290178 HSALNT0290178]
| |
| − | |[[RP11-1008C21.2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289592 HSALNT0289592]
| |
| − | |[[AK123072]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289573 HSALNT0289573]
| |
| − | |[[AK021954]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |atherosclerosis
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288916 HSALNT0288916]
| |
| − | |[[CERNA1]]
| |
| − | |LOC100129973
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |cardiovascular disease
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0018525 HSALNT0018525]
| |
| − | |[[LAMC1-AS1]]
| |
| − | |lnc-LAMC2-1:1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290087 HSALNT0290087]
| |
| − | |[[NONHSAT040387]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |atrial fibrillation
| |
| − | |Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290092 HSALNT0290092]
| |
| − | |[[NONHSAT098586]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |atrial fibrillation
| |
| − | |Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289213 HSALNT0289213]
| |
| − | |[[PCSK6-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289637 HSALNT0289637]
| |
| − | |[[BC016831]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289874 HSALNT0289874]
| |
| − | |[[IGKV]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290196 HSALNT0290196]
| |
| − | |[[RP11-434D9.1]]
| |
| − | |AC112206.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289885 HSALNT0289885]
| |
| − | |[[LCAL6]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289650 HSALNT0289650]
| |
| − | |[[BC088254]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |myocardial hypertrophy
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289596 HSALNT0289596]
| |
| − | |[[AK124454]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289731 HSALNT0289731]
| |
| − | |[[CYP4B1-PS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |diabetic nephropathy
| |
| − | |Endocrine System Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289106 HSALNT0289106]
| |
| − | |[[LINC01405]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290259 HSALNT0290259]
| |
| − | |[[ST8SIA6-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289278 HSALNT0289278]
| |
| − | |[[TRIM52-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |renal cell cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289634 HSALNT0289634]
| |
| − | |[[BC012900]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ulcerative colitis
| |
| − | |Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274011 HSALNT0274011]
| |
| − | |[[UMODL1-AS1]]
| |
| − | |FLJ33471
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289454 HSALNT0289454]
| |
| − | |[[ARRDC1-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289456 HSALNT0289456]
| |
| − | |[[FAM74A3]]
| |
| − | |OTTHUMG00000067149
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289834 HSALNT0289834]
| |
| − | |[[FH]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Fumarase deficiency
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289961 HSALNT0289961]
| |
| − | |[[Lnc-HOXC4-3:1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289994 HSALNT0289994]
| |
| − | |[[Lnc-TEAD4-1:1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290270 HSALNT0290270]
| |
| − | |[[TCONS_00003876]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289825 HSALNT0289825]
| |
| − | |[[EVI1]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290235 HSALNT0290235]
| |
| − | |[[SARCC]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |renal cell cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290360 HSALNT0290360]
| |
| − | |[[Ucoo2kmd.1]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289015 HSALNT0289015]
| |
| − | |[[KAZN-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289722 HSALNT0289722]
| |
| − | |[[CTB-89H12.4]]
| |
| − | |AC021078.1
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289496 HSALNT0289496]
| |
| − | |[[EPB41L4A-AS2]]
| |
| − | |FLJ11235
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer;breast cancer;kidney cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289146 HSALNT0289146]
| |
| − | |[[LINC02567]]
| |
| − | |ENST00000427806
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |attention deficit hyperactivity disorder
| |
| − | |Mental Disorders
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289833 HSALNT0289833]
| |
| − | |[[FGFR3-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |osteosarcoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289707 HSALNT0289707]
| |
| − | |[[CILinc01]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |osteoarthritis
| |
| − | |Musculoskeletal Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289708 HSALNT0289708]
| |
| − | |[[CILinc02]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |osteoarthritis
| |
| − | |Musculoskeletal Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0286597 HSALNT0286597]
| |
| − | |[[LINC00629]]
| |
| − | |LINC00629AB,LINC00629C,LINC00629D,LINC00629
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |choriocarcinoma
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289665 HSALNT0289665]
| |
| − | |[[C2dat1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ischemic brain injury
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289217 HSALNT0289217]
| |
| − | |[[POU6F2-AS2]]
| |
| − | |FLJ12971
| |
| − | |protein localization
| |
| − | |pathogenic process
| |
| − | |oesophageal squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289946 HSALNT0289946]
| |
| − | |[[Lnc13]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |celiac disease
| |
| − | |Nutritional and Metabolic Diseases;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289729 HSALNT0289729]
| |
| − | |[[CTD903]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290093 HSALNT0290093]
| |
| − | |[[NONHSAT104436]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |esophageal squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289550 HSALNT0289550]
| |
| − | |[[AC024560.2]]
| |
| − | |AC024560.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cervical cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289483 HSALNT0289483]
| |
| − | |[[ENST00000436681]]
| |
| − | |AP000552.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |congenital heart defect
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289536 HSALNT0289536]
| |
| − | |[[AA584040]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |congenital heart defect
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289537 HSALNT0289537]
| |
| − | |[[AA709223]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |congenital heart defect
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289657 HSALNT0289657]
| |
| − | |[[BX478947]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |congenital heart defect
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247515 HSALNT0247515]
| |
| − | |[[LINC00668]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289719 HSALNT0289719]
| |
| − | |[[CRNDE-h]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0142879 HSALNT0142879]
| |
| − | |[[SMILR]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |vascular pathologies
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290396 HSALNT0290396]
| |
| − | |[[Z38]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0197213 HSALNT0197213]
| |
| − | |[[LINC00507]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |developmental process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289086 HSALNT0289086]
| |
| − | |[[LINC01082]]
| |
| − | |TCONSNA00024492
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |alveolar capillary dysplasia with misalignment of pulmonary veins
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289094 HSALNT0289094]
| |
| − | |[[LINC01185]]
| |
| − | |FLJ16341
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290160 HSALNT0290160]
| |
| − | |[[PTPRD-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ovarian cancer
| |
| − | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290186 HSALNT0290186]
| |
| − | |[[RP11-254I22.1]]
| |
| − | |MIR583HG
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ovarian cancer
| |
| − | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290204 HSALNT0290204]
| |
| − | |[[RP11-57P19.1]]
| |
| − | |AC009432.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ovarian cancer
| |
| − | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290211 HSALNT0290211]
| |
| − | |[[RP11-80H5.7]]
| |
| − | |AL157400.4
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ovarian cancer
| |
| − | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290215 HSALNT0290215]
| |
| − | |[[RP1-223E5.4]]
| |
| − | |AL441883.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ovarian cancer
| |
| − | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290224 HSALNT0290224]
| |
| − | |[[RP4-799P18.3]]
| |
| − | |AL122008.4
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ovarian cancer
| |
| − | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289126 HSALNT0289126]
| |
| − | |[[LINC01844]]
| |
| − | |LOC101926975
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hirschsprung disease
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289947 HSALNT0289947]
| |
| − | |[[Lnc34a]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289150 HSALNT0289150]
| |
| − | |[[LINP1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289951 HSALNT0289951]
| |
| − | |[[LncARSR]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |renal cell cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289392 HSALNT0289392]
| |
| − | |[[RBM15-AS1]]
| |
| − | |AS-RBM15
| |
| − | |translational control
| |
| − | |pathogenic process
| |
| − | |acute megakaryocytic leukemia
| |
| − | |Neoplasms
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290089 HSALNT0290089] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0255381 HSALNT0255381] |
| − | |[[NONHSAT073641]] | + | |[[RAB11B-AS1]] |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |vascular diseases
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290027 HSALNT0290027]
| |
| − | |[[LOC572558]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |bladder cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289582 HSALNT0289582]
| |
| − | |[[AK033210]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process;developmental process
| |
| − | |bronchopulmonary dysplasia
| |
| − | |Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289848 HSALNT0289848]
| |
| − | |[[GClnc1]]
| |
| − | |NA
| |
| | |transcriptional regulation | | |transcriptional regulation |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289572 HSALNT0289572]
| |
| − | |[[AK021630]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Parkinson's disease
| |
| − | |Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289603 HSALNT0289603]
| |
| − | |[[AL049437]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Parkinson's disease
| |
| − | |Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290007 HSALNT0290007]
| |
| − | |[[LOC100507661]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |thyroid cancer
| |
| − | |Endocrine System Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289084 HSALNT0289084]
| |
| − | |[[LINC01029]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cognitive functions and neuronal plasticity
| |
| − | |Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290169 HSALNT0290169]
| |
| − | |[[RMEL3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |melanoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289959 HSALNT0289959]
| |
| − | |[[Lnc-FRG2C-3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ankylosing spondylitis
| |
| − | |Musculoskeletal Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289966 HSALNT0289966]
| |
| − | |[[Lnc-LIN54-1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ankylosing spondylitis
| |
| − | |Musculoskeletal Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289997 HSALNT0289997]
| |
| − | |[[Lnc-USP50-2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ankylosing spondylitis
| |
| − | |Musculoskeletal Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290000 HSALNT0290000]
| |
| − | |[[Lnc-ZNF354A-1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ankylosing spondylitis
| |
| − | |Musculoskeletal Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288949 HSALNT0288949]
| |
| − | |[[ENST00000455309]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |primary Sjögren's syndrome
| |
| − | |Immune System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289920 HSALNT0289920]
| |
| − | |[[LINC02384]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |primary Sjögren's syndrome
| |
| − | |Immune System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289998 HSALNT0289998]
| |
| − | |[[Lnc-UTS2D-1:1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |primary Sjögren's syndrome
| |
| − | |Immune System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290067 HSALNT0290067]
| |
| − | |[[N336161]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |primary Sjögren's syndrome
| |
| − | |Immune System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290069 HSALNT0290069]
| |
| − | |[[N340599]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |primary Sjögren's syndrome
| |
| − | |Immune System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290099 HSALNT0290099]
| |
| − | |[[NR_002712]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |primary Sjögren's syndrome
| |
| − | |Immune System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290290 HSALNT0290290]
| |
| − | |[[TCONS_l2_00014794]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |primary Sjögren's syndrome
| |
| − | |Immune System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290170 HSALNT0290170]
| |
| − | |[[RMRP]]
| |
| − | |CHH,NME1R,RRP2,RMRP
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289900 HSALNT0289900]
| |
| − | |[[LINC00961]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ovarian cancer
| |
| − | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289077 HSALNT0289077]
| |
| − | |[[LINC00977]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |primary spontaneous pneumothorax
| |
| − | |Respiratory Tract Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289560 HSALNT0289560]
| |
| − | |[[AF085995]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289566 HSALNT0289566]
| |
| − | |[[AK000053]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289571 HSALNT0289571]
| |
| − | |[[AK021595]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289574 HSALNT0289574]
| |
| − | |[[AK022024]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289595 HSALNT0289595]
| |
| − | |[[AK124307]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289639 HSALNT0289639]
| |
| − | |[[BC020384]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289642 HSALNT0289642]
| |
| − | |[[BC030759]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289715 HSALNT0289715]
| |
| − | |[[CR615992]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289954 HSALNT0289954]
| |
| − | |[[Lnc-CC3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cervical cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289614 HSALNT0289614]
| |
| − | |[[APOC1P1-3]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290365 HSALNT0290365]
| |
| − | |[[UNMIBC]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |bladder cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290323 HSALNT0290323]
| |
| − | |[[Uc.167]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ventricular septal defects
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290212 HSALNT0290212]
| |
| − | |[[RP11-838N2.4]]
| |
| − | |GAPLINC
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |glioblastoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289109 HSALNT0289109]
| |
| − | |[[LINC01478]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |blood pressure
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289313 HSALNT0289313]
| |
| − | |[[LINC00342]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289677 HSALNT0289677]
| |
| − | |[[CAR10]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289365 HSALNT0289365]
| |
| − | |[[MAPT-AS1]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |Parkinson's disease
| |
| − | |Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289679 HSALNT0289679]
| |
| − | |[[CAT104]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290260 HSALNT0290260]
| |
| − | |[[STXBP5-AS1]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289861 HSALNT0289861]
| |
| − | |[[HAR1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Huntington disease
| |
| − | |Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290359 HSALNT0290359]
| |
| − | |[[UCHL1-AS1]]
| |
| − | |NA
| |
| − | |translational control
| |
| − | |pathogenic process
| |
| − | |Parkinson's disease
| |
| − | |Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290238 HSALNT0290238]
| |
| − | |[[SCAANT1-AS]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |spinocerebellar ataxia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289648 HSALNT0289648]
| |
| − | |[[BC041488]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |bladder cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290188 HSALNT0290188]
| |
| − | |[[RP11-359E19.2]]
| |
| − | |AC022733.1
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |bladder cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289669 HSALNT0289669]
| |
| − | |[[C6orf176-TV1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289670 HSALNT0289670]
| |
| − | |[[C6orf176-TV2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289851 HSALNT0289851]
| |
| − | |[[GIHCG]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289649 HSALNT0289649]
| |
| − | |[[BC087858]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290353 HSALNT0290353]
| |
| − | |[[Uc004cov.4]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hypertrophic cardiomyopathy
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290357 HSALNT0290357]
| |
| − | |[[Uc022bqu.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hypertrophic cardiomyopathy
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127837 HSALNT0127837]
| |
| − | |[[CFTR-AS1]]
| |
| − | |BGas
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |cystic fibrosis
| |
| − | |Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0046367 HSALNT0046367]
| |
| − | |[[MYOSLID]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |vascular smooth muscle cell (VSMC) contractile phenotype
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290331 HSALNT0290331]
| |
| − | |[[Uc.63]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290106 HSALNT0290106]
| |
| − | |[[Numb]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |uveal melanoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289847 HSALNT0289847]
| |
| − | |[[GCASPC]]
| |
| − | |TCONS_00011605,RP1-56L9.7-001,lnc-SOD2-1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gallbladder cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289568 HSALNT0289568]
| |
| − | |[[AK001094]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289588 HSALNT0289588]
| |
| − | |[[AK093735]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289631 HSALNT0289631]
| |
| − | |[[BC003519]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290100 HSALNT0290100]
| |
| − | |[[NR_003573]]
| |
| − | |ANXA2P2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290119 HSALNT0290119]
| |
| − | |[[P2RX7-V3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |uveal melanoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290308 HSALNT0290308]
| |
| − | |[[TMSB4]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |osteoarthritis
| |
| − | |Musculoskeletal Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288928 HSALNT0288928]
| |
| − | |[[DDX11-AS1]]
| |
| − | |CONCR
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290052 HSALNT0290052]
| |
| − | |[[MELOE]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |melanoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290231 HSALNT0290231]
| |
| − | |[[RSU1P2]]
| |
| − | |RSU1P2
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |cervical cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290165 HSALNT0290165]
| |
| − | |[[RBMY2FP]]
| |
| − | |RBMY2FP
| |
| − | |NA
| |
| − | |NA
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290071 HSALNT0290071]
| |
| − | |[[N375709]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |nasopharyngeal cancer
| |
| − | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289748 HSALNT0289748]
| |
| − | |[[DUXAP8]]
| |
| − | |DUXAP8
| |
| − | |NA
| |
| − | |NA
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290030 HSALNT0290030]
| |
| − | |[[LOC729966]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |papillary thyroid cancer
| |
| − | |Endocrine System Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290143 HSALNT0290143]
| |
| − | |[[POIR]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |periodontitis
| |
| − | |Stomatognathic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0067481 HSALNT0067481]
| |
| − | |[[MELTF-AS1]]
| |
| − | |MFI2-AS1,AC068302.3
| |
| − | |NA
| |
| | |pathogenic process | | |pathogenic process |
| | |osteosarcoma | | |osteosarcoma |
| − | |Neoplasms | + | |_ |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290053 HSALNT0290053] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0237805 HSALNT0237805] |
| − | |[[MFI2]] | + | |[[SNHG29]] |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |osteosarcoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289922 HSALNT0289922]
| |
| − | |[[Linc-223]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |acute myeloid leukemia
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0014603 HSALNT0014603]
| |
| − | |[[LINC01138]]
| |
| − | |LINC00875,FLJ39739
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290262 HSALNT0290262]
| |
| − | |[[SUZ12P1]]
| |
| − | |SUZ12P1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290005 HSALNT0290005]
| |
| − | |[[LOC100505976]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |laryngeal squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290392 HSALNT0290392]
| |
| − | |[[XLOC_l2_010636]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |laryngeal squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0090295 HSALNT0090295]
| |
| − | |[[RASGRF2-AS1]]
| |
| − | |CTC-459I6.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |sepsis-induced endothelial dysfunction
| |
| − | |Bacterial Infections and Mycoses
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289852 HSALNT0289852]
| |
| − | |[[GPC3-AS1]]
| |
| − | |NA
| |
| | |transcriptional regulation | | |transcriptional regulation |
| | |pathogenic process | | |pathogenic process |
| − | |hepatocellular cancer | + | |acute myeloid leukemia, rheumatoid arthritis |
| − | |Neoplasms;Digestive System Diseases | + | |_ |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189472 HSALNT0189472]
| |
| − | |[[HOXC-AS1]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |atherosclerosis
| |
| − | |Cardiovascular Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289157 HSALNT0289157]
| + | |[[SNHG17]] |
| − | |[[LUARIS]] | |
| − | |lncRNA#32
| |
| | |transcriptional regulation | | |transcriptional regulation |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289371 HSALNT0289371]
| |
| − | |[[MIR3936HG]]
| |
| − | |LOC553103,SLC22A5-AS1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer;nasopharyngeal cancer
| |
| − | |Otorhinolaryngologic Diseases;Stomatognathic Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290148 HSALNT0290148]
| |
| − | |[[Ppp1r1b]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |congenital heart defect
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289038 HSALNT0289038]
| |
| − | |[[LINC00460]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290194 HSALNT0290194]
| |
| − | |[[RP1-13P20.6]]
| |
| − | |NA
| |
| − | |NA
| |
| | |pathogenic process | | |pathogenic process |
| | |colorectal cancer | | |colorectal cancer |
| − | |Neoplasms;Digestive System Diseases | + | |_ |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290364 HSALNT0290364]
| |
| − | |[[Unigene56159]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290355 HSALNT0290355]
| |
| − | |[[Uc009yby.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |renal cell cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289406 HSALNT0289406]
| |
| − | |[[TFAP2A-AS2]]
| |
| − | |HIPSTR
| |
| − | |NA
| |
| − | |developmental process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289704 HSALNT0289704]
| |
| − | |[[Chaer]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |cardiac hypertrophy
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289865 HSALNT0289865]
| |
| − | |[[HIF-2α]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211378 HSALNT0211378]
| |
| − | |[[LINC00520]]
| |
| − | |C14orf34
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0087374 HSALNT0087374]
| |
| − | |[[MRPS30-DT]]
| |
| − | |BRCAT54
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289388 HSALNT0289388]
| |
| − | |[[PPP1R12A-AS1]]
| |
| − | |R12A-AS1
| |
| − | |translational control
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289013 HSALNT0289013]
| |
| − | |[[ITFG2-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290088 HSALNT0290088]
| |
| − | |[[NONHSAT041499]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |schizophrenia
| |
| − | |Mental Disorders
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290091 HSALNT0290091]
| |
| − | |[[NONHSAT089447]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |schizophrenia
| |
| − | |Mental Disorders
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289970 HSALNT0289970]
| |
| − | |[[Lnc-NKX2-3-1]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |acute lymphoblastic leukemia
| |
| − | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289989 HSALNT0289989]
| |
| − | |[[Lnc-RTN4R-1]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |acute lymphoblastic leukemia
| |
| − | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289821 HSALNT0289821]
| |
| − | |[[ERL]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Marek's disease
| |
| − | |Immune System Diseases;Hemic and Lymphatic Diseases;Virus Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0192459 HSALNT0192459]
| |
| − | |[[LINC02258]]
| |
| − | |RP11-248E9.5
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |pneumonia
| |
| − | |Respiratory Tract Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0241871 HSALNT0241871]
| |
| − | |[[SKAP1-AS1]]
| |
| − | |RP11-456D7.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |pneumonia
| |
| − | |Respiratory Tract Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289439 HSALNT0289439]
| |
| − | |[[DINOL]]
| |
| − | |DINO
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288901 HSALNT0288901]
| |
| − | |[[CAMTA1-DT]]
| |
| − | |lncCAMTA1
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |liver cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290328 HSALNT0290328]
| |
| − | |[[Uc.345]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |pancreatic cancer
| |
| − | |Endocrine System Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290060 HSALNT0290060]
| |
| − | |[[MSNP1AS]]
| |
| − | |NA
| |
| − | |translational control
| |
| − | |pathogenic process
| |
| − | |autism spectrum disorder
| |
| − | |Mental Disorders
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289376 HSALNT0289376]
| |
| − | |[[NEXN-AS1]]
| |
| − | |C1orf118,FLJ90637
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0183194 HSALNT0183194]
| |
| − | |[[LINC02098]]
| |
| − | |RP11-702B10.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |esophageal cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0198055 HSALNT0198055]
| |
| − | |[[PSPC1-AS2]]
| |
| − | |RP11-523H24.3
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |esophageal cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289155 HSALNT0289155]
| |
| − | |[[LRRC75A-AS1]]
| |
| − | |C17orf45,NCRNA00188,C17orf76-AS1,FAM211A-AS1,MGC40157
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |rheumatoid arthritis
| |
| − | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289220 HSALNT0289220]
| |
| − | |[[PRKG1-AS1]]
| |
| − | |RP11-573I11.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |rheumatoid arthritis
| |
| − | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289262 HSALNT0289262]
| |
| − | |[[SVIL-AS1]]
| |
| − | |RP11-534G20.3
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |rheumatoid arthritis
| |
| − | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289281 HSALNT0289281]
| |
| − | |[[VPS33B-DT]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |rheumatoid arthritis
| |
| − | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289804 HSALNT0289804]
| |
| − | |[[ENST00000438399]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |rheumatoid arthritis
| |
| − | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290228 HSALNT0290228]
| |
| − | |[[RPKG1-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |rheumatoid arthritis
| |
| − | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290350 HSALNT0290350]
| |
| − | |[[Uc004afb.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |rheumatoid arthritis
| |
| − | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289398 HSALNT0289398]
| |
| − | |[[SLC5A4-AS1]]
| |
| − | |RP1-90G24.10
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289411 HSALNT0289411]
| |
| − | |[[TNFRSF10A-AS1]]
| |
| − | |RP11-1149O23.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289727 HSALNT0289727]
| |
| − | |[[CTD-2616J11.14]]
| |
| − | |AC008750.7
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290182 HSALNT0290182]
| |
| − | |[[RP11-150O12.3]]
| |
| − | |AC124067.4
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289730 HSALNT0289730]
| |
| − | |[[CXCL1P1]]
| |
| − | |CXCL1P1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289803 HSALNT0289803]
| |
| − | |[[ENST00000438347]]
| |
| − | |CCND3P1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289897 HSALNT0289897]
| |
| − | |[[LINC00601]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289503 HSALNT0289503]
| |
| − | |[[KIAA0087]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |endometrial cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289827 HSALNT0289827]
| |
| − | |[[FAM212B-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |endometrial cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290010 HSALNT0290010]
| |
| − | |[[LOC102723552]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |endometrial cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290181 HSALNT0290181]
| |
| − | |[[RP11-140I24]]
| |
| − | |LINC01568
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |endometrial cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290201 HSALNT0290201]
| |
| − | |[[RP11-501O2]]
| |
| − | |LINC02046
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |endometrial cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290206 HSALNT0290206]
| |
| − | |[[RP11-600K151]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |endometrial cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290084 HSALNT0290084]
| |
| − | |[[NONHSAG051968]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |papillary thyroid cancer
| |
| − | |Endocrine System Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290090 HSALNT0290090]
| |
| − | |[[NONHSAT076747]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |papillary thyroid cancer
| |
| − | |Endocrine System Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290094 HSALNT0290094]
| |
| − | |[[NONHSAT122730]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |papillary thyroid cancer
| |
| − | |Endocrine System Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0138768 HSALNT0138768]
| |
| − | |[[MIR2052HG]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289096 HSALNT0289096]
| |
| − | |[[LINC01198]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |glioma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289274 HSALNT0289274]
| |
| − | |[[TPT1-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |glioma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289924 HSALNT0289924]
| |
| − | |[[Linc-cdh4-2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0144641 HSALNT0144641]
| |
| − | |[[LINC02055]]
| |
| − | |RP1130-1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289737 HSALNT0289737]
| |
| − | |[[DBCCR1]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |bladder cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289547 HSALNT0289547]
| |
| − | |[[AC012065.7]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |chronic lymphocytic leukemia
| |
| − | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289229 HSALNT0289229]
| |
| − | |[[RAMP2-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |glioblastoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289591 HSALNT0289591]
| |
| − | |[[AK098081]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289644 HSALNT0289644]
| |
| − | |[[BC037331]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289646 HSALNT0289646]
| |
| − | |[[BC040303]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289717 HSALNT0289717]
| |
| − | |[[CR749831]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289250 HSALNT0289250]
| |
| − | |[[SNHG18]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |glioma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0106140 HSALNT0106140]
| |
| − | |[[FOXP4-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0026202 HSALNT0026202]
| |
| − | |[[RNASEH1-AS1]]
| |
| − | |LOC100506054
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288993 HSALNT0288993]
| |
| − | |[[GSEC]]
| |
| − | |ST3GAL4-AS1,DCPS-AS1,FLJ39051
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0060264 HSALNT0060264]
| |
| − | |[[DNAJB8-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0248137 HSALNT0248137]
| |
| − | |[[CHMP1B-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0021970 HSALNT0021970]
| |
| − | |[[TGFB2-AS1]]
| |
| − | |NR_046268
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |early-onset preeclampsia
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0078323 HSALNT0078323]
| |
| − | |[[SLC7A11-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |early-onset preeclampsia
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0134663 HSALNT0134663]
| |
| − | |[[INTS9-AS1]]
| |
| − | |ENST00000520055
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |early-onset preeclampsia
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0231572 HSALNT0231572]
| |
| − | |[[MMP2-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |early-onset preeclampsia
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267869 HSALNT0267869]
| |
| − | |[[SLC12A5-AS1]]
| |
| − | |RP11-465L10.10
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |early-onset preeclampsia
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288921 HSALNT0288921]
| |
| − | |[[CSMD2-AS1]]
| |
| − | |ENST00000434181
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |early-onset preeclampsia
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288997 HSALNT0288997]
| |
| − | |[[HDAC2-AS2]]
| |
| − | |ENST00000421891
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |early-onset preeclampsia
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289012 HSALNT0289012]
| |
| − | |[[INO80-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |early-onset preeclampsia
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289140 HSALNT0289140]
| |
| − | |[[LINC02247]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |early-onset preeclampsia
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289161 HSALNT0289161]
| |
| − | |[[MAGI2-AS3]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |early-onset preeclampsia
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289188 HSALNT0289188]
| |
| − | |[[MNX1-AS2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |early-onset preeclampsia
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289245 HSALNT0289245]
| |
| − | |[[SMIM10L2B-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |early-onset preeclampsia
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289407 HSALNT0289407]
| |
| − | |[[TGFB3-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |early-onset preeclampsia
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289457 HSALNT0289457]
| |
| − | |[[HSD17B3-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |early-onset preeclampsia
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289919 HSALNT0289919]
| |
| − | |[[LINC02246]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |early-onset preeclampsia
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289288 HSALNT0289288]
| |
| − | |[[ZNF710-AS1]]
| |
| − | |ENST00000558334
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |early-onset preeclampsia
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289266 HSALNT0289266]
| |
| − | |[[TDRKH-AS1]]
| |
| − | |RP11-98D18.9
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289128 HSALNT0289128]
| |
| − | |[[LINC01952]]
| |
| − | |AC004854.4
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |recurrent miscarriage
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290075 HSALNT0290075]
| |
| − | |[[NCF4-AS1]]
| |
| − | |CTA-833B7.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |recurrent miscarriage
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289360 HSALNT0289360]
| |
| − | |[[LNCSRLR]]
| |
| − | |lncRNA-SRLR
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |renal cell cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288918 HSALNT0288918]
| |
| − | |[[CFLAR-AS1]]
| |
| − | |ALS2CR10
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |esophageal squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289710 HSALNT0289710]
| |
| − | |[[COL1A2-AS1]]
| |
| − | |TCONS_00013888,lncRNA8975-1
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |hypertrophic scar
| |
| − | |Skin and Connective Tissue Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0075075 HSALNT0075075] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0215138 HSALNT0215138] |
| − | |[[LNCPRESS2]] | + | |[[DICER1-AS1]] |
| − | |lncPRESS2
| |
| | |transcriptional regulation | | |transcriptional regulation |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0011289 HSALNT0011289]
| |
| − | |[[LINC01930]]
| |
| − | |EU358092
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |schizophrenia
| |
| − | |Mental Disorders
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0097120 HSALNT0097120]
| |
| − | |[[HMMR-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |basal-like breast cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0184498 HSALNT0184498]
| |
| − | |[[CCND2-AS1]]
| |
| − | |CCND2-AS2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |glioma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289045 HSALNT0289045]
| |
| − | |[[LINC00578]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |major depression disorder
| |
| − | |Behavior and Behavior Mechanisms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288884 HSALNT0288884]
| |
| − | |[[ADAMTS9-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |epithelial ovarian cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0080041 HSALNT0080041]
| |
| − | |[[FAM198B-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0103007 HSALNT0103007]
| |
| − | |[[LINC00240]]
| |
| − | |C6orf41,NCRNA00240,bA373D17.1
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |esophageal squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289071 HSALNT0289071]
| |
| − | |[[LINC00909]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289509 HSALNT0289509]
| |
| − | |[[LINC00680]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0129070 HSALNT0129070]
| |
| − | |[[LINC00513]]
| |
| − | |AC016831.7
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289129 HSALNT0289129]
| |
| − | |[[LINC02001]]
| |
| − | |RP11-1094M14.11
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289215 HSALNT0289215]
| |
| − | |[[POC1B-AS1]]
| |
| − | |RP11-734K2.4
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289241 HSALNT0289241]
| |
| − | |[[SLC12A9-AS1]]
| |
| − | |RP11-126L15.4
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289275 HSALNT0289275]
| |
| − | |[[TRAM2-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0002243 HSALNT0002243]
| |
| − | |[[ENST00000457898.1]]
| |
| − | |ENSG00000226029
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |oesophageal cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288941 HSALNT0288941]
| |
| − | |[[ELF3-AS1]]
| |
| − | |ENST00000415582
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |papillary thyroid cancer
| |
| − | |Endocrine System Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289134 HSALNT0289134]
| |
| − | |[[LINC02158]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289350 HSALNT0289350]
| |
| − | |[[LINC01671]]
| |
| − | |BC041455
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289124 HSALNT0289124]
| |
| − | |[[LINC01684]]
| |
| − | |lnc-JAM2-6
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |nonalcoholic fatty liver disease
| |
| − | |Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289036 HSALNT0289036]
| |
| − | |[[LINC00365]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |esophageal cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289111 HSALNT0289111]
| |
| − | |[[LINC01554]]
| |
| − | |C5orf27,FLJ38821,FIS
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |esophageal cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289132 HSALNT0289132]
| |
| − | |[[LINC02154]]
| |
| − | |GS1-600G8.5
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |esophageal cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0137721 HSALNT0137721]
| |
| − | |[[LINC02155]]
| |
| − | |RP11-705O24.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |esophageal cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0225363 HSALNT0225363]
| |
| − | |[[LINC02157]]
| |
| − | |RP11-327J17.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |esophageal cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289133 HSALNT0289133]
| |
| − | |[[LINC02156]]
| |
| − | |RP1-90J4.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |esophageal cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0133924 HSALNT0133924]
| |
| − | |[[LINC02153]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |major depression disorder
| |
| − | |Behavior and Behavior Mechanisms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0181656 HSALNT0181656]
| |
| − | |[[LINC02151]]
| |
| − | |TCONS_00019174
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |major depression disorder
| |
| − | |Behavior and Behavior Mechanisms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0227367 HSALNT0227367]
| |
| − | |[[LINC02152]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |major depression disorder
| |
| − | |Behavior and Behavior Mechanisms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029246 HSALNT0029246]
| |
| − | |[[BRE-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289251 HSALNT0289251]
| |
| − | |[[SNHG26]]
| |
| − | |AC005682.5
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |bladder urothelial cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0252719 HSALNT0252719]
| |
| − | |[[LIVAR]]
| |
| − | |lnc18q22.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |nonalcoholic steatohepatiti
| |
| − | |Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289074 HSALNT0289074]
| |
| − | |[[LINC00969]]
| |
| − | |ENST00000453324
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung squamous cell cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289138 HSALNT0289138]
| |
| − | |[[LINC02243]]
| |
| − | |ENST00000441841
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung squamous cell cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289399 HSALNT0289399]
| |
| − | |[[SLC9A3-AS1]]
| |
| − | |UC011CLY.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung squamous cell cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288934 HSALNT0288934]
| |
| − | |[[DM1-AS]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |myotonic dystrophy type 1
| |
| − | |Musculoskeletal Diseases;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0009014 HSALNT0009014]
| |
| − | |[[LINC02238]]
| |
| − | |RP4-788P17.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |B cell lymphoma
| |
| − | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289163 HSALNT0289163]
| |
| − | |[[MEF2C-AS2]]
| |
| − | |CTC-467M3.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |diffuse large B-cell lymphoma
| |
| − | |Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289181 HSALNT0289181]
| |
| − | |[[MIR4422HG]]
| |
| − | |RP11-101C11.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |diffuse large B-cell lymphoma
| |
| − | |Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289403 HSALNT0289403]
| |
| − | |[[SPON1-AS1]]
| |
| − | |RP11-21,L19.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |diffuse large B-cell lymphoma
| |
| − | |Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289461 HSALNT0289461]
| |
| − | |[[CD44-AS1]]
| |
| − | |RP1-68D18.4
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |diffuse large B-cell lymphoma
| |
| − | |Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262277 HSALNT0262277]
| |
| − | |[[LILRB1-AS1]]
| |
| − | |AC009892.10
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0282241 HSALNT0282241]
| |
| − | |[[LINC01186]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289168 HSALNT0289168]
| |
| − | |[[MHENCR]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |melanoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072994 HSALNT0072994]
| |
| − | |[[LINC02232]]
| |
| − | |RP11-707A18.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0080161 HSALNT0080161]
| |
| − | |[[LINC02233]]
| |
| − | |RP11-6C14.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0084027 HSALNT0084027]
| |
| − | |[[LINC02236]]
| |
| − | |RP11-332J15.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091870 HSALNT0091870]
| |
| − | |[[LINC02234]]
| |
| − | |RP11-455B3.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0139521 HSALNT0139521]
| |
| − | |[[LINC02235]]
| |
| − | |RP11-354A14.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0142040 HSALNT0142040]
| |
| − | |[[LINC02237]]
| |
| − | |RP11-1101K5.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289135 HSALNT0289135]
| |
| − | |[[LINC02179]]
| |
| − | |RP11-189E14.4
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289351 HSALNT0289351]
| |
| − | |[[LINC01689]]
| |
| − | |AP000469.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289137 HSALNT0289137]
| |
| − | |[[LINC02231]]
| |
| − | |RP11-766N7.4
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Esophageal squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0220239 HSALNT0220239]
| |
| − | |[[MIR4713HG]]
| |
| − | |RP11-108K3.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288967 HSALNT0288967]
| |
| − | |[[FAM160A1-DT]]
| |
| − | |RP11-610P16.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289239 HSALNT0289239]
| |
| − | |[[SATB2-AS1]]
| |
| − | |NA
| |
| − | |translational control
| |
| | |pathogenic process | | |pathogenic process |
| | |osteosarcoma | | |osteosarcoma |
| − | |Neoplasms | + | |_ |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289512 HSALNT0289512]
| |
| − | |[[LINC01826]]
| |
| − | |lnc-MKI67IP-3
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |atherosclerosis
| |
| − | |Cardiovascular Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289024 HSALNT0289024] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0043929 HSALNT0043929] |
| − | |[[LINC00226]] | + | |[[TTN-AS1]] |
| − | |C14orf97,NCRNA00226
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |pancreatic ductaladenocarcinoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0082192 HSALNT0082192]
| |
| − | |[[F11-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0219108 HSALNT0219108]
| |
| − | |[[SPINT1-AS1]]
| |
| − | |RP11-532F12.5
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |melanoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289177 HSALNT0289177]
| |
| − | |[[MIR200CHG]]
| |
| − | |U47924.27
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |melanoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289328 HSALNT0289328]
| |
| − | |[[LINC00888]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |melanoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289309 HSALNT0289309]
| |
| − | |[[LINC00672]]
| |
| − | |NA
| |
| | |transcriptional regulation | | |transcriptional regulation |
| | |pathogenic process | | |pathogenic process |
| − | |endometrial cancer | + | |esophageal squamous cell carcinoma |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | + | |_ |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289198 HSALNT0289198]
| |
| − | |[[P4HA3-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |parkinson's disease
| |
| − | |Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0197312 HSALNT0197312]
| |
| − | |[[TMEM132D-AS1]]
| |
| − | |LOC283352
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |human dermal fibroblasts
| |
| − | |Cell Physiological Phenomena
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289472 HSALNT0289472] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0152594 HSALNT0152594] |
| − | |[[ATP2C2-AS1]] | + | |[[LINC00092]] |
| − | |RP11-517C16.2-001
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0233849 HSALNT0233849]
| |
| − | |[[WWOX-AS1]]
| |
| − | |RP11-190D6.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |epithelial ovarian cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0128829 HSALNT0128829]
| |
| − | |[[FLNC-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cervical squamous cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289889 HSALNT0289889]
| |
| − | |[[LIF-AS1]]
| |
| − | |Lnc-LIF-AS
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cervical squamous cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0011283 HSALNT0011283]
| |
| − | |[[DPYD-AS2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cervical squamous cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289836 HSALNT0289836]
| |
| − | |[[FLICR]]
| |
| − | |NA
| |
| | |transcriptional regulation | | |transcriptional regulation |
| − | |pathogenic process
| |
| − | |autoimmune diabete
| |
| − | |Immune System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289356 HSALNT0289356]
| |
| − | |[[LINC02402]]
| |
| − | |ENST00000550337.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |diabetes
| |
| − | |Endocrine System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0137118 HSALNT0137118]
| |
| − | |[[CERNA3]]
| |
| − | |CTA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |osteosarcoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0090838 HSALNT0090838]
| |
| − | |[[LINC02488]]
| |
| − | |CTD-2316B1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0174947 HSALNT0174947]
| |
| − | |[[LINC02489]]
| |
| − | |CTD-2589M5
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0220441 HSALNT0220441]
| |
| − | |[[LINC02490]]
| |
| − | |RP11-209E8
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289260 HSALNT0289260]
| |
| − | |[[STK32A-AS1]]
| |
| − | |CTC-255N20
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289143 HSALNT0289143]
| |
| − | |[[LINC02487]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0095585 HSALNT0095585]
| |
| − | |[[SPRY4-AS1]]
| |
| − | |THCAT68
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |bladder cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288927 HSALNT0288927]
| |
| − | |[[DDN-AS1]]
| |
| − | |CAT1507
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |bladder cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0012862 HSALNT0012862]
| |
| − | |[[SLC16A1-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |acute myocardial infarction
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289412 HSALNT0289412]
| |
| − | |[[TNFRSF14-AS1]]
| |
| − | |ENST00000416860.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |acute myocardial infarction
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0259139 HSALNT0259139]
| |
| − | |[[LINC00665]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0040268 HSALNT0040268]
| |
| − | |[[DARS-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |renal disease
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288913 HSALNT0288913]
| |
| − | |[[CEBPA-AS1]]
| |
| − | |CEBPA-DT
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289011 HSALNT0289011]
| |
| − | |[[INHBA-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288988 HSALNT0288988]
| |
| − | |[[GASAL1]]
| |
| − | |GASL1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |liver cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289127 HSALNT0289127]
| |
| − | |[[LINC01857]]
| |
| − | |AC079767.4
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |tuberculosis
| |
| − | |Bacterial Infections and Mycoses
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289091 HSALNT0289091]
| |
| − | |[[LINC01140]]
| |
| − | |FLJ41676
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0281957 HSALNT0281957]
| |
| − | |[[PINCR]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289344 HSALNT0289344]
| |
| − | |[[LINC00890]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |leiomyoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0019828 HSALNT0019828]
| |
| − | |[[LINC00862]]
| |
| − | |C1orf98,SMIM16
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cystic fibrosis
| |
| − | |Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0073790 HSALNT0073790]
| |
| − | |[[LINC02562]]
| |
| − | |RP11-44F21.5
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cystic fibrosis
| |
| − | |Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0263101 HSALNT0263101]
| |
| − | |[[LINC02560]]
| |
| − | |CTD-2619J13.13
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cystic fibrosis
| |
| − | |Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289144 HSALNT0289144]
| |
| − | |[[LINC02551]]
| |
| − | |RP11-890B15.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cystic fibrosis
| |
| − | |Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289458 HSALNT0289458]
| |
| − | |[[DDIT4-AS1]]
| |
| − | |RP11-442H21.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cystic Fibrosis
| |
| − | |Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288992 HSALNT0288992]
| |
| − | |[[GPRC5D-AS1]]
| |
| − | |RP11-392P7.6
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289386 HSALNT0289386]
| |
| − | |[[PCBP1-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289405 HSALNT0289405]
| |
| − | |[[STARD4-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0201547 HSALNT0201547]
| |
| − | |[[LINC00462]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0207103 HSALNT0207103]
| |
| − | |[[SOX1-OT]]
| |
| − | |LINC00403
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0002131 HSALNT0002131]
| |
| − | |[[SLC25A34-AS1]]
| |
| − | |RP11-169K16.4
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289218 HSALNT0289218]
| |
| − | |[[PPP1R26-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289047 HSALNT0289047]
| |
| − | |[[LINC00589]]
| |
| − | |C8orf75,TSLNC8
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289516 HSALNT0289516]
| |
| − | |[[TPM1-AS]]
| |
| − | |TPM1-AS1
| |
| − | |splicing regulation
| |
| − | |pathogenic process
| |
| − | |esophageal cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289314 HSALNT0289314]
| |
| − | |[[LINC01101]]
| |
| − | |FLJ14816
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |HPV-induced cervical neoplasia
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289147 HSALNT0289147]
| |
| − | |[[LINC02572]]
| |
| − | |AC079776.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |epithelial ovarian cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0096804 HSALNT0096804]
| |
| − | |[[LINC02202]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289076 HSALNT0289076]
| |
| − | |[[LINC00973]]
| |
| − | |CTD-2021J15.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288625 HSALNT0288625]
| |
| − | |[[TTTY10]]
| |
| − | |NCRNA00133
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289323 HSALNT0289323]
| |
| − | |[[LINC00319]]
| |
| − | |C21orf125,NCRNA00319,PRED49,FLJ38036
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0015533 HSALNT0015533]
| |
| − | |[[IL6R-AS1]]
| |
| − | |RP11-350G8.5
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0090330 HSALNT0090330]
| |
| − | |[[CKMT2-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0012995 HSALNT0012995]
| |
| − | |[[HIPK1-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289216 HSALNT0289216]
| |
| − | |[[POLH-AS1]]
| |
| − | |RP3-337H4.8
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289276 HSALNT0289276]
| |
| − | |[[TRDN-AS1]]
| |
| − | |HRAT13
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289159 HSALNT0289159]
| |
| − | |[[LY6E-DT]]
| |
| − | |LOC100133669
| |
| − | |NA
| |
| | |pathogenic process | | |pathogenic process |
| | |ovarian cancer | | |ovarian cancer |
| − | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | + | |_ |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288991 HSALNT0288991] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0050704 HSALNT0050704] |
| − | |[[GLIS3-AS1]] | + | |[[THUMPD3-AS1]] |
| − | |C9orf70,MGC16153
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288896 HSALNT0288896]
| |
| − | |[[BNC2-AS1]]
| |
| − | |RP11-62F24.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289292 HSALNT0289292]
| |
| − | |[[ZNF503-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |age-related macular degeneration
| |
| − | |Eye Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0159506 HSALNT0159506]
| |
| − | |[[VIM-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |endometrial cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288882 HSALNT0288882]
| |
| − | |[[ACBD3-AS1]]
| |
| − | |RP11-275I14.4
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |endometrial cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289156 HSALNT0289156]
| |
| − | |[[LRRC8C-DT]]
| |
| − | |FLJ27354
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |endometrial cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289447 HSALNT0289447]
| |
| − | |[[ELN-AS1]]
| |
| − | |CTB-51J22.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |endometrial cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0076712 HSALNT0076712]
| |
| − | |[[LINC02264]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0093666 HSALNT0093666]
| |
| − | |[[LINC02201]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271685 HSALNT0271685]
| |
| − | |[[LINC02573]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289125 HSALNT0289125]
| |
| − | |[[LINC01816]]
| |
| − | |LOC100133985
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289355 HSALNT0289355]
| |
| − | |[[LINC02381]]
| |
| − | |LOC400043
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289366 HSALNT0289366]
| |
| − | |[[MBNL1-AS1]]
| |
| − | |LOC401093
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289513 HSALNT0289513]
| |
| − | |[[MIR4697HG]]
| |
| − | |LINC00947,LOC283174
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289073 HSALNT0289073]
| |
| − | |[[LINC00968]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0114453 HSALNT0114453]
| |
| − | |[[NMBR-AS1]]
| |
| − | |RP11-137J7.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-melanoma skin cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289300 HSALNT0289300]
| |
| − | |[[LINC01518]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-melanoma skin cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0003783 HSALNT0003783]
| |
| − | |[[LINC02574]]
| |
| − | |RP11-288L9.1
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |UVB-irradiated KC & non-melanoma skin cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0032721 HSALNT0032721]
| |
| − | |[[AC007365.1]]
| |
| − | |AC007365.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030828 HSALNT0030828]
| |
| − | |[[LINC02580]]
| |
| − | |AC093609.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |UVB-irradiated KC & non-melanoma skin cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0032808 HSALNT0032808]
| |
| − | |[[LINC02576]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |UVB-irradiated KC & non-melanoma skin cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127022 HSALNT0127022]
| |
| − | |[[LINC02577]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |UVB-irradiated KC & non-melanoma skin cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154722 HSALNT0154722]
| |
| − | |[[LINC02578]]
| |
| − | |RP11-127L21.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |UVB-irradiated KC & non-melanoma skin cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288962 HSALNT0288962]
| |
| − | |[[FAM111A-DT]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |UVB-irradiated KC & non-melanoma skin cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289148 HSALNT0289148]
| |
| − | |[[LINC02575]]
| |
| − | |AP001065.15
| |
| | |transcriptional regulation | | |transcriptional regulation |
| | |pathogenic process | | |pathogenic process |
| − | |UVB-irradiated KC & non-melanoma skin cancer | + | |Neuron death in stroke |
| − | |Skin and Connective Tissue Diseases;Neoplasms | + | |_ |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0177212 HSALNT0177212]
| |
| − | |[[RPS6KB2-AS1]]
| |
| − | |AP003419.16
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |agingâassociated idiopathic pulmonary fibrosis
| |
| − | |Physiological Phenomena
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289072 HSALNT0289072]
| |
| − | |[[LINC00941]]
| |
| − | |lncRNA-MUF
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289338 HSALNT0289338] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0205980 HSALNT0205980] |
| − | |[[LINC00094]] | + | |[[LINC00554]] |
| − | |FLJ35348,bA374P20.3
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung squamous cell cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0114192 HSALNT0114192]
| |
| − | |[[FILNC1]]
| |
| − | |NA
| |
| − | |translational control
| |
| − | |pathogenic process
| |
| − | |renal tumor
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289199 HSALNT0289199]
| |
| − | |[[PARAL1]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |obesity
| |
| − | |Pathological Conditions, Signs and Symptoms;Nutritional and Metabolic Diseases;Physiological Phenomena
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0056667 HSALNT0056667]
| |
| − | |[[LINC02027]]
| |
| − | |LOC728290
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289069 HSALNT0289069]
| |
| − | |[[LINC00880]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0252974 HSALNT0252974]
| |
| − | |[[LINC02582]]
| |
| − | |CTD-2354A18.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289035 HSALNT0289035]
| |
| − | |[[LINC00364]]
| |
| − | |LncRNA00364
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0060981 HSALNT0060981]
| |
| − | |[[NCK1-DT]]
| |
| − | |NCK1-AS1,SLC35G2-AS1
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |cervical cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288890 HSALNT0288890]
| |
| − | |[[BAALC-AS1]]
| |
| − | |lncFZD6,FZD6-DT
| |
| | |transcriptional regulation | | |transcriptional regulation |
| | |pathogenic process | | |pathogenic process |
| | |liver cancer | | |liver cancer |
| − | |Neoplasms;Digestive System Diseases | + | |_ |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0046602 HSALNT0046602]
| |
| − | |[[CPS1-IT1]]
| |
| − | |CPS1-IT,CPS1IT,CPS1IT1,PRO0132
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer;lung cancer;intrahepatic cholangiocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289445 HSALNT0289445]
| |
| − | |[[DLX6-AS1]]
| |
| − | |DLX6-A, DLX6A, Evf-2,NCRNA00212,NCRNA00212,FLJ34048
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |split hand/split foot malformation disorder;lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289891 HSALNT0289891]
| |
| − | |[[LINC00114]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289415 HSALNT0289415]
| |
| − | |[[TSIX]]
| |
| − | |LINC00013,NCRNA00013,XIST-A, XIST-AS1,XISTAS
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |systemic sclerosis
| |
| − | |Skin and Connective Tissue Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217334 HSALNT0217334]
| |
| − | |[[MKRN3-AS1]]
| |
| − | |ZNF127A, MKRN3A, MKRN3-A,FNZ127,NCRNA00009,ZNF127-AS
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Prader-Willi syndrome
| |
| − | |Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290256 HSALNT0290256]
| |
| − | |[[Lnc-SRA1-1:1]]
| |
| − | |lnc-SRA1-1:1,SRA1,ENSG00000213523
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |nonalcoholic fatty liver disease;polycystic ovary syndrome;ovarian cancer;dilated cardiomyopathy;cardiomyopathy;breast cancer;laryngeal squamous cell cancer;uterus cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289442 HSALNT0289442]
| |
| − | |[[HCP5]]
| |
| − | |6S2650E,D6S2650E,P5-1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |AIDS
| |
| − | |Immune System Diseases;Virus Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289284 HSALNT0289284]
| |
| − | |[[Lnc-EIF3M-1:1]]
| |
| − | |WIT1,WIT-1,WT1A, WT1-AS1
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |gastric cancer;primary myelofibrosis;hepatocellular cancer;Wilms' tumor;acute myeloid leukemia
| |
| − | |Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289421 HSALNT0289421]
| |
| − | |[[NONHSAT017524]]
| |
| − | |KCNQ1-AS2,KCNQ10T1,Kncq1,KvDMR1,KvLQT1-A, LIT1,NCRNA00012
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |prostate cancer;colorectal cancer;hepatocelluar cancer;acute myocardial infarction;kidney cancer;Beckwith-Wiedemann syndrome;breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0263784 HSALNT0263784]
| |
| − | |[[PCNA-AS1]]
| |
| − | |PCNAA, PCNA-AS
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |gastric cancer;hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289524 HSALNT0289524]
| |
| − | |[[HCG9]]
| |
| − | |PERB11,HCGIX,HCGIX4,HCGIX-4
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289264 HSALNT0289264]
| |
| − | |[[TCL6]]
| |
| − | |TCL6e1,TNG2,TNG1
| |
| − | |NA
| |
| − | |pathogenic process;developmental process
| |
| − | |renal cell cancer;leukemia
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289203 HSALNT0289203]
| |
| − | |[[ENST00000412654.1]]
| |
| − | |DD3,NCRNA00019,PCAT3
| |
| − | |transcriptional regulation;ceRNA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289462 HSALNT0289462]
| |
| − | |[[NONHSAT017465]]
| |
| − | |ASM,ASM1,BW, D11S813E,LINC00008,NCRNA00008,WT2
| |
| − | |transcriptional regulation;ceRNA
| |
| − | |developmental process;pathogenic process
| |
| − | |prostate cancer;glioma;cancer;breast cancer;ovarian cancer;Marek's disease;gestational trophoblastic diseases;glioblastoma;non-small cell lung cancer;hyperhomocysteinemia;congenital heart defect;congenital hyperinsulinism;pancreatic cancer;Beckwith-Wiedemann syndrome;endometriosis;trophoblastic tumor;adrenocortical cancer;coronary artery disease;Wiedemann-Beckwith syndrome;bladder cancer;melanoma;myeloproliferative polycythaemia vera;hepatocelluar cancer;meningioma;breast adenocarcinoma;neuroblastoma;embryonal cancer;osteosarcoma;esophageal cancer;kidney cancer;malignant digestive cancer;chronic myeloid leukemia;mullerian aplasia;malignant hematopoiesis;gastric cardia adenocarcinoma;cervical cancer;gallbladder cancer;pheochromocytoma;germ cell tumor;colorectal cancer;hydatidiform mole;Pancreatic ductal adenocarcinoma;pre-eclampsia;atherosclerosis;esophageal squamous cell cancer;calcific aortic valve disease;gastric cancer;osteoarthritis;choriocarcinoma;chronic myeloproliferative disorders;neural tube defects;skin cancer;ulcerative colitis;type 2 diabetes;thyroid cancer;pneumoconiosis;infertility;liver cancer;heart failure;medulloblastoma;laryngeal squamous cell cancer;Silver-Russell syndrome;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;growth restriction;Prader-Willi syndrome;diabetic cardiomyopathy;obesity;lung cancer;Parkinson's disease;renal cell cancer;Wilms' tumor
| |
| − | |Nutritional and Metabolic Diseases;Cell Physiological Phenomena;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Physiological Phenomena;Neoplasms;Male Urogenital Diseases;Endocrine System Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Immune System Diseases;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Nervous System Diseases;Digestive System Diseases;Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Respiratory Tract Diseases;Occupational Diseases;Otorhinolaryngologic Diseases;Stomatognathic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288932 HSALNT0288932]
| |
| − | |[[NONHSAT033797]]
| |
| − | |BCM, BCMS1,DLB1,LEU1,LEU2,LINC00021,NCRNA00021,XTP6
| |
| − | |transcriptional regulation;ceRNA
| |
| − | |pathogenic process
| |
| − | |lymphocytic leukemia;B-cell chronic lymphocytic leukemia;myeloma;multiple myeloma;hematopoietic and solid tumors;chronic lymphocytic leukemia;inherited bone marrow failure disorder;lymphoma;breast cancer;head and neck squamous cell cancer
| |
| − | |Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Immune System Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289493 HSALNT0289493]
| |
| − | |[[DBH-AS1]]
| |
| − | |NCRNA00118,BPR
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0088415 HSALNT0088415]
| |
| − | |[[ENST00000506884.1]]
| |
| − | |DKFZP586D0823,NCRNA00206
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer;glioblastoma
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289463 HSALNT0289463]
| |
| − | |[[IGF2-AS]]
| |
| − | |IGF2A,PEG8,IGF2-AS1
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |liver cancer;type 1 diabetes;prostate cancer;Wilms' tumor;hepatocelluar cancer
| |
| − | |Neoplasms;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0269786 HSALNT0269786]
| |
| − | |[[Lnc-CTSZ-5:1]]
| |
| − | |GNASA, GNAS-A,SANG,NESP-A, NESPA, GNAS1A, NCRNA00075
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer;pseudohypoparathyroidism type Ib
| |
| − | |Musculoskeletal Diseases;Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289252 HSALNT0289252]
| |
| − | |[[NONHSAT054526]]
| |
| − | |C6orf160,MGC16362,bA33E24.2,U50HG,NCRNA00044,LINC00044
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer;lymphoma;melanoma
| |
| − | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0023827 HSALNT0023827]
| |
| − | |[[NONHSAT010191]]
| |
| − | |DISC1-AS1,DISC1O, NCRNA00015
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |bipolar disorder;affective disorder;major depressive affective disorder;schizophrenia;autism spectrum disorder;depression
| |
| − | |Bacterial Infections and Mycoses;Mental Disorders;Behavior and Behavior Mechanisms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0203415 HSALNT0203415]
| |
| − | |[[NONHSAT034251]]
| |
| − | |SCA8,KLHL1A,NCRNA00003
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |spinocerebellar ataxia;spinocerebellar ataxia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290312 HSALNT0290312]
| |
| − | |[[TRAF3IP2-AS1]]
| |
| − | |C6UA, C6orf3,NCRNA00248,TRAF3IP2-AS2
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |schizophrenia;cocaine abuse
| |
| − | |Chemically-Induced Disorders;Mental Disorders
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289008 HSALNT0289008]
| |
| − | |[[HYMAI]]
| |
| − | |NCRNA00020
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |transient neonatal diabetes
| |
| − | |Nutritional and Metabolic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288968 HSALNT0288968]
| |
| − | |[[FAM201A]]
| |
| − | |C9orf122
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |leukemia
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288969 HSALNT0288969]
| |
| − | |[[FAM222A-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289484 HSALNT0289484]
| |
| − | |[[FAM226A]]
| |
| − | |CXorf50,NCRNA00246,NCRNA00246A,LINC00246A,MGC34827
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289497 HSALNT0289497]
| |
| − | |[[FAM215A]]
| |
| − | |C17orf88,APR-2,LINC00530
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ovarian cancer;leukemia
| |
| − | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289230 HSALNT0289230]
| |
| − | |[[NONHSAT089783]]
| |
| − | |LUST
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |tumor
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0002923 HSALNT0002923]
| |
| − | |[[LINC00339]]
| |
| − | |NCRNA00339,HSPC157
| |
| − | |NA
| |
| − | |pathogenic process;developmental process
| |
| − | |Pancreatic ductal adenocarcinoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0144027 HSALNT0144027]
| |
| − | |[[ASAP1-IT1]]
| |
| − | |ASAP1-IT,ASAP1IT,ASAP1IT1,DDEF1IT1,HSPC054,NCRNA00050
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ovarian cancer
| |
| − | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289212 HSALNT0289212]
| |
| − | |[[NONHSAT076153]]
| |
| − | |NCRNA00071,LINC00071,PCAT9
| |
| − | |transcriptional regulation;ceRNA
| |
| − | |pathogenic process
| |
| − | |osteoarthritis;prostate cancer;glioma
| |
| − | |Musculoskeletal Diseases;Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289016 HSALNT0289016]
| |
| − | |[[KCNQ1DN]]
| |
| − | |BWRT,HSA404617
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |aging;Wilms' tumor
| |
| − | |Physiological Phenomena;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288933 HSALNT0288933]
| |
| − | |[[NONHSAT033821]]
| |
| − | |DLB2,BCMSUN,RFP2O,LEU2,TRIM13O, NCRNA00022,LINC00022,MIR15AHG
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |lymphocytic leukemia;B-cell chronic lymphocytic leukemia;myeloma;multiple myeloma;chronic lymphocytic leukemia;non-small cell lung cancer
| |
| − | |Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217624 HSALNT0217624]
| |
| − | |[[PWAR4]]
| |
| − | |PAR4,PAR-4
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Prader-Willi syndrome and Angelman syndrome
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289165 HSALNT0289165]
| |
| − | |[[ENST00000553584.1]]
| |
| − | |SNHG23,SNHG24,NCRNA00024,Irm,Rian,Bsr,LINC00024,AL132709.8,lnc-MGC
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Prader-Willi syndrome and Angelman syndrome;temple syndrome
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289482 HSALNT0289482]
| |
| − | |[[CECR7]]
| |
| − | |SAHL1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer;cat eye syndrome
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0074223 HSALNT0074223]
| |
| − | |[[ENST00000504263.1]]
| |
| − | |GDEP,PCAN1,PCA4
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0061175 HSALNT0061175]
| |
| − | |[[PISRT1]]
| |
| − | |NCRNA00195
| |
| − | |transcriptional regulation
| |
| − | |developmental process;pathogenic process
| |
| − | |blepharophimosis syndrome
| |
| − | |Eye Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0190912 HSALNT0190912]
| |
| − | |[[ENST00000538665.1]]
| |
| − | |Tmevpg1,LincR-Ifng-3'A, NEST
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |Hashimoto's thyroiditis;primary immune thrombocytopenia;multiple sclerosis;Sjögren syndrome
| |
| − | |Immune System Diseases ;Immune System Diseases;Endocrine System Diseases;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0038178 HSALNT0038178]
| |
| − | |[[FAM138B]]
| |
| − | |F379
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0145703 HSALNT0145703]
| |
| − | |[[FAM138C]]
| |
| − | |F379
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288963 HSALNT0288963]
| |
| − | |[[FAM138A]]
| |
| − | |F379
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0183947 HSALNT0183947]
| |
| − | |[[FAM138D]]
| |
| − | |F379
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0226092 HSALNT0226092]
| |
| − | |[[FAM138E]]
| |
| − | |F379
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0253925 HSALNT0253925]
| |
| − | |[[FAM138F]]
| |
| − | |F379
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289326 HSALNT0289326]
| |
| − | |[[NONHSAT087716]]
| |
| − | |LOH3CR2A,NCRNA00312,NAG7,NAG-7,ERR10,ERR-10,LMCD1DN
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |nasopharyngeal cancer;bladder cancer;non-small cell lung cancer
| |
| − | |Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Stomatognathic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288886 HSALNT0288886]
| |
| − | |[[ENST00000609176.1]]
| |
| − | |AIR,NCRNA00088,IGF2RA, IGF2R-AS1
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0254857 HSALNT0254857]
| |
| − | |[[MIR7-3HG]]
| |
| − | |C19orf30,NCRNA00306,LINC00306,PGSF1,PGSF1a,PGSF1b,Huh7,uc002mbe.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |liver cancer;hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0185751 HSALNT0185751]
| |
| − | |[[LOH12CR2]]
| |
| − | |LOH2CR12
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |pre-B acute lymphoblastic leukaemia
| |
| − | |Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289479 HSALNT0289479]
| |
| − | |[[DSCR8]]
| |
| − | |C21orf65,MTAG2,CT25.1a,CT25.1b,MMA-1a,MMA-1b
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Down syndrome;melanoma
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289030 HSALNT0289030]
| |
| − | |[[LINC00313]]
| |
| − | |C21orf84,NCRNA00313,
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289029 HSALNT0289029]
| |
| − | |[[LINC00310]]
| |
| − | |C21orf82,NCRNA00310
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0272435 HSALNT0272435]
| |
| − | |[[LINC00161]]
| |
| − | |C21orf100,NCRNA00161
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |osteosarcoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289184 HSALNT0289184]
| |
| − | |[[ENST00000602580.1]]
| |
| − | |C21orf35,FLJ38295,C21orf34,LINC00478,MONC
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |myeloid leukemia
| |
| − | |Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289005 HSALNT0289005]
| |
| − | |[[HOXA11-AS]]
| |
| − | |HOXA11A,HOXA11-AS1,HOXA11, HOXA-AS5,NCRNA00076
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |uterine cervix cancer;ovarian cancer;glioma;cervical cancer;gastric cancer
| |
| − | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0193654 HSALNT0193654]
| |
| − | |[[RMST]]
| |
| − | |NCRM, NCRNA00054,LINC00054
| |
| − | |transcriptional regulation
| |
| − | |developmental process;pathogenic process
| |
| − | |breast cancer;rhabdomyosarcoma
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290079 HSALNT0290079]
| |
| − | |[[NONHSAT102247]]
| |
| − | |NCRUPAR,ENSG00000225407
| |
| − | |transcriptional regulation
| |
| − | |developmental process;pathogenic process
| |
| − | |gastric cancer;colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289167 HSALNT0289167]
| |
| − | |[[MESTIT1]]
| |
| − | |MEST-AS1,MEST-IT,MEST-IT1,NCRNA00040,PEG1-AS
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Silver-Russell syndrome
| |
| − | |Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273791 HSALNT0273791]
| |
| − | |[[DSCAM-AS1]]
| |
| − | |M41
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |adolescent idiopathic scoliosis;breast cancer
| |
| − | |Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289391 HSALNT0289391]
| |
| − | |[[PWARSN]]
| |
| − | |PAR-SN,PARSN
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127791 HSALNT0127791]
| |
| − | |[[ST7-AS1]]
| |
| − | |ST7OT1,ST7AS1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |glioma;autism
| |
| − | |Mental Disorders;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0206298 HSALNT0206298]
| |
| − | |[[DAOA-AS1]]
| |
| − | |DAOAA, DAOA-A,G30
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |panic disorder;schizophrenia;bipolar disorder
| |
| − | |Mental Disorders
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0167060 HSALNT0167060]
| |
| − | |[[OLMALINC]]
| |
| − | |C10orf75,NCRNA00263,LINC00263,bA34D15.5,FLJ12974,HI-LNC80
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |type 2 diabetes
| |
| − | |Nutritional and Metabolic Diseases;Endocrine System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0026878 HSALNT0026878]
| |
| − | |[[LINC00299]]
| |
| − | |C2orf46,NCRNA00299,FLJ45673
| |
| − | |NA
| |
| − | |pathogenic process;developmental process
| |
| − | |intellectual and developmental disability;neurodevelopmental disabilities
| |
| − | |Mental Disorders;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289081 HSALNT0289081]
| |
| − | |[[LINC01020]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0101186 HSALNT0101186]
| |
| − | |[[LINC00518]]
| |
| − | |C6orf218,MGC40222
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0083960 HSALNT0083960]
| |
| − | |[[LINC01018]]
| |
| − | |SRHC
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289361 HSALNT0289361]
| |
| − | |[[LPP-AS2]]
| |
| − | |MYCLo-5,MYCLo-6
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143233 HSALNT0143233]
| |
| − | |[[LINC00964]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289364 HSALNT0289364]
| |
| − | |[[MAPKAPK5-AS1]]
| |
| − | |C12orf47,FLJ39616
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289053 HSALNT0289053]
| |
| − | |[[LINC00635]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289327 HSALNT0289327]
| |
| − | |[[LINC00636]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262657 HSALNT0262657]
| |
| − | |[[ZNF582-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289020 HSALNT0289020]
| |
| − | |[[LINC00115]]
| |
| − | |NCRNA00115,FLJ22639
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289254 HSALNT0289254]
| |
| − | |[[SNHG7]]
| |
| − | |MGC16037,NCRNA00061
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289162 HSALNT0289162]
| |
| − | |[[MAP3K20-AS1]]
| |
| − | |MLK7-AS1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0145357 HSALNT0145357]
| |
| − | |[[RHPN1-AS1]]
| |
| − | |C8orf51,MGC3113
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289343 HSALNT0289343]
| |
| − | |[[NONHSAT137541]]
| |
| − | |DXS399E,NCRNA00001,DXS1089,swd66,LINC00001
| |
| − | |transcriptional regulation;ceRNA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer;B-cell acute lymphoblastic leukemia;bladder cancer;testicular germ cell tumor;colorectal cancer;cancer;ovarian cancer;female cancers;renal collecting duct cancer;membranous nephropathy;Trisomy 21;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;Klinefelter's syndrome;glioblastoma;breast cancer;cystic fibrosis
| |
| − | |Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Nervous System Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289389 HSALNT0289389]
| |
| − | |[[PRNT]]
| |
| − | |M8
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288942 HSALNT0288942]
| |
| − | |[[Lnc-PDZD8-3:1]]
| |
| − | |NCRNA00045,EMX2-AS1
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0200443 HSALNT0200443]
| |
| − | |[[LINC00598]]
| |
| − | |TTL
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289517 HSALNT0289517]
| |
| − | |[[TTTY17A]]
| |
| − | |NCRNA00140
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027901 HSALNT0027901]
| |
| − | |[[MYCNOS]]
| |
| − | |NCYM,N-CYM,MYCN-AS1
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |neuroblastoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0047175 HSALNT0047175]
| |
| − | |[[DIRC3]]
| |
| − | |FLJ14199
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |familial renal cell cancer;breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289363 HSALNT0289363]
| |
| − | |[[ENST00000534336.1]]
| |
| − | |PRO1073,MALAT-1,NCRNA00047,HCN,NEAT2,LINC00047,mascRNA
| |
| − | |splicing regulation;;translational control;transcriptional regulation;protein localization;ceRNA
| |
| − | |pathogenic process
| |
| − | |prostate cancer;glioma;cancer;breast cancer;ovarian cancer;amyotrophic lateral sclerosis;proliferative vitreoretinopathy;glioblastoma;endometrial stromal sarcoma;oral squamous cell cancer;acute myocardial infarction;hemangioma;pancreatic cancer;endometrioid endometrial cancer;melanoma;tongue squamous cell cancer;HIV;hepatocelluar cancer;bladder cancer;neuroblastoma;lung cancer;nasopharyngeal cancer;osteosarcoma;esophageal cancer;kidney cancer;hepatic steatosis;urothelial cancer;diabetes;triple-negative breast cancer;liver fibrosis;cervical cancer;uterus cancer;gallbladder cancer;decreased myogenesis;esophageal squamous cell cancer;fibrosarcoma;colorectal cancer;Pancreatic ductal adenocarcinoma;pre-eclampsia;retinal neurodegeneration;small cell lung cancer;multiple myeloma;gastric cancer;lung adenocarcinoma;uveal melanoma;epithelial ovarian cancer;TDP-43-associated pathological states;thyroid cancer;congenital microtia;liver cancer;renal clear cell cancer;laryngeal squamous cell cancer;pituitary adenoma;hepatocellular cancer;non-small cell lung cancer;pulmonary arterial hypertension;diabetic cardiomyopathy;vulvar squamous cell cancer;hyperglycaemia;papillary thyroid cancer;Parkinson's disease;renal cell cancer;lung cancer brain metastasis
| |
| − | |Eye Diseases;Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Cell Physiological Phenomena;Immune System Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Stomatognathic Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289744 HSALNT0289744]
| |
| − | |[[DLG2-AS1]]
| |
| − | |DLG2A, DLG2-A,PSZA11q14,SZ-1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |schizophrenia;myotonic dystrophy type 1;heart failure
| |
| − | |Pathological Conditions, Signs and Symptoms;Musculoskeletal Diseases;Mental Disorders;Cardiovascular Diseases;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289164 HSALNT0289164]
| |
| − | |[[NONHSAT039745]]
| |
| − | |FP504,GTL2,LINC00023,NCRNA00023,PRO0518,PRO2160,onco-lncRNA-83,prebp1
| |
| − | |translational control;transcriptional regulation;ceRNA
| |
| − | |pathogenic process
| |
| − | |oral squamous cell cancer;phaeochromocytoma;prostate cancer;testicular germ cell tumor;glioma;cancer;osteosarcoma;non-functioning pituitary adenoma;heroin abuse;stroke;non-small cell lung cancer;thrombocytopenic purpura;acute myeloid leukemia;pancreatic cancer;bladder cancer;tongue squamous cell cancer;hepatocelluar cancer;meningioma;drug abuse;liver fibrosis;pancreatic neuroendocrine tumor;esophageal squamous cell cancer;myelodysplastic syndrome;retinoblastoma;chronic myeloid leukemia;type 1 diabetes;breast cancer;cervical cancer;kidney cancer;gallbladder cancer;cholestatic liver injury;colorectal cancer;neuroblastoma;multiple myeloma;gastric cancer;osteoarthritis;lung adenocarcinoma;endometrial cancer;Huntington disease;diabetes;type 2 diabetes;lung cancer;epithelial ovarian cancer;primary myelofibrosis;metabolic syndrome;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;vulvar squamous cell cancer;papillary thyroid cancer;renal cell cancer;Wilms' tumor
| |
| − | |Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Immune System Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Chemically-Induced Disorders;Musculoskeletal Diseases;Mental Disorders;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290298 HSALNT0290298]
| |
| − | |[[TERC]]
| |
| − | |DKCA1,PFBMFT2,SCARNA19,TR,TRC3,hTR
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer;dyskeratosis congenita;lung squamous cell cancer
| |
| − | |Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288907 HSALNT0288907]
| |
| − | |[[CASC2]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer;gastric cancer;endometrial cancer;lung cancer;renal cell cancer;glioma
| |
| − | |Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0205332 HSALNT0205332]
| |
| − | |[[MIR17HG]]
| |
| − | |C13orf25,MIRHG1,FLJ14178,MIRH1,MIHG1,NCRNA00048,miR-17-92,LINC00048
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |diffuse large B-cell lymphoma;syndromic developmental defect;cancer
| |
| − | |Neoplasms;Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288716 HSALNT0288716]
| |
| − | |[[TTTY6]]
| |
| − | |TTY6,TTTY6A,LINC00127
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288731 HSALNT0288731]
| |
| − | |[[TTTY4]]
| |
| − | |TTY4,TTTY4A,LINC00123
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288815 HSALNT0288815]
| |
| − | |[[TTTY3]]
| |
| − | |TTY3,TTTY3A,LINC00121
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288703 HSALNT0288703]
| |
| − | |[[TTTY5]]
| |
| − | |TTY5,LINC00126
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289255 HSALNT0289255]
| |
| − | |[[SNHG8]]
| |
| − | |NCRNA00060,LINC00060
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer;malignant pleural mesothelioma
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289486 HSALNT0289486]
| |
| − | |[[Lnc-EPCAM-1:2]]
| |
| − | |BC200,BC200a,NCRNA00004,LINC00004
| |
| − | |splicing regulation;translational control
| |
| − | |pathogenic process
| |
| − | |aging;lung cancer;glioma;ovarian cancer;esophageal squamous cell cancer;non-small cell lung cancer;esophageal cancer;Alzheimer's disease;tongue cancer;parotid cancer;breast cancer;cervical cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Stomatognathic Diseases;Mental Disorders;Female Urogenital Diseases and Pregnancy Complications;Physiological Phenomena;Endocrine System Diseases;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0144426 HSALNT0144426]
| |
| − | |[[ZFAT-AS1]]
| |
| − | |ZFATAS,ZFAT-AS,SAS-ZFAT,NCRNA00070
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |autoimmune disease
| |
| − | |Immune System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289285 HSALNT0289285]
| |
| − | |[[ZEB1-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |esophageal squamous cell cancer;autoimmune thyroid disease;hepatocelluar cancer
| |
| − | |Immune System Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289185 HSALNT0289185]
| |
| − | |[[MIRLET7BHG]]
| |
| − | |linc-Ppara
| |
| − | |NA
| |
| − | |developmental process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289374 HSALNT0289374]
| |
| − | |[[NBR2]]
| |
| − | |NCRNA00192
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |gastric cancer;breast cancer;cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289417 HSALNT0289417]
| |
| − | |[[NONHSAT084827]]
| |
| − | |FLJ20618,NCRNA00080,LINC00080
| |
| − | |transcriptional regulation;ceRNA
| |
| − | |pathogenic process
| |
| − | |osteosarcoma;prostate cancer;glioma;ovarian cancer;glioblastoma;non-small cell lung cancer;B-cell neoplasms;chronic kidney disease;melanoma;bladder cancer;urothelial cancer of the bladder;esophageal squamous cell cancer;multiple sclerosis;breast cancer;hepatoblastoma;colorectal cancer;multiple myeloma;gastric cancer;Huntington disease;hepatocellular cancer;oesophageal squamous cell cancer;renal cell cancer
| |
| − | |Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288973 HSALNT0288973]
| |
| − | |[[FAS-AS1]]
| |
| − | |FASA, FAS-A,SAF
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |ataxia telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Immune System Diseases;Nutritional and Metabolic Diseases;Cardiovascular Diseases;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288996 HSALNT0288996]
| |
| − | |[[HAS2-AS1]]
| |
| − | |HAS2A, HAS2-A,HASNT,NCRNA00077
| |
| − | |transcriptional regulation
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289390 HSALNT0289390]
| |
| − | |[[PSORS1C3]]
| |
| − | |NCRNA00196
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |rheumatoid arthritis;psoriasis
| |
| − | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289868 HSALNT0289868]
| |
| − | |[[HLA-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |psoriasis;liver injury;multiple sclerosis;AIDS
| |
| − | |Skin and Connective Tissue Diseases;Immune System Diseases;Virus Diseases;Digestive System Diseases;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290154 HSALNT0290154]
| |
| − | |[[NONHSAT011777]]
| |
| − | |NCRNA00074
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |psoriasis;prostate cancer
| |
| − | |Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262809 HSALNT0262809]
| |
| − | |[[PEG3-AS1]]
| |
| − | |PEG3AS,PEG3-AS,APEG3,NCRNA00155
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289533 HSALNT0289533]
| |
| − | |[[Lnc-LRR1-1:1]]
| |
| − | |7S RNA,SRP RNA,4.5S SRP RNA,4.5S RNA,RN7SL1 RNA,ENSG00000258486,lnc-LRR1-1:1
| |
| − | |protein localization
| |
| − | |pathogenic process
| |
| − | |AIDS;Leishmaniasis;dermatomyositis;polymyositis
| |
| − | |Skin and Connective Tissue Diseases;Immune System Diseases;Virus Diseases;Musculoskeletal Diseases;Parasitic Diseases;Nervous System Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290081 HSALNT0290081] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0141703 HSALNT0141703] |
| − | |[[Lnc-C11orf16-1:1]] | + | |[[ZFPM2-AS1]] |
| − | |29A,lnc-C11orf16-1:1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |neuroblastoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289382 HSALNT0289382]
| |
| − | |[[NONHSAT134764]]
| |
| − | |NCRNA00194
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |AIDS;Down syndrome;HIV
| |
| − | |Immune System Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases;Virus Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289253 HSALNT0289253]
| |
| − | |[[Lnc-TCF24-2:3]]
| |
| − | |U87HG,HBII-276HG,NCRNA00058
| |
| − | |translational control;ceRNA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer;hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289653 HSALNT0289653]
| |
| − | |[[NONHSAT017676]]
| |
| − | |AY195961.1,NONHSAT017674,AY034469.1,NONHSAT017675,AY034470.1
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290398 HSALNT0290398]
| |
| − | |[[ENST00000554403.1]]
| |
| − | |Zfh-5AS,ENSG00000157306,ENST00000554403.1
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0011306 HSALNT0011306]
| |
| − | |[[MIR137HG]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |schizophrenia;lung cancer;malignant lymphoma
| |
| − | |Respiratory Tract Diseases;Mental Disorders;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289449 HSALNT0289449]
| |
| − | |[[Lnc-EVX1-9:1]]
| |
| − | |HOXA6as
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |glioma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289451 HSALNT0289451]
| |
| − | |[[CCDC26]]
| |
| − | |MGC27434,RAM
| |
| | |transcriptional regulation | | |transcriptional regulation |
| | |pathogenic process | | |pathogenic process |
| − | |hematological malignancies;glioma;acute myeloid leukemia;leukemia;pancreatic cancer;breast cancer | + | |multiple cancers, gastric carcinogenesis |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Hemic and Lymphatic Diseases;Endocrine System Diseases;Digestive System Diseases | + | |_ |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289893 HSALNT0289893]
| |
| − | |[[LINC00271]]
| |
| − | |C6orf217,NCRNA00271
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |type 2 diabetes;schizophrenia
| |
| − | |Nutritional and Metabolic Diseases;Mental Disorders;Endocrine System Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288892 HSALNT0288892]
| + | |[[HOXB-AS1]] |
| − | |[[BCAR4]] | |
| − | |NA
| |
| | |transcriptional regulation | | |transcriptional regulation |
| | |pathogenic process | | |pathogenic process |
| − | |osteosarcoma;breast cancer;colorectal cancer | + | |autosomal dominant polycistic kidney disease |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases | + | |_ |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289890 HSALNT0289890] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0167650 HSALNT0167650] |
| − | |[[LINC00032]] | + | |[[CFAP58-DT]] |
| − | |C9orf14,NCRNA00032
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |narcolepsy;melanoma
| |
| − | |Mental Disorders;Neoplasms;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274572 HSALNT0274572]
| |
| − | |[[PICSAR]]
| |
| − | |C21orf113,LINC00162,NCRNA00162,NLC1-C,NLC1C,PRED74
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |testicular embryonal cancer;narcolepsy;cutaneous squamous cell cancer
| |
| − | |Male Urogenital Diseases;Mental Disorders;Neoplasms;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0256354 HSALNT0256354]
| |
| − | |[[Lnc-OR10H5-1:1]]
| |
| − | |CUDR,LINC00178,NCRNA00178,UCAT1,onco-lncRNA-36
| |
| − | |transcriptional regulation;ceRNA
| |
| − | |developmental process;pathogenic process
| |
| − | |oral squamous cell cancer;osteosarcoma;prostate cancer;ovarian cancer;non-small cell lung cancer;acute myocardial infarction;pancreaticobiliary maljunction;pancreatic cancer;melanoma;tongue squamous cell cancer;hepatocelluar cancer;bladder cancer;acute myeloid leukemia;esophageal squamous cell cancer;esophageal cancer;liver cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;urinary bladder;gastric cancer;endometrial cancer;breast cancer;hepatocellular cancer;squamous cell cancer;lung cancer;renal cell cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0003871 HSALNT0003871]
| |
| − | |[[Lnc-OR10H5-1:1]]
| |
| − | |NCRNA00014,RNU17C,RNU17D,U17HG,U17HG-A,U17HG-AB
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ovarian cancer;hepatocellular cancer;colorectal cancer;Alzheimer's disease
| |
| − | |Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289475 HSALNT0289475]
| |
| − | |[[Lnc-BIRC7-2:1]]
| |
| − | |HAR1F,NCRNA00064,LINC00064
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |Huntington disease;Alzheimer's disease
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Mental Disorders;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288995 HSALNT0288995]
| |
| − | |[[ENST00000447910.2]]
| |
| − | |HAR1R,NCRNA00065,LINC00065
| |
| | |transcriptional regulation | | |transcriptional regulation |
| | |pathogenic process | | |pathogenic process |
| − | |Huntington disease;hereditary haemorrhagic telangiectasia;Alzheimer's disease | + | |innate immune response to viral infection |
| − | |Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Nervous System Diseases | + | |_ |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288958 HSALNT0288958]
| |
| − | |[[EPB41L4A-AS1]]
| |
| − | |C5orf26,NCRNA00219,TIGA1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer;cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289170 HSALNT0289170]
| |
| − | |[[Lnc-CRYBA4-2:1]]
| |
| − | |C22orf35,FLJ25967,Rncr2,gomafu,NCRNA00066,LINC00066,lncRNA-MIAT
| |
| − | |splicing regulation;ceRNA
| |
| − | |pathogenic process
| |
| − | |prostate cancer;chronic lymphocytic leukemia;cancer;drug abuse;diabetes-induced microvascular dysfunction;schizophrenia;acute myocardial infarction;dilated cardiomyopathy;lung adenocarcinoma;diabetic retinopathy;myocardial infarction;Alzheimer's disease
| |
| − | |Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Chemically-Induced Disorders;Hemic and Lymphatic Diseases;Cardiovascular Diseases;Mental Disorders;Endocrine System Diseases;Nervous System Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289007 HSALNT0289007]
| + | |[[FAM230A]] |
| − | |[[NONHSAT107640]] | + | |_ |
| − | |NCRNA00078,LINC00078,HCCAT1 | + | |_ |
| − | |transcriptional regulation;ceRNA
| + | |_ |
| − | |pathogenic process | + | |_ |
| − | |prostate cancer;glioma;hepatocelluar cancer;osteosarcoma;atherosclerosis;gastric cancer;hepatocellular cancer;esophageal cancer;liver cirrhosis;diffuse large B-cell lymphoma;pancreatic cancer;papillary thyroid cancer;liver cancer;cervical cancer;colorectal cancer | |
| − | |Neoplasms;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases | |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288940 HSALNT0288940]
| |
| − | |[[NONHSAT087635]]
| |
| − | |EGO,NCRNA00190
| |
| − | |NA
| |
| − | |pathogenic process;developmental process
| |
| − | |prostate cancer;breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289387 HSALNT0289387] | + | |[[CPNE8-AS1]] |
| − | |[[PINK1-AS]]
| |
| − | |PINK1-AS1,FLJ00387,PINK1A, naPINK1
| |
| | |transcriptional regulation | | |transcriptional regulation |
| − | |pathogenic process
| |
| − | |glucose metabolism disorder;Parkinson's disease;diabetes
| |
| − | |Nutritional and Metabolic Diseases;Endocrine System Diseases;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289225 HSALNT0289225]
| |
| − | |[[ENST00000513868.2]]
| |
| − | |NCRNA00079,LINC00079,onco-lncRNA-100,MIR1204HG,PVT
| |
| − | |transcriptional regulation;translational control
| |
| − | |pathogenic process
| |
| − | |murine plasmacytomas;prostate cancer;cancer;ovarian cancer;renal cancer;B-cell lymphoma;non-small cell lung cancer;pancreatic cancer;Hodgkin's lymphoma;asthma;hepatocelluar cancer;bladder cancer;plasmacytoma;cleft lip;acute promyelocytic leukemia;diabetic nephropathy;esophageal cancer;kidney cancer;type 1 diabetes;breast cancer;cervical cancer;diabetic kidney disease;hematological malignancies;colorectal cancer;neuroblastoma;cardiac hypertrophy;multiple myeloma;gastric cancer;lymphoma;type 2 diabetes;thyroid cancer;pleural mesothelioma;lung squamous cell cancer;Burkitt lymphoma;hepatocellular cancer;renal cell cancer
| |
| − | |Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Immune System Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289189 HSALNT0289189]
| |
| − | |[[ENST00000604258.1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |papillary thyroid cancer
| |
| − | |Endocrine System Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0246525 HSALNT0246525]
| |
| − | |[[NARF-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0147433 HSALNT0147433]
| |
| − | |[[NONHSAT130421]]
| |
| − | |CDKN2BA,ANRIL,RP11-145E5.4,NCRNA00089,p15A, CDKN2B-A, PCAT12
| |
| − | |siRNA;transcriptional regulation;ceRNA
| |
| − | |pathogenic process
| |
| − | |glaucoma;prostate cancer;glioma;cancer;osteosarcoma;neurofibromatosis;ischemic heart failure;stroke;non-small cell lung cancer;hypertension;intracranial aneurysm;aortic aneurysm;periodontitis;acute lymphoblastic leukemia;Alzheimer's disease;coronary artery disease;melanoma;bladder cancer;abdominal aortic aneurysm;ovarian cancer;esophageal cancer;basal cell cancer;breast cancer;cervical cancer;coronary heart disease;gallbladder cancer;acute myocardial infarction;colorectal cancer;neuroblastoma;peripheral artery disease;esophageal squamous cell cancer;atherosclerosis;leukemia;hereditary cutaneous malignant melanoma;gastric cancer;cardiovascular disease;coronary disease;frailty;diabetes;type 2 diabetes;thyroid cancer;primary open-angle glaucoma;ischemic stroke;plexiform neurofibroma;laryngeal squamous cell cancer;hepatocellular cancer;nasopharyngeal cancer;myocardial infarction;lung cancer;endometriosis;primary myelofibrosis
| |
| − | |Eye Diseases;Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Stomatognathic Diseases;Immune System Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Mental Disorders;Nervous System Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0050854 HSALNT0050854]
| |
| − | |[[NONHSAT087920]]
| |
| − | |NCRNA00068,GHRL-AS1
| |
| − | |transcriptional regulation
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288959 HSALNT0288959]
| |
| − | |[[ENST00000583516.1]]
| |
| − | |HESRG
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |embryonal cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287173 HSALNT0287173]
| |
| − | |[[FMR1-AS1]]
| |
| − | |FMR1A, FMR1-A,ASFMR1,FMR4
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |fragile X syndrome;neurological disorder
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289499 HSALNT0289499]
| |
| − | |[[HCG4]]
| |
| − | |HCGIV-10,HCGIV.9
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288994 HSALNT0288994]
| |
| − | |[[HAND2-AS1]]
| |
| − | |DEIN,NBLA00301,FLJ11539
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |neuroblastoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289286 HSALNT0289286]
| |
| − | |[[NONHSAT074775]]
| |
| − | |ZEB2A, ZEB2-A,ZEB2NAT
| |
| − | |splicing regulation
| |
| − | |pathogenic process
| |
| − | |bladder cancer;hepatocellular cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0017702 HSALNT0017702]
| |
| − | |[[NONHSAT007663]]
| |
| − | |SNHG2,NCRNA00030
| |
| − | |transcriptional regulation;ceRNA
| |
| − | |pathogenic process
| |
| − | |varicose great saphenous veins;prostate cancer;glioma;cancer;ovarian cancer;non-small cell lung cancer;hypertension;pancreatic cancer;B-cell neoplasms;melanoma;head and neck cancer;hepatocelluar cancer;bladder cancer;autoimmune disease;liver fibrosis;kidney cancer;breast cancer;cervical cancer;colorectal cancer;multiple myeloma;gastric cancer;osteoarthritis;endometrial cancer;lymphoma;type 2 diabetes;pleural mesothelioma;hepatocellular cancer;lung adenocarcinoma;lung cancer;renal cell cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Nutritional and Metabolic Diseases;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288891 HSALNT0288891]
| |
| − | |[[NONHSAT024403]]
| |
| − | |BACE1A,FJ573250,NCRNA00177,BACE1-AS1
| |
| − | |translational control;transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |ovarian cancer;colorectal cancer;Alzheimer's disease
| |
| − | |Neoplasms;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Nervous System Diseases;Endocrine System Diseases;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289414 HSALNT0289414]
| |
| − | |[[TRPM2-AS]]
| |
| − | |TRPM2-AS1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |melanoma;prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288935 HSALNT0288935]
| |
| − | |[[DNM3OS]]
| |
| − | |DNM3-AS1,MIR199A2HG
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |epithelial ovarian cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288930 HSALNT0288930]
| |
| − | |[[DGCR5]]
| |
| − | |NCRNA00037,LINC00037
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |Huntington disease;DiGeorge syndrome;velocardiofacial syndrome;clear cell renal cell cancer
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Endocrine System Diseases;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288893 HSALNT0288893]
| |
| − | |[[ENST00000499008.3]]
| |
| − | |BDNFO,BT2A,BT2B,BT2C,BT2D,NCRNA00049,BDNF-AS1,BDNFAS
| |
| − | |siRNA;transcriptional regulation
| |
| − | |developmental process;pathogenic process
| |
| − | |Huntington disease;schizophrenia;psychiatric disease;obesity
| |
| − | |Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nutritional and Metabolic Diseases;Mental Disorders;Physiological Phenomena;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0120317 HSALNT0120317]
| |
| − | |[[Lnc-EVX1-12:1]]
| |
| − | |HOXA-AS1,NCRNA00179,HOXA1-AS1
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process;developmental process
| |
| − | |colorectal cancer;Pancreatic ductal adenocarcinoma;promyelocytic leukemia;acute myeloid leukemia;infiltrating ductal cancers ;acute promyelocytic leukemia;leukemia;glioma
| |
| − | |Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290158 HSALNT0290158]
| |
| − | |[[NONHSAT129210]]
| |
| − | |PTCSC,AK023948,NCRNA00197
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |papillary thyroid cancer
| |
| − | |Endocrine System Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289004 HSALNT0289004]
| |
| − | |[[NONHSAT028508]]
| |
| − | |HOXC-AS4,HOXC11-AS1,NCRNA00072
| |
| − | |siRNA;transcriptional regulation;ceRNA
| |
| − | |pathogenic process
| |
| − | |oral squamous cell cancer;prostate cancer;glioma;cancer;breast cancer;osteosarcoma;renal cancer;glioblastoma;non-small cell lung cancer;sarcoma;pancreatic cancer;large B-Cell lymphoma;bladder transitional cell cancer;B-cell neoplasms;melanoma;asthenozoospermia;hepatocelluar cancer;bladder cancer;acute myeloid leukemia;aortic valve calcification;infiltrating ductal cancers ;ovarian cancer;diffuse large B-cell lymphoma;gastrointestinal stromal tumor;atypical teratoid rhabdoid tumor;urothelial cancer;triple-negative breast cancer;gastric cardia adenocarcinoma;cervical cancer;temporomandibular joint osteoarthritis;gallbladder cancer;esophageal squamous cell cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;rheumatoid arthritis;gastric cancer ;pre-eclampsia;acute leukemia;small cell lung cancer;multiple myeloma;gastric cancer;osteoarthritis;LPS-induced sepsis;endometrial cancer;head and neck squamous cell cancer;gastric adenocarcinoma;lung cancer;liver cancer;ischemic stroke;ischemic heart failure;laryngeal squamous cell cancer;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;lung adenocarcinoma;papillary thyroid cancer;Parkinson's disease;renal cell cancer;gastrointestinal cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Musculoskeletal Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289192 HSALNT0289192]
| |
| − | |[[ENST00000501122.2]]
| |
| − | |NCRNA00084,TncRNA,MENepsilon/beta,LINC00084,VINC
| |
| − | |transcriptional regulation;ceRNA
| |
| − | |pathogenic process
| |
| − | |oral squamous cell cancer;glioma;ovarian cancer;amyotrophic lateral sclerosis;paraspeckle disintegration;nasopharyngeal cancer;AIDS;frontotemporal lobar degeneration;prostate cancer;systemic lupus erythematosus;renal syndrome;TDP-43-associated pathological states;HIV;Huntington disease;chronic lymphocytic leukemia;acute promyelocytic leukemia;esophageal squamous cell cancer;multiple sclerosis;breast cancer;intrauterine growth restriction;colorectal cancer;leukemia;gastric cancer;malignant pleural mesothelioma;endometrial cancer;gastric adenocarcinoma;papillary thyroid cancer;infertility;bladder cancer;hepatocellular cancer;non-small cell lung cancer;obesity;lung cancer;Parkinson's disease;laryngeal squamous cell cancer
| |
| − | |Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Nutritional and Metabolic Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Physiological Phenomena;Nervous System Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0095094 HSALNT0095094]
| |
| − | |[[NONHSAT104072]]
| |
| − | |U19H,NCRNA00059
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |myelodysplastic syndrome
| |
| − | |Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0245443 HSALNT0245443]
| |
| − | |[[NONHSAT056039]]
| |
| − | |ncRAN,Nbla12061,Nbla10727
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |bladder cancer;bladder cancer;colorectal cancer;neuroblastoma
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288897 HSALNT0288897]
| |
| − | |[[BOK-AS1]]
| |
| − | |BOKA,NCRNA00151,NAToB
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |esophageal squamous cell cancer;testicular cancer;cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289532 HSALNT0289532]
| |
| − | |[[NONHSAT113149]]
| |
| − | |7-3 RNA,K-RNA,7SK-RNA,7SK snRNA,RN7SK,ENSG00000202198,NONHSAT113149
| |
| − | |transcriptional regulation
| |
| − | |developmental process;pathogenic process
| |
| − | |cancer;cardiac hypertrophy;gastric cancer;AIDS;multiple sclerosis;colorectal adenocarcinoma
| |
| − | |Neoplasms;Immune System Diseases;Virus Diseases;Cardiovascular Diseases;Digestive System Diseases;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289182 HSALNT0289182]
| |
| − | |[[MIR4435-2HG]]
| |
| − | |MIR4435-1HG,LINC00978,AGD2,AK001796,lncRNA-AWPPH,MORRBID
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289200 HSALNT0289200]
| |
| − | |[[PARTICL]]
| |
| − | |PARTICLE
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |low-dose irradiation
| |
| − | |Disorders of Environmental Origin
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289172 HSALNT0289172]
| |
| − | |[[ENST00000517411.1]]
| |
| − | |LINC01604,TCONS_00015189
| |
| − | |transcriptional regulation;ceRNA
| |
| − | |pathogenic process
| |
| − | |gallbladder cancer;Burkitt lymphoma
| |
| − | |Neoplasms;Immune System Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0001792 HSALNT0001792]
| |
| − | |[[NPPA-AS1]]
| |
| − | |NPPAA, NPPA-AS
| |
| − | |splicing regulation
| |
| − | |pathogenic process
| |
| − | |cardiovascular disease
| |
| − | |Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290230 HSALNT0290230]
| |
| − | |[[RRP1B]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |spinocerebellar ataxia;laryngeal squamous cell cancer;cancer
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289467 HSALNT0289467]
| |
| − | |[[CLLU1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289173 HSALNT0289173]
| |
| − | |[[ENST00000531381.1]]
| |
| − | |AGD1,lncRNA-N2,linc-NeD125
| |
| − | |NA
| |
| − | |developmental process;pathogenic process
| |
| − | |myeloid leukemia;myopia;cervical cancer;neuroblastoma
| |
| − | |Eye Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0059175 HSALNT0059175]
| |
| − | |[[NONHSAT091315]]
| |
| − | |LINC00902,LSAMP-AS1,LSAMP-AS3,LSAMPAS3,NCRNA00295
| |
| − | |transcriptional regulation;ceRNA
| |
| − | |pathogenic process
| |
| − | |glioma;Pancreatic ductal adenocarcinoma;osteosarcoma;esophageal squamous cell cancer;ischemic heart failure;gastric cancer;hepatocellular cancer;non-small cell lung cancer;acute myeloid leukemia;colorectal cancer
| |
| − | |Respiratory Tract Diseases;Cardiovascular Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289647 HSALNT0289647]
| |
| − | |[[BC040587]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |osteosarcoma;breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0059186 HSALNT0059186]
| |
| − | |[[LINC00901]]
| |
| − | |LSAMP-AS4,TCONS_00005428,BC040587
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |osteosarcoma;gastric cancer;breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0233366 HSALNT0233366]
| |
| − | |[[HCCAT5]]
| |
| − | |HTA,FJ222407
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290040 HSALNT0290040]
| |
| − | |[[LSINCT5]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |chronic heart failure;colorectal cancer;ovarian cancer;gastric cancer;lung cancer;breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0179611 HSALNT0179611]
| |
| − | |[[DISC1FP1]]
| |
| − | |Boymaw
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |schizophrenia
| |
| − | |Mental Disorders
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217643 HSALNT0217643]
| |
| − | |[[SNHG14]]
| |
| − | |115HG,IC-SNURF-SNRPN,LNCAT,NCRNA00214,U-UBE3A-AT, UBE3A-A, UBE3A-AS1,UBE3AATS
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |Angelman syndrome;cerebral infarction;Prader-Willi syndrome
| |
| − | |Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289273 HSALNT0289273]
| |
| − | |[[TP73-AS1]]
| |
| − | |KIAA0495,PDAM
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |esophageal squamous cell cancer;oligodendroglial tumors;non-small cell lung cancer;glioblastoma;multiple myeloma
| |
| − | |Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290311 HSALNT0290311]
| |
| − | |[[TP53COR1]]
| |
| − | |Trp53cor1
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |prostate cancer;colorectal cancer;hepatocelluar cancer;atherosclerosis;Burkitt lymphoma;chronic lymphocytic leukemia;B cell lymphoma;lung cancer;cervical cancer
| |
| − | |Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289221 HSALNT0289221]
| |
| − | |[[NONHSAT129019]]
| |
| − | |CARLo-3,PCAT8
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |gastric cancer;prostate cancer;glioma;colorectal cancer
| |
| − | |Male Urogenital Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0020131 HSALNT0020131]
| |
| − | |[[PCAT6]]
| |
| − | |KDM5B-AS1,ncRNA-a2,PCAN-R1,KDM5BAS1,onco-lncRNA-96
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |prostate cancer;triple-negative breast cancer;lung cancer
| |
| − | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289277 HSALNT0289277]
| |
| − | |[[TRERNA1]]
| |
| − | |LINC00651,ncRNA-a7,treRNA
| |
| − | |transcriptional regulation
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0014972 HSALNT0014972]
| |
| − | |[[ENST00000416894.1]]
| |
| − | |LINC00568,ncRNA-a1,FAL1
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |ovarian cancer;thyroid cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290008 HSALNT0290008]
| |
| − | |[[Lnc-SNAI1-1:1]]
| |
| − | |Noncoding RNA activating7: ncRNA-a7,ENST00000431460.1,ENSG00000231265,TRERNA1
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290248 HSALNT0290248]
| |
| − | |[[Lnc-BSPH1-1:1]]
| |
| − | |EU035784.1,lnc-BSPH1-1:1
| |
| − | |transcriptional regulation
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289342 HSALNT0289342]
| |
| − | |[[Lnc-ZCCHC13-1:1]]
| |
| − | |NCRNA00183,ENOX,LINC00183,DCBALD06
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289280 HSALNT0289280]
| |
| − | |[[VLDLR-AS1]]
| |
| − | |lincRNA-VLDLR
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288982 HSALNT0288982]
| |
| − | |[[ENST00000602812.1]]
| |
| − | |NCRNA00182,MIR374AHG,LINC00182,FLJ33139
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer;breast cancer;colorectal cancer;hepatocelluar cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091079 HSALNT0091079]
| |
| − | |[[MEF2C-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer;Prader-Willi syndrome and Angelman syndrome
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189341 HSALNT0189341]
| |
| − | |[[PCBP2-OT1]]
| |
| − | |TUC338
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer;tongue squamous cell cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290373 HSALNT0290373]
| |
| − | |[[WRAP53]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer;cancer;dyskeratosis congenita
| |
| − | |Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289265 HSALNT0289265]
| |
| − | |[[NONHSAT112472]]
| |
| − | |LINC00532,lincRNA-NRNA024015
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |esophageal squamous cell cancer;gastric cancer;testicular cancer;aplastic anemia
| |
| − | |Male Urogenital Diseases;Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289175 HSALNT0289175]
| |
| − | |[[NONHSAT081499]]
| |
| − | |MIRHG2,BIC,NCRNA00172
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |B-cell chronic lymphocytic leukemia;chronic lymphocytic leukemia;breast cancer;glioma
| |
| − | |Immune System Diseases;Skin and Connective Tissue Diseases;Neoplasms;Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289051 HSALNT0289051]
| |
| − | |[[LINC00620]]
| |
| − | |NA
| |
| − | |NA
| |
| | |pathogenic process | | |pathogenic process |
| | |cervical cancer | | |cervical cancer |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms | + | |_ |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0120390 HSALNT0120390]
| |
| − | |[[NONHSAT119717]]
| |
| − | |NCRNA00213,HOXA-AS6,RP1-170O19.3,HOXA13-AS1
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |hirschsprung disease;colorectal cancer;prostate cancer;tongue squamous cell cancer;Pancreatic ductal adenocarcinoma;osteosarcoma;hepatocelluar cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;pancreatic cancer;lung cancer;glioma
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289287 HSALNT0289287]
| |
| − | |[[NONHSAT080206]]
| |
| − | |C20orf199,NCRNA00275,ZNFX1-AS1,HSUP1,HSUP2
| |
| − | |transcriptional regulation;ceRNA
| |
| − | |pathogenic process
| |
| − | |gastric cancer;hepatocellular cancer;ductal cancer;colorectal cancer;breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289259 HSALNT0289259]
| |
| − | |[[Lnc-NDFIP1-3:1]]
| |
| − | |SPRIGHTLY
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |prostate cancer;melanoma;glioma;esophageal squamous cell cancer;pre-eclampsia;bladder cancer;renal clear cell cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;lung cancer;breast cancer;cervical cancer;colorectal cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0105595 HSALNT0105595]
| + | |[[THORLNC]] |
| − | |[[Lnc-CDKN1A-1:1]] | |
| − | |PANDA
| |
| | |transcriptional regulation | | |transcriptional regulation |
| | |pathogenic process | | |pathogenic process |
| − | |colorectal cancer;cancer;bladder cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;p53-associated pathological states;breast cancer;renal cell cancer | + | |melanoma, skin squamous cell carcinoma,osteosarcoma, renal cell carcinoma |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
| + | |_ |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0068185 HSALNT0068185]
| |
| − | |[[HTT-AS]]
| |
| − | |HTT-AS1,HTTAS
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Huntington disease
| |
| − | |Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0099036 HSALNT0099036]
| |
| − | |[[HEIH]]
| |
| − | |LINC-HEIH,lncRNA-HEIH,LINC00848,HCCAT2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases | |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222533 HSALNT0222533]
| |
| − | |[[NPTN-IT1]]
| |
| − | |lncRNA-LET
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gallbladder cancer;colorectal cancer;hepatocelluar cancer;esophageal squamous cell cancer;lung squamous cell cancer;nasopharyngeal cancer;gastric cancer;hypoxia;squamous cell lung cancer;cervical cancer
| |
| − | |Pathological Conditions, Signs and Symptoms;Neoplasms;Respiratory Tract Diseases;Stomatognathic Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Digestive System Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289747 HSALNT0289747]
| + | |[[IATPR]] |
| − | |[[DQ786243]] | |
| − | |NA
| |
| | |transcriptional regulation | | |transcriptional regulation |
| | |pathogenic process | | |pathogenic process |
| − | |crohn's disease;colorectal cancer;hepatocelluar cancer | + | |breast cancer, gallbladder cancer |
| − | |Neoplasms;Digestive System Diseases
| + | |_ |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289204 HSALNT0289204]
| |
| − | |[[ENST00000561978.1]]
| |
| − | |PCAT-1,PCA1
| |
| − | |transcriptional regulation;ceRNA
| |
| − | |pathogenic process
| |
| − | |prostate cancer;colorectal cancer;esophageal squamous cell cancer;bladder cancer;hepatocellular cancer;lung cancer
| |
| − | |Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275894 HSALNT0275894]
| |
| − | |[[PCAT14]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211999 HSALNT0211999]
| |
| − | |[[HIF1A-AS2]]
| |
| − | |3'aHIF-1A,aHIF
| |
| − | |translational control
| |
| − | |pathogenic process
| |
| − | |bladder cancer;osteosarcoma;renal cancer;glioblastoma;gastric cancer;acute myocardial infarction;kidney cancer;breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288999 HSALNT0288999]
| |
| − | |[[HIF1A-AS1]]
| |
| − | |5'aHIF-1A,5'aHIF1alpha
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |acute myocardial infarction;non-small cell lung cancer;cardiovascular disease;aortic aneurysm;thoracoabdominal aorta aneurysm;kidney cancer
| |
| − | |Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications | |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289258 HSALNT0289258] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0242280 HSALNT0242280] |
| − | |[[SOX2-OT]] | + | |[[PICART1]] |
| − | |SOX2OT,DKFZp761J1324,NCRNA00043
| |
| | |transcriptional regulation | | |transcriptional regulation |
| | |pathogenic process | | |pathogenic process |
| − | |colorectal cancer;esophageal squamous cell cancer;lung squamous cell cancer;retinal neurodegeneration;neurodevelopmental syndromes associated with the SOX2 locus;hepatocellular cancer;lung cancer;breast cancer;Alzheimer's disease | + | |breast cancer, colorectal cancer, lung cancer |
| − | |Eye Diseases;Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Mental Disorders;Digestive System Diseases;Nervous System Diseases
| + | |_ |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289700 HSALNT0289700]
| |
| − | |[[CDR1-AS]]
| |
| − | |CDR1NAT,ciRS-7,CDR1as
| |
| − | |ceRNA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289149 HSALNT0289149]
| |
| − | |[[LINCMD1]]
| |
| − | |MIR133BHG,LINC-MD1
| |
| − | |ceRNA
| |
| − | |developmental process;pathogenic process
| |
| − | |Duchenne muscular dystrophy
| |
| − | |Musculoskeletal Diseases | |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288894 HSALNT0288894]
| |
| − | |[[BGLT3]]
| |
| − | |LINC01083,BGL3,lncRNA-BGL3
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |chronic myeloid leukemia
| |
| − | |Neoplasms;Hemic and Lymphatic Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289042 HSALNT0289042]
| + | |[[LINC02599]] |
| − | |[[LINC00473]] | |
| − | |C6orf176,bA142J11.1
| |
| | |transcriptional regulation | | |transcriptional regulation |
| | |pathogenic process | | |pathogenic process |
| − | |non-small cell lung cancer;renal cell cancer
| |
| − | |Respiratory Tract Diseases;Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0101681 HSALNT0101681]
| |
| − | |[[LINC01108]]
| |
| − | |LncRNA-ES1
| |
| − | |NA
| |
| − | |developmental process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289418 HSALNT0289418]
| |
| − | |[[TUNAR]]
| |
| − | |LINC00617,TUNA,HI-LNC78
| |
| − | |transcriptional regulation
| |
| − | |developmental process;pathogenic process
| |
| | |breast cancer | | |breast cancer |
| − | |Skin and Connective Tissue Diseases;Neoplasms | + | |_ |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289197 HSALNT0289197]
| |
| − | |[[ENST00000500949.2]]
| |
| − | |cyrano,linc-OIP5
| |
| − | |NA
| |
| − | |developmental process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289046 HSALNT0289046]
| |
| − | |[[Lnc-PRL-6:2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |West Syndrome;West syndrome
| |
| − | |Nervous System Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289656 HSALNT0289656] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0183231 HSALNT0183231] |
| − | |[[BX118339]] | + | |[[ETS1-AS1]] |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |West syndrome
| |
| − | |Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0021726 HSALNT0021726]
| |
| − | |[[LINC00538]]
| |
| − | |Yiya,PROX1UT
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer;cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273249 HSALNT0273249]
| |
| − | |[[CBR3-AS1]]
| |
| − | |PlncRNA-1,PlncRNA1
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |esophageal squamous cell cancer;hepatocellular cancer;prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289179 HSALNT0289179]
| |
| − | |[[NONHSAT130385]]
| |
| − | |LOC554202,hsa-lnc-31,LncHIFCAR
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |bladder cancer;gastric cancer;breast cancer;colorectal cancer;Pancreatic ductal adenocarcinoma
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288925 HSALNT0288925]
| |
| − | |[[NONHSAT096369]]
| |
| − | |KIAA0114,SNHG13,ANCR,AGU2,lncRNA-ANCR
| |
| | |transcriptional regulation | | |transcriptional regulation |
| − | |developmental process;pathogenic process
| |
| − | |prostate cancer;colorectal cancer;osteosarcoma;bone diseases;postmenopausal osteoporosis;hepatocellular cancer;breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Musculoskeletal Diseases;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290329 HSALNT0290329]
| |
| − | |[[Uc.388]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289842 HSALNT0289842]
| |
| − | |[[FR0348383]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289279 HSALNT0289279]
| |
| − | |[[TTTY15]]
| |
| − | |DKFZP434I143,NCRNA00138
| |
| − | |NA
| |
| | |pathogenic process | | |pathogenic process |
| − | |NA | + | |gastric cancer, neuroblastoma |
| − | |NA | + | |_ |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289718 HSALNT0289718]
| |
| − | |[[Lnc-IRX3-4:2]]
| |
| − | |LOC643911,LINC00180,CRNDEP
| |
| − | |transcriptional regulation;ceRNA
| |
| − | |pathogenic process
| |
| − | |gallbladder cancer;colorectal cancer;ovarian cancer;medulloblastoma;chronic lymphocytic leukemia;renal cell cancer;glioma
| |
| − | |Neoplasms;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289685 HSALNT0289685]
| + | |[[MAPK6-DT]] |
| − | |[[CCND1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |tumor;cervical cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289935 HSALNT0289935]
| |
| − | |[[LincRNA-p21]] | |
| − | |NA
| |
| | |transcriptional regulation | | |transcriptional regulation |
| | |pathogenic process | | |pathogenic process |
| − | |lung cancer;cancer | + | |liver cancer |
| − | |Respiratory Tract Diseases;Neoplasms
| + | |_ |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290134 HSALNT0290134]
| |
| − | |[[PCNCR1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289492 HSALNT0289492]
| |
| − | |[[NONHSAT099821]]
| |
| − | |DBE-T,DUX4L30
| |
| − | |transcriptional regulation
| |
| − | |developmental process;pathogenic process
| |
| − | |facioscapulohumeral muscular dystrophy
| |
| − | |Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases | |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289455 HSALNT0289455] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0036655 HSALNT0036655] |
| − | |[[BANCR]] | + | |[[IL1R1-AS1]] |
| − | |LINC00586
| |
| | |transcriptional regulation | | |transcriptional regulation |
| | |pathogenic process | | |pathogenic process |
| − | |osteosarcoma ;lung cancer;melanoma;colorectal cancer;osteosarcoma;esophageal squamous cell cancer;bladder cancer;eosinophilic esophagitis;gastric cancer;hepatocellular cancer;non-small cell lung cancer;retinoblastoma;papillary thyroid cancer | + | |Oral squamous cell carcinoma, breast cancer |
| − | |Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
| + | |_ |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0209589 HSALNT0209589]
| |
| − | |[[ENST00000556013.2]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |papillary thyroid cancer;thyroid cancer
| |
| − | |Endocrine System Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289103 HSALNT0289103]
| |
| − | |[[LINC01268]]
| |
| − | |LOC285758
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA | |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289070 HSALNT0289070] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0001134 HSALNT0001134] |
| − | |[[LINC00887]] | + | |[[LINC01672]] |
| − | |linc-ATP13A4-8,HEIRCC
| |
| | |transcriptional regulation | | |transcriptional regulation |
| | |pathogenic process | | |pathogenic process |
| − | |hypoxic and inflammatory renal epithelial injury;renal clear cell cancer | + | | Esophageal squamous cell carcinoma |
| − | |Male Urogenital Diseases;Neoplasms | + | |_ |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288931 HSALNT0288931]
| |
| − | |[[NONHSAT035954]]
| |
| − | |C14orf167,PRO1488,AS1DHRS4
| |
| − | |transcriptional regulation
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288974 HSALNT0288974] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0135857 HSALNT0135857] |
| − | |[[FENDRR]] | + | |[[SIRLNT]] |
| − | |FOXF1-AS1,TCONS_00024240,lincFOXF1,onco-lncRNA-21
| |
| − | |transcriptional regulation
| |
| − | |developmental process;pathogenic process
| |
| − | |osteosarcoma;gastric cancer;non-small cell lung cancer;lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0106473 HSALNT0106473]
| |
| − | |[[LINC01512]]
| |
| − | |LOC100132354,TCONS_00011120,HI-LNC77
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma;type 2 diabetes
| |
| − | |Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Endocrine System Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289059 HSALNT0289059]
| |
| − | |[[LINC00673]]
| |
| − | |HI-LNC75,HILNC75,LUCAIR1,SLNCR,SLNCR1
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |pancreatic cancer;type 2 diabetes;non-small cell lung cancer;melanoma;Pancreatic ductal adenocarcinoma
| |
| − | |Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Endocrine System Diseases;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289107 HSALNT0289107]
| |
| − | |[[LINC01433]]
| |
| − | |LOC728228
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143571 HSALNT0143571]
| |
| − | |[[NONHSAT129017]]
| |
| − | |CARLo-5,onco-lncRNA-40
| |
| | |ceRNA | | |ceRNA |
| | |pathogenic process | | |pathogenic process |
| − | |gallbladder cancer;glioma;hepatocelluar cancer;ovarian cancer;acute myeloid leukemia;gastric cancer;hepatocellular cancer;non-small cell lung cancer;lung adenocarcinoma;endometrial cancer;lung cancer;breast cancer;colorectal cancer | + | | Breast cancer |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
| + | |_ |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289408 HSALNT0289408]
| |
| − | |[[ENST00000448587.1]]
| |
| − | |ENST00000448587.1,FLJ90734,NCRNA00036,LINC00036,onco-lncRNA-16
| |
| − | |translational control
| |
| − | |pathogenic process;developmental process
| |
| − | |bladder cancer;colorectal cancer;esophageal squamous cell cancer;gastric cancer;skin desease;squamous cell cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289152 HSALNT0289152]
| |
| − | |[[LNCPRESS1]]
| |
| − | |lncPRESS1
| |
| − | |translational control
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289145 HSALNT0289145]
| |
| − | |[[LINC02561]]
| |
| − | |RP11-445P17.8
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |cystic fibrosis
| |
| − | |Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289065 HSALNT0289065]
| |
| − | |[[LINC00850]]
| |
| − | |KUCG1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Duchenne muscular dystrophy
| |
| − | |Musculoskeletal Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289431 HSALNT0289431]
| |
| − | |[[AFAP1-AS1]]
| |
| − | |AFAP1A, AFAP1-A,MGC10981
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;esophageal squamous cell cancer;hepatocellular cancer;nasopharyngeal cancer;lung adenocarcinoma;pancreatic cancer;Barrett's Esophagus;lung cancer
| |
| − | |Neoplasms;Respiratory Tract Diseases;Stomatognathic Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289519 HSALNT0289519]
| |
| − | |[[XACT]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0248684 HSALNT0248684]
| |
| − | |[[GATA6-AS1]]
| |
| − | |locus5689,BM742401
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer;chronic lymphocytic leukemia
| |
| − | |Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289222 HSALNT0289222]
| |
| − | |[[ENST00000430058.1]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |papillary thyroid cancer
| |
| − | |Endocrine System Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289655 HSALNT0289655]
| |
| − | |[[BTG3-AS1]]
| |
| − | |ASBEL
| |
| − | |translational control
| |
| − | |pathogenic process
| |
| − | |ovarian cancer;colorectal cancer
| |
| − | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289224 HSALNT0289224]
| |
| − | |[[NONHSAT130775]]
| |
| − | |NONHSAT130775,PTENpg1,PTEN2,ENSG00000237984
| |
| − | |transcriptional regulation;ceRNA
| |
| − | |pathogenic process
| |
| − | |gastric cancer;prostate cancer;renal cell cancer;cancer;hepatocelluar cancer
| |
| − | |Male Urogenital Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290129 HSALNT0290129]
| |
| − | |[[PAN]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |Kaposi's sarcoma
| |
| − | |Neoplasms;Virus Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289939 HSALNT0289939]
| |
| − | |[[LINC-ROR]]
| |
| − | |lincRNA-RoR,lincRNA-ST8SIA3,ROR
| |
| − | |transcriptional regulation;ceRNA
| |
| − | |pathogenic process
| |
| − | |gallbladder cancer;liver cancer;glioma;malignant melanoma;unveal melanoma;breast cancer;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;pancreatic cancer;endometrial cancer;triple-negative breast cancer;colorectal cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Stomatognathic Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases | |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290322 HSALNT0290322] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0135484 HSALNT0135484] |
| − | |[[UBE3A-ATS]] | + | |[[LINC01605]] |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Angelman syndrome
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091004 HSALNT0091004]
| |
| − | |[[LINC00461]]
| |
| − | |EyeLinc1,Visc-1a,Visc-1b,Visc-2,LOC645323
| |
| − | |NA
| |
| − | |pathogenic process;developmental process
| |
| − | |retinal and visual function
| |
| − | |Eye Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289491 HSALNT0289491]
| |
| − | |[[CTBP1-AS]]
| |
| − | |PCAT10
| |
| | |transcriptional regulation | | |transcriptional regulation |
| | |pathogenic process | | |pathogenic process |
| − | |chronic hepatitis C;prostate cancer;polycystic ovary syndrome | + | |Colon Cancer, Bladder cancer |
| − | |Neoplasms;Male Urogenital Diseases;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases | + | |_ |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0037401 HSALNT0037401] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0184552 HSALNT0184552] |
| − | |[[ENST00000441383.1]] | + | |[[GAU1]] |
| − | |LINC00876,AC096655.1-002
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0120344 HSALNT0120344]
| |
| − | |[[NONHSAT119676]]
| |
| − | |HOXA3as
| |
| | |transcriptional regulation | | |transcriptional regulation |
| | |pathogenic process | | |pathogenic process |
| − | |promyelocytic leukemia;gastric cancer | + | |Neuroblastoma and retinoblastoma |
| − | |Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases | + | |_ |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091313 HSALNT0091313] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287294 HSALNT0287294] |
| − | |[[ENST00000511918.1]] | + | |[[LINC00894]] |
| − | |SCAL1
| |
| | |transcriptional regulation | | |transcriptional regulation |
| | |pathogenic process | | |pathogenic process |
| − | |non-small cell lung cancer;lung cancer | + | |Lung adenocarcinoma |
| − | |Respiratory Tract Diseases;Neoplasms | + | |_ |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289425 HSALNT0289425] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0000250 HSALNT0000250] |
| − | |[[BLACAT1]] | + | |[[LINC02593]] |
| − | |linc-UBC1,LINC00912,onco-lncRNA-30 | + | |_ |
| − | |transcriptional regulation
| |
| | |pathogenic process | | |pathogenic process |
| − | |bladder cancer;gastric cancer | + | |breast cancer, hepatocellular carcinoma |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases | + | |_ |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0149012 HSALNT0149012] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0241060 HSALNT0241060] |
| − | |[[GLIDR]] | + | |[[LINC02594]] |
| − | |LINC01172,MGC21881,TCONS_00015562 | + | |_ |
| − | |NA | + | |_ |
| − | |pathogenic process
| |
| − | |glioblastoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217561 HSALNT0217561]
| |
| − | |[[PWAR5]]
| |
| − | |PAR5,PAR-5
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |glioblastoma;Prader-Willi syndrome and Angelman syndrome;Prader-Willi syndrome
| |
| − | |Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289272 HSALNT0289272]
| |
| − | |[[TP53TG1]]
| |
| − | |TP53AP1,H_RG012D21.9,LINC00096
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer;ataxia telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Nutritional and Metabolic Diseases;Cardiovascular Diseases;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289598 HSALNT0289598]
| |
| − | |[[AK126698]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217598 HSALNT0217598]
| |
| − | |[[NONHSAT041063]]
| |
| − | |NCRNA00002
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |Prader-Willi syndrome
| |
| − | |Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143633 HSALNT0143633]
| |
| − | |[[CCAT2]]
| |
| − | |NCCP1,LINC00873
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer;oral squamous cell cancer;colorectal cancer;ovarian cancer;esophageal squamous cell cancer;bladder cancer;small cell lung cancer;gastric cancer;hepatocellular cancer;prostate cancer;cervical squamous cell cancer;lung cancer;breast cancer;cervical cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289026 HSALNT0289026]
| |
| − | |[[LINC00261]]
| |
| − | |C20orf56,NCRNA00261,bA216C10.1,HCCDR1,TCONS_00027846,ALIEN,DEANR1,onco-lncRNA-17
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |pancreatic cancer;non-small cell lung cancer;gastric cancer
| |
| − | |Respiratory Tract Diseases;Endocrine System Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289078 HSALNT0289078]
| |
| − | |[[LINC00982]]
| |
| − | |FLJ42875
| |
| − | |NA
| |
| − | |pathogenic process
| |
| | |gastric cancer | | |gastric cancer |
| − | |Neoplasms;Digestive System Diseases | + | |_ |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290082 HSALNT0290082]
| |
| − | |[[NEAT1_2]]
| |
| − | |NEAT1_2
| |
| − | |protein localization
| |
| − | |pathogenic process
| |
| − | |amyotrophic lateral sclerosis
| |
| − | |Nutritional and Metabolic Diseases;Nervous System Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288989 HSALNT0288989] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0022481 HSALNT0022481] |
| − | |[[GATA3-AS1]] | + | |[[LINC01705]] |
| − | |NA
| |
| | |transcriptional regulation | | |transcriptional regulation |
| − | |pathogenic process
| |
| − | |renal cell cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289427 HSALNT0289427]
| |
| − | |[[GNG12-AS1]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290395 HSALNT0290395]
| |
| − | |[[YAM1]]
| |
| − | |Yam-1
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process;developmental process
| |
| − | |skeletal myogenesis
| |
| − | |Musculoskeletal Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289202 HSALNT0289202]
| |
| − | |[[PAX8-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |malignant pleural mesothelioma;cervical cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0054469 HSALNT0054469]
| |
| − | |[[RASSF1-AS1]]
| |
| − | |ANRASSF1
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290261 HSALNT0290261]
| |
| − | |[[SUMO1P3]]
| |
| − | |SUMO1P3
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |bladder cancer;gastric cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289002 HSALNT0289002]
| |
| − | |[[HNF1A-AS1]]
| |
| − | |C12orf27,NCRNA00262,FLJ38690,HAS1
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |esophageal adenocarcinoma;osteosarcoma;esophageal squamous cell cancer;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;adenocarcinoma;lung adenocarcinoma;pancreatic cancer
| |
| − | |Neoplasms;Respiratory Tract Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Stomatognathic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289377 HSALNT0289377]
| |
| − | |[[NIPBL-AS1]]
| |
| − | |NIPBL-DT,NIPBL-AS
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |autism spectrum disorder
| |
| − | |Mental Disorders
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289249 HSALNT0289249]
| |
| − | |[[SNHG15]]
| |
| − | |C7orf40,FLJ38860,MYO1GUT,Linc-Myo1g
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer;hepatocellular cancer;hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0235898 HSALNT0235898]
| |
| − | |[[ENST00000574306.1]]
| |
| − | |C17orf91,MGC14376,DKFZp686O06159
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ovarian cancer
| |
| − | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0235898 HSALNT0235898]
| |
| − | |[[ENST00000574306.1]]
| |
| − | |C17orf91,MGC14376,DKFZp686O06159
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288984 HSALNT0288984]
| |
| − | |[[ENST00000579368.1]]
| |
| − | |MTCL1-AS1,HMlincRNA717
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |pancreatic cancer;non-small cell lung cancer;gastric cancer
| |
| − | |Respiratory Tract Diseases;Endocrine System Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289369 HSALNT0289369]
| |
| − | |[[MIF-AS1]]
| |
| − | |LOC284889,MIF-AS
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |malaria;nephrolithiasis
| |
| − | |Skin and Connective Tissue Diseases;Male Urogenital Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Parasitic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0129086 HSALNT0129086]
| |
| − | |[[NONHSAT123382]]
| |
| − | |MKLN1-AS1,FLJ43663,PINT,LincRNA-Pint
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |colorectal cancer;heart failure
| |
| − | |Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289240 HSALNT0289240]
| |
| − | |[[NONHSAT075852]]
| |
| − | |LINC00913,SChLAP1,PCAT11
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |bladder cancer;prostate cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0193241 HSALNT0193241]
| |
| − | |[[SOCS2-AS1]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0138824 HSALNT0138824]
| |
| − | |[[CASC9]]
| |
| − | |ESCCAL-1,ESSCAL1,LINC00981
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |esophageal squamous cell cancer;esophageal cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267627 HSALNT0267627]
| |
| − | |[[HNF4A-AS1]]
| |
| − | |uc002xlx
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289194 HSALNT0289194]
| |
| − | |[[NKILA]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |nasopharyngeal cancer;breast cancer;tongue squamous cell cancer
| |
| − | |Skin and Connective Tissue Diseases;Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289304 HSALNT0289304]
| |
| − | |[[LINC00942]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ovarian cancer;autism spectrum disorder
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Mental Disorders;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289187 HSALNT0289187]
| |
| − | |[[MNX1-AS1]]
| |
| − | |CCAT5,LOC645249
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ovarian cancer;colorectal cancer
| |
| − | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289518 HSALNT0289518]
| |
| − | |[[VPS9D1-AS1]]
| |
| − | |MYU
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ovarian cancer;colorectal cancer
| |
| − | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290266 HSALNT0290266]
| |
| − | |[[TC0101441]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |epithelial ovarian cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289426 HSALNT0289426]
| |
| − | |[[ERLNC1]]
| |
| − | |TC0101441,ElncRNA1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ovarian cancer
| |
| − | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290050 HSALNT0290050]
| |
| − | |[[ENST00000416928.2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0043560 HSALNT0043560]
| |
| − | |[[ENST00000416928.2]]
| |
| − | |HOXD-AS1,Mdgt
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |bladder cancer;neuroblastoma
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289092 HSALNT0289092]
| |
| − | |[[LINC01158]]
| |
| − | |PANTR1,linc-Brn1a,linc-POU3F3
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process;developmental process
| |
| − | |esophageal squamous cell cancer;gastric cancer;glioma
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289448 HSALNT0289448]
| |
| − | |[[GHET1]]
| |
| − | |lncRNA-GHET1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |bladder cancer;gastric cancer;colorectal cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289514 HSALNT0289514]
| |
| − | |[[PEG13]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |intellectual disabilities
| |
| − | |Behavior and Behavior Mechanisms;Pathological Conditions, Signs and Symptoms;Mental Disorders;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289183 HSALNT0289183]
| |
| − | |[[ENST00000414769.1]]
| |
| − | |MGC16121,H19X
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |choriocarcinoma
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289201 HSALNT0289201]
| |
| − | |[[NONHSAT018635]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process;developmental process
| |
| − | |uveal melanoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288956 HSALNT0288956]
| |
| − | |[[LINC01234]]
| |
| − | |LCAL84,onco-lncRNA-32
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |oesophageal squamous cell cancer;breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289021 HSALNT0289021]
| |
| − | |[[CYTOR]]
| |
| − | |C2orf59,NCRNA00152,MGC4677
| |
| − | |transcriptional regulation;ceRNA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer;gastric cancer;hepatocellular cancer;pancreatic cancer;breast cancer;renal cell cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289706 HSALNT0289706]
| |
| − | |[[CHRF]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |cardiac hypertrophy;silicosis
| |
| − | |Respiratory Tract Diseases;Occupational Diseases;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143635 HSALNT0143635]
| |
| − | |[[ENST00000502056.1]]
| |
| − | |LINC00860,CARLo-1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143672 HSALNT0143672]
| |
| − | |[[CASC11]]
| |
| − | |TCONS_00014535,LINC00990,CARLo-7,ENST00000518376
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer;colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289032 HSALNT0289032]
| |
| − | |[[LINC00323]]
| |
| − | |PRED42,FLJ37173
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer;hereditary haemorrhagic telangiectasia
| |
| − | |Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0024655 HSALNT0024655]
| |
| − | |[[LINC01139]]
| |
| − | |LINK-A,TCONS_00000027
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289018 HSALNT0289018]
| |
| − | |[[LEF1-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia;colorectal cancer
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247326 HSALNT0247326]
| |
| − | |[[LINC00667]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hereditary haemorrhagic telangiectasia
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290145 HSALNT0290145]
| |
| − | |[[POU3F3]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |esophageal squamous cell cancer;glioma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0199349 HSALNT0199349]
| |
| − | |[[LINC00426]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |primary Sjögren's syndrome
| |
| − | |Immune System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0155974 HSALNT0155974]
| |
| − | |[[LINC00963]]
| |
| − | |MetaLnc9
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer;renal cell cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289211 HSALNT0289211]
| |
| − | |[[PCF11-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer;adolescent idiopathic scoliosis
| |
| − | |Musculoskeletal Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289534 HSALNT0289534]
| |
| − | |[[91H]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |osteosarcoma;esophageal squamous cell cancer;breast cancer;colorectal cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289446 HSALNT0289446]
| |
| − | |[[ELFN1-AS1]]
| |
| − | |MYCLo-2
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288883 HSALNT0288883]
| |
| − | |[[ACTA2-AS1]]
| |
| − | |uc001kfo.1,ZXF1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289443 HSALNT0289443]
| |
| − | |[[NONHSAT121673]]
| |
| − | |RSBN1L-AS1
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |liver fibrosis;glioblastoma
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289986 HSALNT0289986]
| |
| − | |[[LncRNA-MVIH]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer;non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289977 HSALNT0289977]
| |
| − | |[[LncRNA-ATB]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer;hepatocelluar cancer;gastric cancer;pancreatic cancer;renal cell cancer;pneumoconiosis
| |
| − | |Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Occupational Diseases;Endocrine System Diseases;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289622 HSALNT0289622]
| |
| − | |[[ATB]]
| |
| − | |NA
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |prostate cancer;glioma;keloid;gastric cancer;hepatocellular cancer;pancreatic cancer;breast cancer;colorectal cancer
| |
| − | |Pathological Conditions, Signs and Symptoms;Skin and Connective Tissue Diseases;Neoplasms;Tissues;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289586 HSALNT0289586]
| |
| − | |[[AK057054]]
| |
| − | |NA
| |
| − | |NA
| |
| | |pathogenic process | | |pathogenic process |
| | |gastric cancer | | |gastric cancer |
| − | |Neoplasms;Digestive System Diseases | + | |_ |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0278370 HSALNT0278370]
| |
| − | |[[LINC01315]]
| |
| − | |lnc-C22orf32-1,C22orf32-1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |nasopharyngeal cancer
| |
| − | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0055601 HSALNT0055601]
| |
| − | |[[ADAMTS9-AS2]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer;glioma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289383 HSALNT0289383]
| |
| − | |[[ENST00000608917.1]]
| |
| − | |PACER,PTGS2-AS1
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |osteosarcoma;osteoarthritis;inflammation and cancer
| |
| − | |Musculoskeletal Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289268 HSALNT0289268]
| |
| − | |[[TGFB2-OT1]]
| |
| − | |FLJ11812
| |
| − | |ceRNA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288938 HSALNT0288938]
| |
| − | |[[DUBR]]
| |
| − | |LINC00883
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |asthma and chronic obstructive pulmonary disease
| |
| − | |Respiratory Tract Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290147 HSALNT0290147]
| |
| − | |[[POXCUT]]
| |
| − | |TCONS_00011636
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289440 HSALNT0289440] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0022477 HSALNT0022477] |
| − | |[[Lnc-FOXC1-1:1]] | + | |[[LINC02474]] |
| − | |LINC01379,TCONS_00011636
| |
| | |transcriptional regulation | | |transcriptional regulation |
| − | |pathogenic process
| |
| − | |esophageal squamous cell cancer;basal-like breast cancer;oral squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288924 HSALNT0288924]
| |
| − | |[[CYP51A1-AS1]]
| |
| − | |ENST00000453068,LRRD1-AS1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |renal cell cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289395 HSALNT0289395]
| |
| − | |[[RPL34-AS1]]
| |
| − | |FLJ37673,RP11-462C24.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer;colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289435 HSALNT0289435]
| |
| − | |[[C5orf66-AS1]]
| |
| − | |CTC-276P9.1,Epist
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |esophageal squamous cell cancer;bladder cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289052 HSALNT0289052]
| |
| − | |[[LINC00623]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |nasopharyngeal cancer
| |
| − | |Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289831 HSALNT0289831]
| |
| − | |[[FER1L4]]
| |
| − | |FER1L4
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |gastric cancer;endometrial cancer;colorectal cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288985 HSALNT0288985]
| |
| − | |[[ENST00000426539.1]]
| |
| − | |LINC01458,lncRNA-AC130710
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ovarian cancer;gastric cancer
| |
| − | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288881 HSALNT0288881]
| |
| − | |[[ABHD11-AS1]]
| |
| − | |WBSCR26,LINC00035,NCRNA00035
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer;mutant huntingtin
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0282263 HSALNT0282263]
| |
| − | |[[ZNF674-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289207 HSALNT0289207]
| |
| − | |[[PCAT29]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer;glioma;bladder cancer;renal clear cell cancer;skin melanoma;hepatocellular cancer;lung adenocarcinoma;stomach adenocarcinoma
| |
| − | |Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289672 HSALNT0289672]
| |
| − | |[[CADM1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289297 HSALNT0289297]
| |
| − | |[[LINC01527]]
| |
| − | |lnc-SPRR2D-1,RP1-13P20.6
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289158 HSALNT0289158]
| |
| − | |[[LUNAR1]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |diffuse large B-cell lymphoma;T cell acute lymphoblastic leukemia
| |
| − | |Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289830 HSALNT0289830]
| |
| − | |[[FAR2P-1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma;non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289263 HSALNT0289263]
| |
| − | |[[ENST00000607033.1]]
| |
| − | |EYA4-AS1
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |kidney clear cell sarcoma
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0145373 HSALNT0145373]
| |
| − | |[[MAFA-AS1]]
| |
| − | |RP11-909N17.3,TCONS_00014882
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma;non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290229 HSALNT0290229]
| |
| − | |[[RPLP0P2]]
| |
| − | |RPLP0P2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289291 HSALNT0289291]
| |
| − | |[[ZNF295-AS1]]
| |
| − | |C21orf121,NCRNA00318,PRED87
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma;epithelial ovarian cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0084473 HSALNT0084473]
| |
| − | |[[LINC01513]]
| |
| − | |RP11-1C1.7,TCONS_00009352
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289471 HSALNT0289471]
| |
| − | |[[IRAIN]]
| |
| − | |IGF1R-AS
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |pancreatic cancer;acute myeloid leukemia;non-small cell lung cancer;breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Endocrine System Diseases;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290402 HSALNT0290402]
| |
| − | |[[ZNRD1-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer;lung cancer;cervical cancer
| |
| − | |Respiratory Tract Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289504 HSALNT0289504]
| |
| − | |[[LCAL1]]
| |
| − | |onco-lncRNA-27
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289169 HSALNT0289169]
| |
| − | |[[MHRT]]
| |
| − | |Myheart
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |heart hypertrophy;acute myocardial infarction
| |
| − | |Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289859 HSALNT0289859]
| |
| − | |[[HA117]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hirschsprung disease
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0026673 HSALNT0026673]
| |
| − | |[[ENST00000414795.1]]
| |
| − | |lncRNA-CMPK2
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |chronic hepatitis C;HCV
| |
| − | |Digestive System Diseases;Virus Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289887 HSALNT0289887]
| |
| − | |[[LET]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gallbladder cancer;esophageal squamous cell cancer;gastric cancer;nasopharyngeal cancer;renal cell cancer;cervical cancer
| |
| − | |Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Digestive System Diseases;Stomatognathic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0007921 HSALNT0007921]
| |
| − | |[[NFIA-AS1]]
| |
| − | |RP5-833A20.1
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |atherosclerosis;glioma
| |
| − | |Cardiovascular Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247156 HSALNT0247156]
| |
| − | |[[GAPLINC]]
| |
| − | |LINC01540,TCONS_00026238,lncRNA-uc002kmd.1
| |
| − | |siRNA
| |
| − | |pathogenic process
| |
| − | |gastric cancer;colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288917 HSALNT0288917]
| |
| − | |[[CERNA2]]
| |
| − | |HOST2,lncRNA-HOST2
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer;epithelial ovarian cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289113 HSALNT0289113]
| |
| − | |[[LINC01564]]
| |
| − | |TCONS_00011314
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289088 HSALNT0289088]
| |
| − | |[[LINC01105]]
| |
| − | |FLJ30594,LOC150622
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer;leukemia and neuroblastoma
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289464 HSALNT0289464]
| |
| − | |[[AGAP2-AS1]]
| |
| − | |LOC100130776,PUNISHER
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer;glioma;leukemia and neuroblastoma
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288960 HSALNT0288960]
| |
| − | |[[EWSAT1]]
| |
| − | |TMEM84,NCRNA00277,LINC00277,FLJ33768
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |Ewing sarcoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289242 HSALNT0289242]
| |
| − | |[[SLC25A25-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289317 HSALNT0289317]
| |
| − | |[[KCNK15-AS1]]
| |
| − | |RP11-445H22.4
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |osteoarthritis;breast cancer
| |
| − | |Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289864 HSALNT0289864]
| |
| − | |[[HIF2PUT]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |osteosarcoma;colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289267 HSALNT0289267]
| |
| − | |[[TEX41]]
| |
| − | |DKFZp686O1327,LINC00953
| |
| − | |transcriptional regulation
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290361 HSALNT0290361]
| |
| − | |[[UFC1]]
| |
| − | |NA
| |
| − | |transcriptional regulation;ceRNA
| |
| − | |pathogenic process
| |
| − | |osteoarthritis;hepatocellular cancer
| |
| − | |Musculoskeletal Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289886 HSALNT0289886]
| |
| − | |[[LEIGC]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289367 HSALNT0289367]
| |
| − | |[[MDC1-AS1]]
| |
| − | |MDC1-AS
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |bladder cancer;glioma
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289190 HSALNT0289190]
| |
| − | |[[NBAT1]]
| |
| − | |CASC14,NBAT-1
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |breast cancer;renal clear cell cancer;neuroblastoma
| |
| − | |Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0234826 HSALNT0234826]
| |
| − | |[[LINC00917]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |intervertebral disc degeneration;breast cancer
| |
| − | |Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289419 HSALNT0289419]
| |
| − | |[[LINC00173]]
| |
| − | |NCRNA00173,FLJ42957
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |HIV-1-infected;hepatocelluar cancer
| |
| − | |Virus Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290138 HSALNT0290138]
| |
| − | |[[PEG10]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |diffuse large B-cell lymphoma;esophageal cancer
| |
| − | |Neoplasms;Hemic and Lymphatic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289136 HSALNT0289136]
| |
| − | |[[LINC02224]]
| |
| − | |BRCAT107,ENST00000505706
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |active tuberculosis
| |
| − | |Bacterial Infections and Mycoses
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289866 HSALNT0289866]
| |
| − | |[[HIT]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer;breast cancer
| |
| − | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0003927 HSALNT0003927]
| |
| − | |[[SNHG12]]
| |
| − | |ASLNC04080,C1orf79,LINC00100,NCRNA00100,PNAS-123
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |osteosarcoma;endometrial cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289099 HSALNT0289099]
| |
| − | |[[LINC01225]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290047 HSALNT0290047]
| |
| − | |[[MALAT2]]
| |
| − | |NA
| |
| − | |NA
| |
| | |pathogenic process | | |pathogenic process |
| | |gastric cancer | | |gastric cancer |
| − | |Neoplasms;Digestive System Diseases | + | |_ |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0176345 HSALNT0176345]
| |
| − | |[[NONHSAT021826]]
| |
| − | |LINC00057,NCRNA00057,U22HG,UHG,lncRNA16
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |astrocytoma;hepatocellular cancer;non-small cell lung cancer;Parkinson's disease;neuroblastoma
| |
| − | |Respiratory Tract Diseases;Neoplasms;Digestive System Diseases;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0094592 HSALNT0094592]
| |
| − | |[[WSPAR]]
| |
| − | |TCONS_00009511-XLOC_004555,lncTCF7
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer;liver cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289308 HSALNT0289308]
| |
| − | |[[LINC00511]]
| |
| − | |onco-lncRNA-12
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma;breast cancer
| |
| − | |Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289452 HSALNT0289452]
| |
| − | |[[FAM83H-AS1]]
| |
| − | |onco-lncRNA-3
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289041 HSALNT0289041]
| |
| − | |[[LINC00472]]
| |
| − | |C6orf155,dJ288M22.3,FLJ13189
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ovarian cancer;breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Endocrine System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289925 HSALNT0289925]
| |
| − | |[[Linc-ITGB1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gallbladder cancer;breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0016239 HSALNT0016239]
| |
| − | |[[LINC01133]]
| |
| − | |lncRNA-PAGBC
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer;colorectal cancer;lung squamous cell cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms;Digestive System Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289489 HSALNT0289489] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030809 HSALNT0030809] |
| − | |[[CCEPR]] | + | |[[LINC02590]] |
| − | |CCHE1,lncRNA-CCHE1
| |
| | |transcriptional regulation | | |transcriptional regulation |
| − | |pathogenic process
| |
| − | |hepatocellular cancer;cervical cancer
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289402 HSALNT0289402]
| |
| − | |[[SOX21-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma;oral squamous cell cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288905 HSALNT0288905]
| |
| − | |[[CASC15]]
| |
| − | |LINC00340,lnc-SOX4-1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |basal cell cancer;melanoma;neuroblastoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289555 HSALNT0289555]
| |
| − | |[[AC104699.1]]
| |
| − | |NA
| |
| − | |NA
| |
| | |pathogenic process | | |pathogenic process |
| | |gastric cancer | | |gastric cancer |
| − | |Neoplasms;Digestive System Diseases | + | |_ |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0096322 HSALNT0096322]
| |
| − | |[[CLMAT3]]
| |
| − | |SPARC-AS1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289233 HSALNT0289233]
| |
| − | |[[RGMB-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung adenocarcinoma;non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289908 HSALNT0289908]
| |
| − | |[[LINC01419]]
| |
| − | |LVCAT7,TCONS_00014497
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289541 HSALNT0289541]
| |
| − | |[[AB209630]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hypopharyngeal squamous cell cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289608 HSALNT0289608]
| |
| − | |[[AOC4P]]
| |
| − | |AOC4P
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer;hepatocelluar cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289082 HSALNT0289082]
| |
| − | |[[LINC01021]]
| |
| − | |LINC01021,LOC643401,RP11-46C20.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0196121 HSALNT0196121]
| |
| − | |[[LINC01089]]
| |
| − | |LIMT
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer;astrocytoma
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0123080 HSALNT0123080]
| |
| − | |[[EGFR-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289539 HSALNT0289539] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0170966 HSALNT0170966] |
| − | |[[AB073614]] | + | |[[MUC5B-AS1]] |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ovarian cancer;glioma
| |
| − | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0242418 HSALNT0242418]
| |
| − | |[[CACNA1G-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |keloid
| |
| − | |Pathological Conditions, Signs and Symptoms;Skin and Connective Tissue Diseases;Tissues
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0170814 HSALNT0170814]
| |
| − | |[[MIR210HG]]
| |
| − | |NA
| |
| | |transcriptional regulation | | |transcriptional regulation |
| | |pathogenic process | | |pathogenic process |
| − | |hypoxic and inflammatory stress | + | | lung adenocarcinoma |
| − | |NA | + | |_ |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288979 HSALNT0288979] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275151 HSALNT0275151] |
| − | |[[FOXC2-AS1]] | + | |[[FAM230D]] |
| − | |ODRUL | + | |_ |
| − | |NA | + | |_ |
| − | |pathogenic process | + | |_ |
| − | |osteosarcoma | + | |_ |
| − | |Neoplasms
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289022 HSALNT0289022] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275163 HSALNT0275163 ] |
| − | |[[LINC00160]] | + | |[[FAM230E]] |
| − | |C21orf52,NCRNA00160 | + | |_ |
| − | |NA | + | |_ |
| − | |pathogenic process | + | |_ |
| − | |breast cancer | + | |_ |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0105274 HSALNT0105274] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275179 HSALNT0275179 ] |
| − | |[[LINC01016]] | + | |[[FAM230F]] |
| − | |NA | + | |_ |
| − | |NA | + | |_ |
| − | |pathogenic process | + | |_ |
| − | |breast cancer | + | |_ |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288904 HSALNT0288904]
| |
| − | |[[CARMN]]
| |
| − | |MIR143HG,CARMEN
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |cardiac differentiation
| |
| − | |Cardiovascular Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289123 HSALNT0289123] | + | |[[FAM230G]] |
| − | |[[LINC01630]]
| + | |_ |
| − | |LOC100287225
| + | |_ |
| − | |NA
| + | |_ |
| − | |pathogenic process
| + | |_ |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288971 HSALNT0288971]
| |
| − | |[[FAM30A]]
| |
| − | |C14orf110,KIAA0125,HSPC053
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |gallbladder cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289506 HSALNT0289506]
| |
| − | |[[LINC00346]]
| |
| − | |C13orf29,NCRNA00346
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer;breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289643 HSALNT0289643]
| |
| − | |[[BC032469]]
| |
| − | |NA | |
| − | |ceRNA
| |
| − | |pathogenic process | |
| − | |esophageal squamous cell cancer;gastric cancer | |
| − | |Neoplasms;Digestive System Diseases | |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289580 HSALNT0289580]
| |
| − | |[[AK024171]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |intervertebral disc degeneration;gastric cancer
| |
| − | |Musculoskeletal Diseases;Neoplasms;Digestive System Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290187 HSALNT0290187]
| + | |[[FAM230H]] |
| − | |[[RP11-284N8.3.1]] | + | |_ |
| − | |NA | + | |_ |
| − | |NA
| + | |Papillary thyroid carcinoma |
| − | |pathogenic process | + | |_ |
| − | |ovarian cancer | |
| − | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289839 HSALNT0289839]
| |
| − | |[[FMR6]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |fragile X syndrome;fragile X-associated premature ovarian insufficiency
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Female Urogenital Diseases and Pregnancy Complications;Nervous System Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290152 HSALNT0290152]
| + | |[[FAM230I]] |
| − | |[[PRAL]] | + | |_ |
| − | |lncRNA-PRAL | + | |_ |
| − | |NA
| + | |_ |
| − | |pathogenic process | + | |_ |
| − | |hepatocellular cancer;lung cancer | |
| − | |Respiratory Tract Diseases;Neoplasms;Digestive System Diseases | |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289380 HSALNT0289380] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275150 HSALNT0275150] |
| − | |[[NORAD]] | + | |[[FAM230J]] |
| − | |LINC00657 | + | |_ |
| − | |transcriptional regulation;translational control | + | |_ |
| − | |pathogenic process | + | |_ |
| − | |breast cancer | + | |_ |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0086803 HSALNT0086803] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0103387 HSALNT0103387] |
| − | |[[LIFR-AS1]] | + | |[[HCG14]] |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |preterm
| |
| − | |Female Urogenital Diseases and Pregnancy Complications
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0076183 HSALNT0076183]
| |
| − | |[[PANCR]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |atrial fibrillation
| |
| − | |Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288975 HSALNT0288975]
| |
| − | |[[FEZF1-AS1]]
| |
| − | |NA
| |
| | |transcriptional regulation | | |transcriptional regulation |
| | |pathogenic process | | |pathogenic process |
| − | |gastric cancer;colorectal cancer | + | |Celiac disease, Nutritional and Metabolic Diseases |
| − | |Neoplasms;Digestive System Diseases | + | |_ |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0238475 HSALNT0238475] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0001419 HSALNT0001419] |
| − | |[[CCDC144NL-AS1]] | + | |[[LNCTAM34A]] |
| − | |NA
| |
| | |ceRNA | | |ceRNA |
| − | |pathogenic process
| |
| − | |ovarian cancer;cardiac hypertrophy
| |
| − | |Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Cardiovascular Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290102 HSALNT0290102]
| |
| − | |[[NR_026689]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ovarian cancer;lung cancer
| |
| − | |Respiratory Tract Diseases;Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289522 HSALNT0289522]
| |
| − | |[[ADARB2-AS1]]
| |
| − | |C10orf109,NCRNA00168,bA466B20.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer;pancreatic ductal adenocarcinoma
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288936 HSALNT0288936]
| |
| − | |[[DPP10-AS1]]
| |
| − | |BC032913
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |breast cancer;colorectal cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289474 HSALNT0289474]
| |
| − | |[[GAS8-AS1]]
| |
| − | |C16orf3
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |papillary thyroid cancer;breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Endocrine System Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289063 HSALNT0289063]
| |
| − | |[[LINC00704]]
| |
| − | |LINC00704
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289238 HSALNT0289238]
| |
| − | |[[SAMMSON]]
| |
| − | |LINC01212
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |melanoma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289027 HSALNT0289027]
| |
| − | |[[LINC00302]]
| |
| − | |C1orf46,NCRNA00302,XP33
| |
| − | |NA
| |
| | |developmental process | | |developmental process |
| − | |NA | + | |Colon Cancer |
| − | |NA | + | |_ |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0245543 HSALNT0245543]
| |
| − | |[[SNHG20]]
| |
| − | |C17orf86,NCRNA00338,LINC00338,PRO0872,FLJ25582,DKFZp686L05235,SCARNA16HG
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer;colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0015631 HSALNT0015631]
| |
| − | |[[DCST1-AS1]]
| |
| − | |RP11-307C12.11
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ovarian cancer
| |
| − | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0149810 HSALNT0149810]
| + | |[[LINC01510]] |
| − | |[[PGM5-AS1]] | + | |transcriptional regulation, ceRNA |
| − | |FAM233A,LOC572558 | |
| − | |NA
| |
| | |pathogenic process | | |pathogenic process |
| − | |bladder cancer | + | |Colorectal cancer, Non-small cell lung cancer |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms | + | |_ |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290236 HSALNT0290236]
| |
| − | |[[SBF2-AS1]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290325 HSALNT0290325]
| + | |[[LNCOC1]] |
| − | |[[Uc.338]] | |
| − | |NA
| |
| | |transcriptional regulation | | |transcriptional regulation |
| | |pathogenic process | | |pathogenic process |
| − | |hepatocellular cancer;lung cancer | + | |Ovarian cancer |
| − | |Respiratory Tract Diseases;Neoplasms;Digestive System Diseases
| + | |_ |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289973 HSALNT0289973]
| |
| − | |[[LNCRI]]
| |
| − | |lnc-RI
| |
| − | |ceRNA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA | |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290002 HSALNT0290002]
| |
| − | |[[LOC100130476]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |esophageal squamous cell cancer;gastric cardia adenocarcinoma
| |
| − | |Neoplasms
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289049 HSALNT0289049] | + | |[[LGALSL-DT]] |
| − | |[[Lnc-TNKS-1:1]]
| |
| − | |Rncr3
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |diabetes
| |
| − | |Endocrine System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0020406 HSALNT0020406]
| |
| − | |[[LINC00628]]
| |
| − | |NA
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |gastric cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289478 HSALNT0289478]
| |
| − | |[[DSCR4]]
| |
| − | |DCRB
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Down syndrome
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0017675 HSALNT0017675]
| |
| − | |[[GAS5-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |oral submucous fibrosis;non-small cell lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms;Stomatognathic Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289523 HSALNT0289523]
| |
| − | |[[HCG11]]
| |
| − | |bK14H9.3,FLJ14049,FLJ30357
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |prostate cancer
| |
| − | |Male Urogenital Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0134828 HSALNT0134828]
| |
| − | |[[LINC02099]]
| |
| − | |AC145110.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |rheumatoid arthritis;breast cancer
| |
| − | |Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0209098 HSALNT0209098]
| |
| − | |[[G2E3-AS1]]
| |
| − | |CAT1647
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |bladder cancer
| |
| − | |Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289139 HSALNT0289139]
| |
| − | |[[LINC02245]]
| |
| − | |lnc-SERTAD2-3,AC007386.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |ovarian cancer
| |
| − | |Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0008167 HSALNT0008167]
| |
| − | |[[FOXD3-AS1]]
| |
| − | |pasFOXD3
| |
| − | |transcriptional regulation
| |
| − | |pathogenic process
| |
| − | |glioma
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289335 HSALNT0289335]
| |
| − | |[[LINC00998]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |major depression disorder
| |
| − | |Behavior and Behavior Mechanisms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289379 HSALNT0289379]
| |
| − | |[[NNT-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0055497 HSALNT0055497]
| |
| − | |[[PSMD6-AS1]]
| |
| − | |ENST00000462717,lnc00462717
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |papillary thyroid cancer;glioma
| |
| − | |Endocrine System Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289130 HSALNT0289130]
| |
| − | |[[LINC02081]]
| |
| − | |CTD-2357A8.3,XLOC_012582
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |esophageal cancer
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289306 HSALNT0289306]
| |
| − | |[[LINC00052]]
| |
| − | |TMEM83,NCRNA00052,FLJ31461
| |
| − | |ceRNA
| |
| − | |pathogenic process
| |
| − | |hepatocellular cancer;breast cancer
| |
| − | |Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0199070 HSALNT0199070]
| |
| − | |[[PLUT]]
| |
| − | |PDX1-AS1,PLUTO,HI-LNC71
| |
| | |transcriptional regulation | | |transcriptional regulation |
| | |pathogenic process | | |pathogenic process |
| − | |type 2 diabetes | + | |Postmenopausal osteoporosis (PMOP) |
| − | |Nutritional and Metabolic Diseases;Endocrine System Diseases | + | |_ |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289341 HSALNT0289341]
| |
| − | |[[LINC01505]]
| |
| − | |RP11-308N19.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| | |- | | |- |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289315 HSALNT0289315] | + | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0002862 HSALNT0002862] |
| − | |[[LINC01116]] | + | |[[LINC02596]] |
| − | |TALNEC2
| |
| | |transcriptional regulation | | |transcriptional regulation |
| | |pathogenic process | | |pathogenic process |
| − | |prostate cancer;glioblastoma | + | |Postmenopausal osteoporosis (PMOP) |
| − | |Male Urogenital Diseases;Neoplasms | + | |_ |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0006439 HSALNT0006439]
| |
| − | |[[FOXD2-AS1]]
| |
| − | |MGC12982
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |lung cancer
| |
| − | |Respiratory Tract Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0252387 HSALNT0252387]
| |
| − | |[[LINC00305]]
| |
| − | |C18orf20,NCRNA00305,MGC39571,HsT1235
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289473 HSALNT0289473]
| |
| − | |[[FBXL19-AS1]]
| |
| − | |NCRNA00095,MGC125469,MGC125470,MGC125472
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |colorectal cancer
| |
| − | |Neoplasms;Digestive System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0187807 HSALNT0187807]
| |
| − | |[[LINC02555]]
| |
| − | |AC079630.2
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |papillary thyroid cancer
| |
| − | |Endocrine System Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0251493 HSALNT0251493]
| |
| − | |[[LINC01929]]
| |
| − | |CTD-2171N6.1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |papillary thyroid cancer
| |
| − | |Endocrine System Diseases;Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0244776 HSALNT0244776]
| |
| − | |[[LINC01152]]
| |
| − | |TCONS_00025128,CMPD
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0284591 HSALNT0284591]
| |
| − | |[[DIAPH2-AS1]]
| |
| − | |NA
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Hodgkin's disease
| |
| − | |Neoplasms
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289226 HSALNT0289226]
| |
| − | |[[PWAR1]]
| |
| − | |PAR1,PAR-1
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |Prader-Willi syndrome and Angelman syndrome
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289339 HSALNT0289339]
| |
| − | |[[LINC00950]]
| |
| − | |FP588
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289740 HSALNT0289740]
| |
| − | |[[DGCR12]]
| |
| − | |DGS-E
| |
| − | |NA
| |
| − | |pathogenic process;developmental process
| |
| − | |DiGeorge syndrome
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Endocrine System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275220 HSALNT0275220]
| |
| − | |[[DGCR9]]
| |
| − | |DGS-A,POM121L5P
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |DiGeorge syndrome
| |
| − | |Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Endocrine System Diseases
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288929 HSALNT0288929]
| |
| − | |[[DGCR10]]
| |
| − | |DGS-B
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| − | |-
| |
| − | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289494 HSALNT0289494]
| |
| − | |[[DGCR11]]
| |
| − | |DGS-D
| |
| − | |NA
| |
| − | |pathogenic process
| |
| − | |NA
| |
| − | |NA
| |
| | |- | | |- |
| − | |} | + | |_ |
| | + | |[[DEC1]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[RN7SK]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[RN7SL1]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[MYOPARR]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[PCED1B-AS1]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[UMLILO]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[LINC02631]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[BMNCR]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[ZEBTR]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[SNHG31]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[ILF3-DT]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[LINC00574]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[CEBPA-DT]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[BABAM2-AS1]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[SNHG30]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[RCC2-AS1]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[NIPBL-DT]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[PRDM16-DT]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[BCL6-AS1]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[C1orf220]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[MIR122HG]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[RB1-DT]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[PANTR1]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[C11orf72]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[CT66]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[CAPN10-DT]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[MIR1915HG]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[CT75]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[MIR9-3HG]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[RN7SL2]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[RN7SL3]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[CT70]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[CT69]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[FLVCR1-DT]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[C10orf91]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[CEP83-DT]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[CSTF3-DT]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[CTBP1-DT]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[FAM201B]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[MAFG-DT]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[RPP38-DT]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[CDRT3]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |[[DLEU2L]] |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
| | + | |_ |
